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Rebecca JM Goss 
This thesis explores the biosynthesis of two secondary metabolites, fluoroacetate 
and longianone, and involves the synthesis and feeding of deuterated putative 
intermediates. 
The bacterium Streptomyces cattleya produces fluoroacetate and 4-
fluorothreonine; the mechanism by which C-F bond formation occurs is 
unknown. The stereochemistry of the fluorination event was investigated by 
feeding [2,2,3,3-^H4]-succinate and (27?)-[l-^H2]- and (25)-[l-^Hz]-glycerols. The 
chirality of the resultant [2-^H]-fluoroacetate was determined by chiral liquid 
crystal ^H-NMR and the fluorination was demonstrated to proceed with 
retention of stereochemistry. 
Longianone is produced by the slow growing fungus Xylaria longiana. This 
simple bicyclic metabolite is an isomer of the notorious fiingal toxin patulin. 
Putative deuterated intermediates were administered to the fungus and the 
longianone produced analysed by ^H-NMR. It was demonstrated that longianone 
is biosynthesised from 6-methylsalicylic acid in a pathway closely related to that 
found in patulin biosynthesis. 
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C H A P T E R 1 
Introduction 
C H A P T E R 1 
Introduction 
1.1 Secondary metabolism 
1.1.1 Primary and secondary metabolism 
In the early 19* century, at the birth of biochemistry as a distinct field of study, the 
scientific community believed that living matter was composed of a substance that 
was qualitatively very different to that of non-living matter. There existed a notion 
that the substance of living matter disobeyed the known laws of physics and 
chemistry. It must have come as something of a surprise to a colleague of Friedrich 
Wohler, when in 1828 he received a letter fi-om the aforementioned, excitedly stating: 
" I must tell you that I can prepare urea without requiring a kidney or an animal, either 
man or dog."^ Wohler's laboratory preparation of urea, by heating ammonium 
cyanate, is the first documented example of an organic compound, a substance 
previously only found in living systems, being formed fi-om an inorganic salt which 
had not originated fi-om an organism. At the time, this novel discovery had little effect 
in dispelling the persistent belief in vitalism, a theory which held that certain reactions 
could only take place in living organisms. 
Today, primary metabolism has been almost fiilly elucidated. It exists as an intricate 
network of enzyme-catalysed cycles and pathways driven by adenosine triphosphate 
(ATP), the universal energy currency of the cell. From the meagre beginning of 
carbon dioxide, photosynthesis generates glucose, which is converted by the plant and 
its consumers to a wealth of diverse compounds known as primary metabolites. 
Primary metabolites include amino acids, sugars, acetyl-coenzyme A, fatty acids, 
mevalonic acid, and nucleotides. These compounds are essential to the growth and 
existence of the organism that produces them. The pathways producing the primary 
metabolites may be found in similar, though not identical forms, in all living 
organisms; the obvious exception being photosynthesis, which is unique to plants and 
phototrophic bacteria. 
The mystery that once surrounded "organic" molecules as a whole, to some extent 
remains with secondary metabolites. Though named "secondary metabolites", 
idiolites or natural products, are perhaps more suitable names. There is nothing 
secondary in terms of these compounds' biological significance and their usefulness 
to mankind. Since prehistoric times plant extracts have been used to drug, heal and 
kiU. Calabar beans and hemlock were used as judicial poisons and curare on the tips 
of poisoned arrows. In Shakespeare's play, "Romeo and Juliet", a visit to an 
apothecary is made to purchase a fatal poison,^ whilst Friar Laurence supplies Juliet 
with a plant extract which sends her into a death like coma.^  Famously, fi-ankincense, 
the sweet resin fi'om a spruce tree, and myrrh, a bitter aromatic transparent gum of use 
as a perfimie and a medicine were presented by the magi at the birth of Christ."* The 
use of natural products is not restricted to history and folk law. Today, we rely upon 
many natural products as medicines to combat a range of illnesses. 
The definition of a secondary metabolite has stimulated considerable debate. The 
compounds perform a variety of different roles fi-om antibiotics to sex attractants, trail 
markers and antifoulants and antifeedants. Unlike primary metabolites, they have a 
restricted distribution and are often characteristic of individual species or strains. 
Their structure and size range fi'om small simple molecules to the large and extremely 
elaborate. 
A. L. Demain proposes that the simplest criterion by which to classify a secondary 
metabolite is that i f you eliminate a secondary metabolic pathway, the organism will 
continue to grow.^ In contradiction to this definition is the compound lanosterol, 
biosynthesised by sheep and excreted as a waterproofing agent. By itself, lanosterol is 
not essential to the existence of the sheep but it is an intermediate on the biosynthetic 
pathway to cholesterol, without which the sheep would die. Though secondary 
metabolites are biosynthesised from compounds produced in primary metabolism, it is 
not always the case that their synthesis is delayed until the cessation of growth, one 
notable example would be the production of idiolites by immature plants. In general, 
primary metabolites do not accumulate but are present in the organism at a low steady 
state concentration. However, the use of such a definition becomes contradictory in 
the case of yeasts, which produce alcohol as part of their growth process and yet use it 
to inhibit other forms of life. 
To use Occam's razor, it should be stated that a secondary metabolite, whilst having 
no significant role in the internal economy of the producing organism, imparts the 
producer with an increased evolutionary fitness by its ability to protect itself and 
interact with its external surroundings. 
So how did these natural products arise? Some theories suggest that natural products 
are merely shunt metabolites, an organism's method of removing toxins arising from 
secondary metabolism,^ whilst others propose that they are designed in an organism's 
molecular playground.^ However, many idiolites are highly complex and energetically 
very costly to produce, being encoded by many thousands of kilobases. The genetic 
code for "successfiil" natural products, has, in cases, been conserved for thousands of 
millions of years.^  One would expect natural selection to work to obtain the desired 
physiological response at the minimum cost to the producer, but in some cases the 
natural products are so sophisticated that their interaction with the target sites mirror 
those between enzymes and their substrates. Such relationships are clearly not 
accidental. 
The various groups of secondary metabolites may be classified by their biosynthetic 
origin. Fatty acids and their derivatives (e.g. prostaglandins) originate from the 
iterated decarboxylative condensation of malonyl extender units followed by a 
reduction an elimination and a fiarther reduction, consecutively. The keto group is 
reduced to a hydroxyl, water is eliminated producing a double bond in the carbon 
chain which is then saturated (see section 5.4). Polyketides are formed in a very 
similar manner, although the reduction of the polyketone backbone is not complete as 
in the case of the fatty acids; it may stop at any one of the three stages (see section 
5.5). The intermediates formed by the partial reductions may undergo cyclisations and 
aromatisations. The fact that most polyketide synthase (PKS) and fatty acid synthase 
(FAS) genes have a common evolutionary origin is suggested by a significant level of 
sequence homology, irrespective of their host. Some surprising findings have been 
made, however, in that the P. patulum PKS is genetically closer to a vertebrate FAS 
than its own fiingal FAS.^ This is not a case in isolation as the erythromycin 
producing PKS from Saccharopolyspora erythraea has the same order of active sites 
and general organisation as a vertebrate FAS. 
Other classes of secondary metabolites include the alkaloids and non ribosomal 
polypeptides, which both originate from the pool of aminoacids supplied by primary 
metabolism, and isoprenoids, which are formed by two discrete pathways utilising 
either deoxyxylulose or mevalonic acid as the starting material. 
1.1.2 Secondary metabolism in microbial systems 
Phase dependent biosynthesis of secondary metabolites is particularly apparent in 
micro-organisms. When the micro-organism is first introduced into a complex growth 
media there is a lag period before cell growth commences. Once the cells from the 
initial inoculum are established in primary metabolism, cell division and exponential 
growth occur, this is known as the tropophase. The tropophase continues until most of 
the available nutrients have been consumed. At this stage cell death begins and the 
idiophase has been entered. The factors instigating the production of the idiolites are 
complex and not well understood. The rate of growth is known to be important. A 
deficiency in nutrients is also significant, one piece of evidence for this is that few 
secondary metabolites are produced by bacteria living within the gut where there is a 
continuous and plentifiil supply of nutrients. It is highly likely that other different 
factors stimulate various organisms into secondary metabolite production, for 
instance, Streptomyces cattleya requires both a reduced growth rate and a phosphate 
deficiency to produce its antibiotic, thienamycin. 
Once faced by these unfavourable conditions, the organism seeks to maximise its 
chances of survival by becoming involved in secondary metabolism and sporulation. 
Secondary metabolism provides the chemical weapons with which to eliminate any 
other microorganism competing for the dwindling nutrient supply, whilst sporulation 
produces heat resistant cells, which may remain dormant until the organism is, once 
more, in a favourable growth environment. These two events occur concomitantly and 
in the Streptomyces spp. there is evidence that this is not just a coincidence as both are 
controlled by the same genes, known as "pleiotropic switches". 
It is likely that evolution dictates that such organisms only produce their natural 
products in the idiophase as many have antibiotic activity. Often resistance genes are 
clustered next to those encoding for the toxin, but these resistance mechanisms are 
inducible, and it is possible that the antibiotic could kill the producing culture i f 
manufactured too early. 
1.2 Methods of investigating the biosynthesis of secondary metabolites 
There are two questions to be asked when investigating the biosynthesis of a 
secondary metabolite; firstly, from which primary metabolite does it have its origin 
and secondly, by what mechanisms and through which intermediates is it processed? 
The structures of the secondary metabolites often hold many clues which allow 
speculation to the answers of both these questions. Large numbers of secondary 
metabolites are formed from one or two repeating units and compounds of polyketide 
or terpenoid origin are often easUy identified. Other metabolites of similar structure, 
produced by the same or related species, are also helpfiil in predicting a possible 
biosynthesis. These speculations may be tested by a variety of methods now available 
to the chemist and biochemist. 
1.2.1 Inhibition of enzymes 
One method of determining the unknown intermediates upon a biosynthetic pathway 
is by using enzymatic inhibitors. A biosynthetic sequence may be summarised as:-
A ^ B ^ C ^ D where D is the secondary metabolite under investigation and A, B and 
C are the unknown intermediates. I f an enzyme that is responsible for catalysing the 
conversion of C to D is inhibited, it is probable that unknown intermediate C will 
accumulate in sufficient quantities to be analysed, providing that C is not too unstable. 
' .0 
'"''I 
Fig 1.1 Chaetoglobosin A (1.1) and metvrapone (1.2) 
In this manner the biosynthesis of chaetoglobosin A (1.1), produced by Chaetomium 
subaffine^ was investigated. Chaetoglobosin A exhibits a considerable degree of 
oxidation, the workers thought it likely that the oxidative enzyme responsible was a 
cytochrome P-450. By using metyrapone (1.2), an inhibitor that blocks the P-450 
enzyme, though not completely, a range of precursors accumulated in quantities large 
enough to be analysed, and the respective levels of each of the partially oxidised 
precursors provided information as to the sequence of the oxidations.'^ The same 
approach was used by Steven J Gould and co-workers in isolating the precursors of 
blasticidin S (1.3) in Streptomyces griseochromogenes}^ The bioavailability of L-a-
arginine was reduced by using L-a-arginine biosynthetic inhibitors. Transaminase and 
methyl transferase inhibitors were also employed to block transamination and A^ -
methylation, respectively. Using this strategy, it was possible for the workers to 
observe and identify previously unknown intermediates and thereby elucidate the 
biosynthesis of the compound. 
o 
NH m2 O HO2C 
H2N N ^ N 
^ • H 
1.3 
Fig. 1.2 Blasticidin S a.3) 
1.2.2 Genetic mutations 
Rather than using an enzymatic inhibitor to block the biosynthetic pathway and 
accumulate precursors of the compound being investigated, it is also possible to 
disable enzyme expression at the genetic level. Mutations of the wild type organism 
may be effected by using UV, X-ray or chemical mutagenesis. The mutations 
generated by these methods are random and genes encoding for the enzymes involved 
in primary metabolism may also undergo mutations leading to the death of the 
organism. As the genes encoding for a polyketide are often clustered, more 
sophisticated techniques may be employed to cause mutations to specific genes, 
disabling specific enzymes so that their substrates may be elucidated. 
Polyketides have been subject to significant investigation at the genetic level. One 
reason for this is the desire for a thorough understanding of how these complex and 
often bioactive molecules are constructed such that fiirther molecules, of potential 
pharmaceutical use, may be made using a combinatorial genetic approach. 
Though the fimgal polyketide synthase (PKS), 6-methylsalicylic acid (6MSA) 
synthase, was the first functional polyketide synthase to be isolated, the majority of 
the genetic studies on the PKSs have involved bacterial systems. These investigations 
have revealed that all of the genes encoding for the antibiotic, and resistance to it, 
tend to be clustered together. These systems, therefore, readily facilitate over 
expression and cloning. 
As with fatty acid synthases (FASs), PKSs may be classified as type I or type I I . Type 
I PKSs are giant multiftmctional enzymes containing different sets of active sites for 
each round of polyketide chain extension; type I I PKSs consist of a few largely 
monofimctional enzyme subunits which cluster together into a complex. 
The erythromycin PKS (6-deoxyerythronolide B synthase (DEBS)), has become the 
workhorse of many chemists and geneticists trying to develop a greater understanding 
as to how the PKSs fiinction. DEBS, a type I PKS, is responsible for the sequential 
condensation and reduction cycles of propionyl Co-A with six units of malonyl Co-A 
generating the enzyme free intermediate 6-deoxyerythronolide B (1.4). This 
macrolide is fiirther tailored to generate a series of active antibiotics. Genetic 
sequencing has revealed three large open reading frames (ORFs) eryAI, eryAII, and 
eryAIII encoding for the giant multiftmctional proteins ("cassettes") DEBSl, DEBS2 
and DEBS3, respectively.^^' Each cassette of DEBS contains two modules, each of 
which is able to mediate a condensation event followed by the appropriate number of 
reductive transformations. The three cassettes fiinction together as an assembly line to 
which the intermediates remain bound by thioester links. 
r 
eryAI eryAII 
r 
eryAIII 
module 1 module 2 module 3 module 4 module 5 module 6 
t Al ACH A! KR ACP KS A! KH y^CP ; T 
s s s 
/ H O ^ HOi . 
K5 AT DH ER KK ACP 
A T = acyltransferase 
A C P = acylcarrier protein 
K S = p-keto-ACP synthase 
KR = p-keto-ACP reductase 
DH = dehydrogenase 
E R = enoyi reductase 
T E = thioesterase 
1.4 
= / • O : 
Scheme 1.1 The assembly of 6-deoxythronolide B (1.4) 
To investigate how the PKS functions, domains have been relocated along the gene. 
The first experiment of this type was the repositioning of the thioesterase, the final 
catalytic site on DEBS3, to the terminus of DEBSl.^^ This modified PKS resulted in 
the termination of the biosynthesis at the end of module 2, the polyketide chain was 
lactonised and released by the thioesterase domain to form the novel metabolite 
(3S,5R)-dihydToxy-(2R, 4i?)-dimethyl-«-heptanoic acid-5-lactone (1.5). This truncated 
form of the erythromycin polyketide synthase is known as "DEBS 1-TE" and is a 
usefiil tool with which to perform in-vitro mechanistic studies. 
eryAI 
A r 
module 1 module 2 
I Al AUH KS Al KK ACP KS A 
s s 
  l KK /j^ CP ibS OH 
^ O ^ O 
1.5 
Scheme 1.2 The truncated erythromycin polyketide svnthase DEBS 1 TE 
Other genetic manipulations of the PKSs include substituting the loading modules to 
facilitate the production of a range of molecules with different starter units. One 
example of this is the incorporation of the loading module from the avermectin PKS 
into the DEBS 1 TE construct to produce lactones 1.6 and 1.7.^^ 
OH OH 
^-•^0^0 0 ^ 0 
1.6 I 1.7 
Fig 1.3 Novel lactones 1.6 and 1.7 produced by incorporating the loading module 
from the avermectin PKS into the DEBS 1 TE construct 
1.2.3 Radioisotopic labelling studies 
One of the more classical methods of investigating the biosynthesis of secondary 
metabolites has involved using radioisotopes. A compound, which is thought to be an 
intermediate on a biosynthetic pathway, is synthesised containing a radioisotope such 
as "^^ C, ^H, or ^^ P. After feeding of the "labelled" putative precursor to the producing 
organism, the resultant secondary metabolite is analysed by scintillation counting to 
determine whether the fed material has become incorporated. 
One particular advantage of this technique is that it is very sensitive and even very 
low levels of incorporation may be recorded. In addition, the half life of '"^ C is 5600 
years and that for is 12.26 years so a reduction in the count due to decay may be 
neglected. 
However, the feeding of radiolabelled precursors does not directly yield site specific 
information. In order to determine where the radiolabel is incorporated in the 
metabolite, each carbon (hydrogen, or phosphorus) must be essentially carved out 
from the metabolite, by a series of degradation reactions, and then analysed. Because 
the degree of sensitivity is so high, the metabolite and any degradation products must 
be rigorously purified prior to analysis to prevent any cross contamination of 
radiolabel. In addition to this disadvantage, the risk to the health of the individuals 
carrying out the investigations may also be a concern. 
1.2.4 Stable isotope labelling studies 
Due to the considerable advances that have been made in the fields of high field 
nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS), the 
use of stable isotopic labels such as and ^^ C in biosynthetic studies, has 
substantially replaced the use of radioisotopes. 
Compounds that have been synthesised with isotopic labels incorporated at specific 
sites are fed to the organism. The compound whose biosynthesis is being investigated 
is harvested, purified and then analysed by either NMR or mass spectrometry. 
Single label feeding studies 
^^ C may also be used as a single label within a putative precursor. Comparison of the 
peak integrals from a natural abundance ^^ C spectrum of the metabolite with those 
resulting from the feeding of the labelled compound, readily demonstrates the level of 
incorporation. The wide chemical shift range observed in a C NMR spectrum and 
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the low natural abundance of '^C make this a particularly usefiil tool for examining 
site specific incorporations. 
has an even lower natural abundance of 0.016 % meaning that it is possible to 
detect even smaller levels of incorporation accurately. The chemical shifts in a 
NMR spectrum closely correspond to those of the proton, making assignation of the 
peaks simple. The peaks may also be readily integrated to provide precise information 
about the levels of incorporation of the labelled precursor. However, deuterium has a 
low gyromagnetic ratio meaning that detection of the nucleus is less sensitive; it is 
often necessary to run the NMR analysis experiments on high field spectrometers and 
for extensive periods of time. Deuterium possesses a quadrupolar nucleus with 
nuclear spin (I) =1, this leads to an increased nuclear relaxation time and thus 
broadening of the signals. 
^H. The sophistication of modem NMR techniques has also brought about a 
resurgence in the use of tritium. Tritium lends itself particularly well to NMR analysis 
as it has the highest gyromagnetic ratio of any element and is thus readily detected. It 
has a very low natural abundance of 10'^ ^%, so it is possible to detect very low levels 
of incorporation. Though detection of tritium by scintillation counting is the more 
sensitive technique, the use of NMR for analysis can provide site specific information 
about the incorporations. 
Double label feeding studies "bond labelling" 
Often in a biosynthetic investigation, the first labelled molecule to be administered to 
the organism is [ 1,2-^^Cz]-acetate. The two carbon nuclei couple to each other and i f 
the acetate bond is not broken during the biosynthetic process then the coupling is 
retained in the final metabolite and may be observed by ^^ C NMR. This provides a 
useful method of investigating how the carbon skeleton of the molecule is formed. As 
the natural abundance of '^C is only 1.1 %, the possibility of two '^ Cs naturally 
occurring together in the metabolite may be calculated as 1.1% x 1.1%. The technique 
is, therefore, highly sensitive. 
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Using "reporter" nuclei in ^^ C NMR analysis 
and ^^ C 
The fate of a deuterium label may also be followed by '^C NMR as the and ^^ C 
will couple together. Furthermore, a carbon will be shifted upfield by between 0.25 
and 0.3 ppm per deuterium attached to it ( this is known as the a effect). A deuterium 
decoupled ^^ C NMR spectrum may be used to determine how many deuteria are 
incorporated at one site. The feeding of ^^C-^H labelled material may also be used to 
determine whether a particular C-H bond is broken during the biosynthesis of a 
particular metabolite. 
A carbon atom can also report on the number of deuteria attached to the directly 
neighbouring carbon atoms. The p effect is also additive, v^th one deuterium leading 
to an upfield shift of 0.05-0.08 ppm. It is not necessary to employ decoupling to 
clearly observe the p effect, as there is no '^Juc-iu-
and ^^ C 
1 ft ^ 
Though O itself, may not be observed directly by NMR, its incorporation into a 
molecule may also be witnessed by monitoring the induced chemical shift on an 
adjacent carbon-13 atom. 
Mass spectrometry analysis 
Mass spectrometry is often an attractive alternative to NMR analysis as much smaller 
amounts of metabolite may be analysed. I f the fragmentation pattern of the metabolite 
is easily identified it is sometimes possible to assign the isotopic incorporation to a 
particular site. 
Though the use of stable isotope labelling experiments is, on the whole, preferable to 
radioisotopic labelling, due to the decreased sensitivity of detection, it is often 
necessary to feed the labelled putative precursor at a much higher concentration. 
There is a danger of the ordinary metabolism of the organism being perturbed, or at 
worst, the death of the organism resulting. 
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1.3 Stereochemical biosynthetic investigations 
Almost all enzyme catalysed reactions proceed with very high stereo specificity. The 
substrates utilised by the enzyme must be of a strictly defined configuration and the 
products, in turn, are formed with a particular stereochemistry. In some cases the 
stereochemistry of the enzymatic reaction is immediately apparent as it occurs at a 
chiral centre. However, enzymes may also act stereo specifically at achiral centres or 
prochiral groups within a molecule. One such example is the alcohol dehydrogenase 
mediated conversion of ethanol (1.8) to acetaldehyde (1.9), using nicotinamide 
adenine dinucleotide (NAD^) as the co-enzyme (Scheme 1.3). Although the enzyme 
is presented with the possibility of removing one of two chemically equivalent 
hydrogens, in the oxidation of the ethanol, only the pro-R is abstracted. This may be 
demonstrated by isotopically labelling the pro-R position with deuterium and noting 
the absence of label in the acetaldehyde produced. 
v^Hs I Alcohol 
H.e^ dehydrogenase 
1.8 
H2NOC 
NAD"" NAD^ 
Scheme 1.3 The alcohol dehydrogenase mediated conversion of ethanol (1.8) to 
acetaldehvde (1.9) 
Although within a methyl group the three hydrogens are homotopic, the biochemical 
reactions generating the methyl group may be stereospecific. For example, the methyl 
group may be formed by the protonation of a methylene group operating on one side 
of the molecule only. The steric course of the reaction, in such cases, is not evident 
fi*om the inspection of the substrates and to elucidate the strereochemical course by 
which the enzyme is operating it is often necessary to prepare chiral versions of the 
methyl group by using heavy isotopes. 
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The "chiral methyl group" is frequently used in the elucidation of the stereochemistry 
of biosynthetic transformations.^^ The methodology relies upon the kinetic isotope 
effect which dictates that a C-H bond is more readily broken than a C-D bond, which 
is, in turn, more readily broken than a C-T bond (see section 2.1). 
The activation of acetyl-CoA to malonyl-Co, mediated by acetyl-CoA carboxylase, 
was demonstrated to proceed with retention of stereochemistry, by Sedgwick and 
Comforth's use of chiral acetyl-CoA.'^' 
O O 
^ II acetyl-CoA carboxylase 
SCoA ^ "'^'r?r 
T T 
2S-[2-^H, 2-^H] acetyl-CoA 2S-[2-^H, 2-^H] malonyl-CoA 
Scheme 1.4 The conversion of 2^-[2-^H. 2-^H\ acetyl-CoA to 2S-l2-^n. 2-^H1 
malonyl-CoA mediated by acetyl-CoA carboxylase 
Studies into the manner in which a substrate is stereochemically processed can 
provide mechanistic information about the way in which the enzyme fiinctions 
(Chapter 4). 
1.4 Topics addressed in this thesis 
This thesis investigates the biosynthesis of two idiolites, longianone and fluoroacetate, 
using stable isotope labelling techniques (section 1.2.3). 
Longianone is an intriguing, highly fimctionalised metabolite of the fimgus Xylaria 
longiana. It is an isomer of the notorious fiingal toxin, patului. The biosynthesis of 
patulin is examined to provide clues as to the biosynthesis of longianone. 
Intermediates on the patulin pathway are synthesised carrying an isotopic label and 
incubated with the X. longiana, to determine whether they are intermediates upon the 
biosynthetic pathway to longianone as well. 
Although fluoroacetate, the most common of the fluorinated metabolites, was 
discovered by Marais in 1943 as the toxic component of the South Afiican plant 
Dichapetalum cymosum,^^ the simple compound's biosynthesis has not yet been fiilly 
elucidated. This thesis addresses the stereochemistry of the fluorination event, in 
order to gain insight into the mechanism by which the biological fluorination occurs. 
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This problem is approached by the feeding of stereoselectively deuterated, known 
precursors of fluoroacetate. Chiral liquid crystal NMR is used to determine the 
chirality of the fluoroacetate produced from these deuterated biosynthetic 
intermediates, and a sample of sodium (.S>[^H]-fluoroacetate is biosynthesised as a 
standard. 
The power of chiral liquid crystal NMR as a tool for resolving enantiomers, chiral by 
virtue only of the substitution of a proton by a deuterium is fiuther investigated. 
Fluoro-deutero-alkanes are synthesised and examined by chiral liquid crystal NMR to 
determine the limit of the techniques resolution, where only a subtle difference in the 
chirality of each enantiomer exists. 
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CHAPTER 2 
Chiral Analysis by Chiral Liquid Crystal ^H-NMR 
17 
CHAPTER 2 
Chiral Analysis by Chiral Liquid Crystal Deuterium NMR 
Introduction and Background 
2.1 Methods of determining enantiomeric excess 
There are many occasions when it is highly important that a chemist should be able to 
measure the enantiomeric excess (ee) of a chiral compound. Sometimes, the reason 
for doing so is promoted by a desire to understand the mechanism of a reaction; on 
other occasions it may be necessary to test that the material contains only one 
enantiomer so that it may be used in the synthesis of pharmaceutical or agrochemical 
products. 
When determining the ee of molecules that are chiral by virtue only of isotopic 
substitution, such as with deuterium for hydrogen, the methods available to the 
chemist are very limited. The shape of the molecule is little altered and thus 
separation of the two enantiomers by gas chromatography (GC) or high pressure 
liquid chromatography (HPLC) with a chiral column, is not viable. Additional 
problems arise i f the material to be analysed is of biosynthetic origin and thus 
available only in milligram quantities with, often, an isotopic enrichment well below 
100 %. 
An elegant, though rather time consuming, means of measuring the chirality of methyl 
groups, chiral by virtue of tritium and deuterium substitution, has been used for many 
years to investigate the chirality of biosynthetic acetate.^  The method employs two 
enzymes and takes advantage of the kinetic isotope effect. The analysis was initially 
developed with synthetic (R)- and (5)-[^H, ^H]-acetic acid.^ 
Malate synthase mediates the irreversible condensation of acetyl-CoA (2.1) with 
glyoxylic acid (2.2). The condensation occurs with the loss of a hydrogen atom. The 
hydrogen or the isotope that is lost is dictated by the primary isotope effect (kn > kD> 
kr). This means that the loss of hydrogen is favoured over deuterium, which, in turn, 
18 
is favoured over tritium. When (RyfR, ^H]-acetyl-CoA (2.1a) is condensed with 
glyoxylic acid, malic acid (2.3a), resulting from the loss of a proton, is generated as 
the major isomer (77%). A small amount of the minor isomer (2.3b) (23%) is 
generated by the less kinetically favourable loss of a deuteron. Similarly, when (5)-
[^H, ^H]-acetyl-CoA (2.1b) is condensed with glyoxylic acid, malic acids 2.3c and 
2.3d are generated as the major and minor isomers, respectively (Scheme 2.1). 
S C o A 
(R)-acetyi-CoA (2.1a) 
malate synthase 
HO2Q 
glyoxylic acid (2.2) 
S C o A 
(R)-acetY(-CoA(2.1a) 
malate synthase 
HO2Q 
glyoxylic acid (2.2) 
H 0 2 C ^ " " / ^ 0 H 
H 
(2.3a) 
major isomer 
H 
(2.3b) 
minor isomer 
T 
S C o A + 
HO2Q. 
O 
O H H 
(S)-acetyl-CoA(2.1b) (2.3c) (2.3d) 
major isomer minor isomer 
Scheme 2.1 The reaction of chiral acetvl-CoA (2.1) with glvoxvlic acid (2.2) 
The resultant malic acid is subsequently isolated and incubated with fiimarase. 
Fumarase mediates the loss of water from malic acid, in a stereospecific manner, to 
generate fiimaric acid (2.4). The material is incubated until no fiirther TOH is lost: the 
levels of tritium remaining within the material are then measured. From the original 
investigation, using synthetic (R)- and (S)-[ H, H]-acetic acid, it was observed that 
(i?)-[^H, ^H]-acetic acid incubated with malate synthase and then ftimarase led to a 
77% retention of tritium, whereas only 23 % retention of tritium resulted from the 
incubation of (»S)-[^H, ^H]-acetic acid with the two enzymes (Scheme 2.2). From this 
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information, the technique could be used to deduce the chirality of many biosynthetic 
acetic acid samples. 
SCQA 
I H 
^ _ + \r 
H H 
(«)-acetyl-CoA (2.1a) (2.3c) 
major isomer 
(2.3d) 
minor isomer 
H 
(2.3c) 
major isomer 
H 
(2.3d) 
minor isomer 
T 
SCoA 
(S)-acetyl-CoA (2.1b) 
fumarase fumarase 
XO2H 
HO2C" 
(2.4a) 
H CO2H 
fumarate 
HO2C H 
(2.4b) 
H CO2H T v ^ C 0 2 H 
II 
HO2C H 
N 
HO2C H 
(2.4b) (2.4a) 
77 % retention of tritium 23 % retention of tritium 
Scheme 2.2 The resolution of chiral methvl groups using the kinetic isotope effect 
In certain cases, it has been shown possible to discriminate between two enantiomers 
whose chirality results from the substitution of a proton with a deuteron, by chiral 
optical methods. Such techniques are difficult due to the weak circular dichroism 
response elicited. Another method of enantiomeric resolution is the use of chiral 
derivatising reagents. This involves derivatising the compound with an 
enantiomerically pure material. The resultant diastereoisomeric compound will have a 
chemical shift non-equivalence. However, not only may manipulation of the sample 
be tricky and time consuming, especially when only small amounts of the biosynthetic 
compound are available for derivatisation, but also, retrieval of the product for fiirther 
analysis may be problematic. To ensure an accurate analysis of the ee, using this 
method, the derivatising agent must be enantiomerically pure. The formation of the 
diastereoisomer must occur under conditions that exclude racemisation, and an excess 
of the derivatising agent used to minimise kinetic resolution due to differences in 
reaction rates between the enantiomers. Care must be taken, throughout the 
purification, not to include any techniques, such as crystallisation, which might favour 
the enrichment of one diastereoisomer. 
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One of the most frequently used chiral derivatising agents is a-methoxy-a-
(trifluoromethyl)phenyl-acetic acid (MTPA) (2.5).^ Introduced by Mosher,"^  this 
compound is highly favoured as the absence of a proton a to the carboxy group 
prohibits racemisation. The presence of the trifluoromethyl group allows analysis by 
integrating the signals for the two diastereoisomers in the ^^ F NMR spectra. 
Ph 
C O 2 H 
OMe 
Fig 2.1 a-methoxv-a-(trifluoromethyl)phenvl-acetic acid (2.5) 
2.2 The chiral analysis of labelled biosynthetic fluoroacetate 
To gain a better understanding of the mechanism of biological fluorination by the 
bacterium Streptomyces cattleya, it became appropriate to assay the enantiomeric 
excess of a biosynthetic sample of fluoroacetate, chiral by virtue of deuterium 
substitution alone (Chapter 4). 
Analysis of the enantiomeric excess of a-deuterated carboxylic acids, alcohols and 
amines by first forming their MTPA derivative has been shown to be largely 
unsuccessfiil and other derivatising agents must be employed.^ In the past, workers at 
Durham have attempted to analyse the ee of [2-^H]-fluoroacetate by derivatising it as 
the methyl mandelate ester (2.6) and also as the amide of a-methyl benzylamine (2.7). 
However, NMR analysis of the two derivatives using a 500 MHz spectrometer 
failed to resolve the diastereotopic hydrogens of the fluoromethyl groups. 
O O 
O O 
2.6 2.7 
Fig 2.2 Chiral derivatives of fluoroacetate 
The condensation of fluoroacetyl-CoA (2.8) with oxaloacetate (2.9) in the fatal 
conversion to fluorocitrate (2.10) mediated by citrate synthase, is known to be highly 
stereospecific. The 2-pro-S proton of fluoroacetyl-CoA is abstracted exclusively to 
afford {2R, 3i?)-2-fluorocitrate as the only isomer (section 3.7.4). It was anticipated 
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that by incubating the biosyntheticaUy derived [^Hi]-fluoroacetate with citrate 
synthase, the presence, or absence, of deuterium in the resultant fluorocitrate would 
provide an assay for the R or S configuration. Mass spectral data indicating the 
percentage of fluorocitrate molecules containing deuterium could then be used to 
calculate an enantiomeric excess. However, development of this methodology in 
Durham was unsuccessftil. 
Si face attack 
O ^ O 
HO2C. At^.. R CO2H 
oxaloacetate(2.9) 
citrate synthase ^ HoSP.'^X^ X O ^ H 
SCoA inversion at C-2 
(f?H2- H]-fluoroacetyl-CoA 
(2.8a) 
(2R, 3R)-2-fluoro-[2-H]-Gitrate (2.10a) 
° Citrate synthase, HO^CI'^X^^^CO^H 
'SCoA inversion at C-2 
Ds 
(SH2-^H]-fluoroacetyl-CoA 
(2.8b) 
H 
(2R, 3R)-2-fluonocitrate (2.10b) 
Scheme 2.3 The condensation of fluoroacetvl-CoA (2.8) with oxaloacetate (2.9) 
Retey reported the synthesis of both {Sy and (R)-[ H]-fluoroacetate and distinguished 
the enantiomers analytically by circular dichroism (Fig 2.3).^ Accordingly, attempts 
were made to similarly analyse the [^Hi]-fluoroacetate recovered from Streptomyces 
cattleya. Due to the milligram quantities of the metabolite, which were no more than 
15 % deuterated and which contained inorganic impurities, analysis by this method 
was frustrated. (Samples were analysed at King's College London.) 
-2.5 10' h . . . . I 
C D ( m d g) 
\ J n m ) 
Fig. 2.3 Retev's analysis of (S)- and r/?)-[^H1-fluoroacetate by CD in CF^CH^OH^ 
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2.3 The use of ehiral liquid crystal deuterium NMR for chiral resolution 
In recent years, a novel and extremely sensitive technique for enantiomeric assay has 
emerged in the literature. The observation by NMR analysis of a range of nuclei (^H, 
*^F, and ^^ C included) of compounds solvated in a chiral liquid crystalline medium, 
can be used to discriminate between enantiomers. The resolution of the two 
enantiomers may be particularly pronounced for quadrupolar nuclei, such as 
deuterium, where the nuclear spin I > Yz.^' ^ 
2.3.1 An introduction to liquid crystals 
The liquid crystalline phase, a state occurring between solid and liquid, was first 
discovered by Reintzer in 1888.^  He observed that a cholesteryl ester existing as an 
opaque liquid at room temperature, became a clear isotropic liquid upon heating. This 
new state he termed a "mesophase", meaning "in between phases". 
In 1956 Flory postulated that concentrated solutions of rigid rod like polymers should 
form ordered structures when in solution at a critical concentration.^ This was 
subsequently found to be the case. These two instances refer to two different types of 
liquid crystalline state, termed thermotropic and lyotropic, respectively. 
The mesophase may be fiirther broken down into three main categories determined by 
the level of ordering of the liquid crystal:-
The smectic state (smegma ~ Greek for soap) is very highly ordered. The molecules 
arrange themselves in parallel lines, and the centres of gravity of the molecules are 
confined to layers (Fig 2.4a). The nematic, or thread like, phase is slightly less 
ordered, and although the molecules are arranged in parallel lines, the centres of 
gravity of the molecules are randomly distributed through space. As a consequence of 
this lesser degree of ordering, the nematic phase is far more fluid than the smectic 
phase, though, still exhibiting birefringence (Fig. 2.4 b). 
When a lyotropic liquid crystalline phase is formed by the addition of polymer to a 
solvent, initially the viscosity increases whilst the solution remains isotropic and clear. 
At a critical concentration, determined by temperature, solvent and molecular weight 
of the polymer, the viscosity of the material sharply decreases. At this stage the 
formation of orientated nematic domains occurs, in which the chains are lined parallel 
to the direction of flow thereby reducing the frictional drag on the molecules and thus 
the viscosity of the material. 
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In the third type of mesophase, the "chiral nematic state", the mesogens have a chiral 
centre. In each layer of the material there is directional ordering, as in the case of the 
nematic phase. The presence of the chiral centre causes the director of each layer to be 
displaced, each time, by an angle 0, thus giving a helical twist to the material. The 
result of this effect is a liquid crystal of high optical activity with the abUity to reflect 
circularly polarised light of a particular wavelength (Fig 2.4c). The solvation of poly 
y-benzyl L-glutamate (PBLG), gives rise to such a material as this. 
Fig. 2.4a Fig. 2.4b 
Fig. 2.4c 
Fig. 2.4 The molecular ordering in the three liquid crystalline phases 
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2. 3. 2 The use of P B L G as a solvent for NMR analysis 
The presence of a chiral environment created by the liquid crystalline PBLG in 
chloroform leads to differing orientations of the different enantiomers of a molecule 
solvated by the material. The differential ordering induces different magnetic 
environments. 
For ordinary enantiomers, it is the difference in shape which leads to the different 
solvent/solute interactions. For molecules that are chiral only by virtue of isotopic 
substitution and for prochiral groups, the chiral environment of the PBLG helices can, 
perhaps, be compared to the a helices present at the active site of an enzyme, 
imparting diastereotopicity to the substrate. In such a manner, the two nuclei or 
groups are induced into magnetic non equivalence. The differential ordering effects, 
caused by the presence of the chiral environment, induces different chemical shifts 
and different quadrupolar interactions for each enantiomer. 
Quadrupolar couplings may be observed for nuclei with spins I > Yz. In such nuclei 
there exists an anisotropic distribution of charge. The interaction of this nuclear 
quadrupole moment with the electric field gradient of the molecule (caused by the 
molecule's asymmetry) leads to quadrupolar coupling. 
When a racemic mixture of a compound, bearing an atom vsdth a quadrupolar nuclei, 
such as deuterium, is solvated in an isotropic medium, tumbling of the molecule can 
occur. The electric field gradients of the molecules are averaged out, and a single 
broad line is observed in the NMR spectrum (Fig 2.5a). I f the same material is 
dissolved in a nematic liquid crystal, the solute molecules become partially orientated 
and the average quadrupolar coupling becomes non zero: a doublet is observed with a 
quadrupolar splitting of AVQ (Fig 2.5b). When the same material is dissolved in a 
chiral nematic liquid crystalline solvent, such as poly y-benzyl L-glutamate, due to the 
difference of ordering of each enantiomer within the chiral environment, two doublets 
are observed whose intensity is equal to the concentration of each enantiomer present 
(Fig 2.5c). 
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a) 
b) 
V 
ISO 
D 
V D 
aniso 
Q 
Figure 2.5 The ^H NMR of a racemic RCHDOH in a) an isotropic solvent, b) a 
nematic hquid crystalline solvent, c) a chiral nematic liquid crvstaUine solvent^^ 
Even though the differences in ordering for the two enantiomers may be very small; 
due to the large values for the quadrupolar coupling, discemable differences in the 
quadrupolar sphttings may be observed (Equation 2.1). 
AVQ = I Q D J V C D SCD 
2 h 
ScD = */2<3cos^e^cD-l> 
Q D = deuterium quadrupolar moment 
VcD = the electric field gradient along the carbon deuterium bond 
SCD the order parameter along the carbon deuterium axis 
O^CD = the angle between the electric field gradient and the external magnetic field 
< >denotes an average value over the anisotropic molecular reorientations 
Equation 2.1 
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The differences in AVQ produced by the technique means that it is particularly good 
for examining the ee in cases when the molecule is chiral only by virtue of deuterium 
incorporation, even when the degree of incorporation is extremely low, as for the case 
of many biosynthetic materials. 
2.3.3 Sample preparation for chiral liquid crystal NMR 
Samples for chiral liquid crystal NMR analysis are prepared by weighing, accurately, 
PBLG (120 mg, 13%, DP~800, MW 150,000-350,000) into a 5mm diameter NMR 
tube. A noted mass of material to be analysed is added to the NMR tube, and finally 
chloroform (803 mg, 87%) is added. The contents of the tube are left to dissolve in the 
chloroform before being thoroughly mixed. Mixing is achieved by drawing the 
material from one end of the tube to the other at least 40 times. As the material is very 
viscous, it is beneficial to introduce a centriftigal force to drag the material from one 
end of the tube to the other. After centrifiigation, the NMR tube is reweighed so that 
any loss of chloroform, due to evaporation, may be accounted for. The NMR of the 
sample is immediately run so that the homogeneity of the sample is not lost by fiirther 
evaporation of chloroform. 
Initially, all chiral liquid crystalline deuterium NMR analysis were performed on a 
Bruker AC-250 at the Institut de Chimie Moleculaire d'Orsay, Universite de Paris 
Sud, France. Experiments were performed in our laboratories to adapt the technique to 
our equipment. The greatest challenge lay in the sample preparation, and our ability to 
thoroughly mix the liquid crystal. In our initial experiments, the NMR tube was 
placed at an angle of 60°, in a specially designed conical flask (Fig 2.6) and spun on 
an orbital shaker at 500 rpm. Using this technique, it took almost ten minutes for the 
material to be spun from the top to the bottom of the tube. Finally, a MSB Chilspin 
centriftjge, fitted with an 8 x 100 ml angle head rotor, was employed to spin the tubes. 
This model of centriftige has sufficient head-space to allow for the height of an NMR 
tube, with the lid closed. The deuterium NMR were obtained on a Unity Inova 500 
MHz. Gradient shimming was employed to increase the resolution of the spectra. 
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Fig. 2.6 Modified conical flask used to centrifuge the liquid crystalline material within 
the NMR tube 
2.4 The synthesis of (5)-l^Hl-nuoroacetate 
In order to determine whether chiral liquid crystal ^H NMR would be a suitable 
technique by which to resolve the S and R enantiomers of [^H]-fluoroacetate (2.10), it 
was necessary to synthesise a reference sample. To provide a standard against which 
the biosynthetic material could be compared, it was decided to prepare [^H]-
fluoroacetate with an ee m favour of the S configuration. 
Keck has reported the synthesis of (/?)-[^H]-fluoroacetate.'' Using (7?)-[^H]-glycine, 
the synthesis was based upon deaminative halogenation methodology established by 
Pattison et al, the substitution proceeding with retention of configuration.'^ In this 
synthesis glycine (2.11) is reacted in a pyridinium poly(hydrogen fluoride) solution 
containing an excess of sodium nitrite. Initially, in situ diazotisation generates an 
intermediate diazonium salt, this is followed by a subsequent dediazonization to 
fiimish fluoroacetate. 
H R ^ H S C5H5NH ( H F ) X F ' 
HO2C Nz"^  HO2C F HO2C' 'NH2 NaN02 
(2.11) (2.10) 
Scheme 2.4 The synthesis of fluoroacetate (2.10) from glycine (2.11) 
This synthesis was employed by Walsh to obtain a sample of (/?)-[ H]-fluoroacetate 
with which to test the stereochemistry of the dehalogenation of fluoroacetate to 
glycolate by a halidohydrolase enzyme.'^ 
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starting material. Ethyl magnesium bromide is then used to deprotonate the alkyne at 
the terminal position, and the resultant anion reacted with trimethylsilyl chloride to 
fiimish l-(trimethylsilyl)oct-l-yn-3-ol (2.13). The reduction, of this material, with 
lithium aluminium hydride followed by a deuterium oxide quench yields 1-
(trimethylsilyl)[l-^H]oct-l-en-3-ol {E)I{Z) 5:1 (2.14). Retey reports the selective 
epoxidation of the (^-isomer, alone, under Sharpless conditions using both 
enantiomers of diisopropyl tartrate as the chiral ligand to generate either (li?, 2R, 3Ry 
or (IS, IS, 35)-l-(trimethylsnyl)-l,2-epoxy[l-^H]octan-3-ols (2.15, 2.15a). 
Deprotection of the trimethyl silyl group was achieved by reaction with KO(/-Bu) and 
with BU4NF. The oxirane ring was opened with Et3N.3HF to afford the two fluoro-
octane diols (2.16, 2.16a), which were subsequently cleaved with sodium 
metaperiodate to fiimish both isomers of fluoroacetic acid (2.17, 2.17a). 
Retey's synthesis is lengthy and not so efficient particularly as one sixth of the lithium 
aluminium hydride reduction proceeds in a cz-s-fashion to yield Z-allyl alcohol, which 
is discarded. Also, 50% of the material becomes redundant following the Sharpless 
kinetic resolution. 
29 
OH 
2.12 
EtMgBr. THF, MeaSiCI 
H2SO4 
OH 
M e s S i - ^ — ^CsHu 
2.13 
LiAIH4, THF 
D2O 
MegSi H D H 
.C5H1 
MeaSi 
2-140H 
E 
CcHi 
OH 
(-)-DIPT, Ti[0(i 
f-BuOOH 
DIPT, Ti[0(i-Pr0]4 
f-BuOOH 
Me-,Si. 
AOH 
MezSi H 
C5H11 
D' b' ^ ' 
OH 
(1R,2f?, 3/?)2.15 
MegSi-
D ' 
MeaSi 
-CsHi 
OH 
(1S, 2S, 3S)2.15a 
HO " 
{E.R) 
BU4NF, THF, KO{t-Bu) 
C5H1 
O 
H ~ ^ ^ H 
-C5H1 
OH OH 
EtsN.aHF 
Di^  OH 
2.16, OH 
H OH 
D 
F Y^CsHu 
2.16a OH 
RuQa, Nal04, Ca4/MeCN/H20 
D. OH 
2.17 
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Scheme 2.5 Retev's synthesis of chiral [2-^H]-fluoroacetate 
At the outset of the project this route was considered, however, the Sharpless 
epoxidation of 1-(trimethylsilyl)[l-^H]octan-3-ol (2.14) was unsuccessfiil in my 
hands. 
An alternative route for the synthesis of chiral deuterated sodium fluoroacetate was 
investigated. It was chosen to utilise the well known Midland methodology'"* for the 
asymmetric reduction of benzaldehyde, to introduce the stereogenic centre. 
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LiAID4, THF 
OEt 
PCC, DCM 
2.18 2.19 2.20 
O. *'"H 
D 
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2.17a 
KMn04, 
KIO4, 
water 
9-BBN, THF, 
(ISH-)-a-pinene 
S-hydroxyquinoline 
OH 
DAST, DCM 
2.22 2.21 
Scheme 2.6 The synthesis of f5^-[2-^H1-fluoroacetate (2,17a) from [7-^H]-
benzaldehvde (2.20) 
Although the starting material, [7-^H]-benzaldehyde (2.20), may be purchased from 
Aldrich, it is expensive. [7- H]-Benzaldehyde may be made, in a straightforward 
manner and in good yield, by a two-step process involving the lithium aluminium 
deuteride reduction of ethyl benzoate (2.18), followed by the pyridinium chloro 
chromate (PCC) oxidation of the resulting alcohol (2.19). 
5'-Alpine-Borane (B-isopinocamphenyl-9-borabicyclo[3.3.1]-nonane) (2.24), the 
asymmetric reducing agent, is created in situ by the addition of (15)-(-)-a-pinene to a 
solution of 9-BBN in THF. The 9-BBN adds syn across the double bond, on the 
opposite side of the ring to the isopropyl moiety (scheme 2.7). 
The 5'-Alpine-Borane stereoselectively hydroborates the pro-S face of the 
benzaldehyde concomitantly releasing the chiral template, (15)-(-)-a-pinene. In order 
to ensure that all of the 5'-Alpine-Borane has been consumed, acetaldehyde is added to 
the reaction mixture. The pinene and ethanol generated are removed under vacuum. 
Midland details the use of ethanolamine to precipitate the 9-BBN as an adduct, thus 
liberating the benzyl alcohol. Ethanolamine has a boiling point of 170 °C, whereas 
benzyl alcohol boils at 205 °C. To increase the ease of purification, it was decided to 
use 8-hydroxyquinoline (2.25) (b.p. 267°C) to precipitate the 9-BBN. The 
enantiomeric excess of the resultant (i?)-[7-'^H]-benzyl alcohol was shown to be 88%, 
by chiral liquid crystal NMR, using PBLG and chloroform as solvent (Fig. 2.7a). 
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Scheme 2.7 The stereoselective reduction of [7-^H]-benzaldehvde with ^-Alpine-
Borane 
The (;?)-[7-^H]-benzyl alcohol (2.21) was converted to (5)-[7-^H]-benzyl fluoride 
(2.22), using DAST (diethylaminosulphur trifluoride) as the fluorinating agent. The 
enantiomeric excess of the benzyl fluoride was shown, by chiral liquid crystal D 
NMR, to be 38% (Fig.2.7b). 
OH 
r 
DAST Predominant inversion product 
0-SF2NEt2 
A H . 
H 
+ ^ ~OSF2NEt2 
O 
II E t j N - S F p 
r r 
r A " h . r A ' . 
SN1 products 
Scheme 2.8 The steric course of an alcohol's reaction with DAST 
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Although the fluorination by DAST proceeds predominantly by an inversion process, 
DAST is renowned for its ability to stabilise carbocations (scheme 2.8). The aromatic 
group will stabilise carbocation character at the benzylic position. These two factors 
lead to the reaction proceeding with a considerable degree of S n I character, and thus a 
loss in enantiomeric excess of the resultant benzyl fluoride. There are reports in the 
literature o f greater steric control with DAST reactions at lower temperatures, such as 
-50°C.*^ This was investigated in the case of (i?)-[7-^H]-benzyl alcohol; however, 
although the reaction took longer at the lower temperature, the resultant material 
showed no increase in enantiomeric purity when examined by chiral liquid crystal ^D 
NMR. In a further attempt to increase the stereospecificity of the fluorination reaction, 
Ishikawa's reagent, N , N-diethyl-l,l,2,3,3,3-hexafluoropropylamine,^^ was also 
investigated; the product of this reaction showed no greater enantiomeric excess 
either. It may be concluded that the aromatic ring plays a considerable role in 
stabilising a benzylic carbocation. For the purpose of a chiral standard for chiral liquid 
crystal NMR analysis, an enantiomeric excess of 38 % was considered sufiScient. 
Fluorinating Reagent %ee 
DAST 38% 
DAST (-50 °C) 38% 
Ishikawa's reagent 38% 
(i?)-[7-^H]-benzyl alcohol (88% ee) subjected to different fluorinating conditions 
JC 
r r 
r 
L.a 3.0 2.0 1.0 0.0 -1 .0 -2 .0 -3.0 -4,0 
Fig 2.7a NMR of m-[7-^H]-benzvl alcohol displaving an ee of 88% (Bruker AC-
250. 250.133 MHz) 
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Fig 2.7b NMR of (^-r7-^H]-benzvlf[uoride, displaying an ee of 38%.(Bruker AC-
250.250.133 MHz) 
Fig2.7 
(materials are analysed in a liquid crystalline solvent of PBLG and chloroform) 
O'Hagan reported the preparation of a series of fluorinated carboxylic acids, including 
3-fluoropropanoic acid,''' by the oxidation of their corresponding aromatics, under 
Sharpless conditions. Accordingly, benzyl fluoride was added to a solution of 
ruthenium trichloride and potassium periodate in water, acetonitrile and carbon 
tetrachloride (3:1:1). After 48 hours, no fluoroacetate was observed in the aqueous 
phase by '^F NMR. The reaction was repeated, replacing the ruthenium trichloride 
with ruthenium tetraoxide; once more, no reaction was observed. Finally, potassium 
permanganate and potassium periodate, in aqueous solution, was shown to effectively 
convert the benzyl fluoride to fluoroacetate. Purification of the fluoroacetate was 
achieved by acidifying the supernatant and lyophilizing the fluoroacetic acid, which 
was subsequently neutralised and freeze dried. 
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2.5 Chiral analysis of (5)-[^H1-fluoroacetate 
F F 
+ N a O ^ i) SOCI2, DCM 2.26 0 
D 
O 0 ii) sodium fluoroacetate 
2.17a jjj) hexanol 
1 50 \ ^ ^ " ^ V H 
F 
D 
0 
Scheme 2.9 Derivatisation of (.S^-[^H]-fluoroacetate as its hexyl ester 
Due to its poor solubility, in the PBLG solvent system required for the chiral liquid 
crystal NMR analysis, (*S)-[^H]-fluoroacetate was converted to its hexyl ester. As the 
biosynthetic fluoroacetate from Streptomyces cattleya had only a low level of 
deuterium incorporation, a similar system was required to determine whether chiral 
liquid crystal NMR could be a suitable technique for the analysis. Commercial, 
unlabelled sodium fluoroacetate was added to the synthetic material to dilute the 
deuterium label to a level comparable with that of the biosynthetic material. 
Accordingly, a 50-fold excess of undeuterated fluoroacetate was added to the (5)-
[^H]-fluoroacetate and one equivalent of thionyl chloride introduced to the mixture to 
form fluoroacetyl chloride. To ensure that all of the thionyl chloride had been 
consumed an additional aliquot of unlabeled fluoroacetate was added to the reaction 
mixture. Addition of hexanol to the reaction mixture and flash silica chromatography 
fiimished the hexyl fluoroacetate (scheme 2.9), which was analysed by H chiral 
liquid crystal NMR (Fig 2.8). 
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CDCl; CDC13 
400 300 200 100 0 -100 -200 
(Hz) 
Fig 2.8 NMR of hexvl (2^-[2-^H]-fluoroacetate in PBLG and chloroform, 
displaving an ee of 38% (Bruker AC-250 , 250.133 MHz) 
The ^H NMR of hexyl (25)-[2-^H]-fluoroacetate in poly y-benzyl L-glutamate and 
chloroform exhibits a considerable difference in the quadrupolar splittings of the S 
and R enantiomers. The difference in splittings is very striking particularly as the 
molecules are only chiral by virtue of deuterium substitution. Only 2% of the hexyl 
fluoroacetate molecules analysed contained deuterium, this level of incorporation is 
comparable with the material that could be prepared from the biosynthetic 
fluoroacetate. It may be concluded that chiral liquid crystal ^H NMR is a powerful 
technique for examining the chirality of biosynthetically derived [^Hi]- fluoroacetate. 
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A number of mid chain, fluorinated, alkanes have found applications in the liquid 
crystal industry particularly as ferroelectric liquid crystals. To date, no analytical 
technique has been capable of demonstrating the enantiomeric excess of such 
compounds with fluorine at a remote chiral centre. Impressed by chiral liquid crystal 
^H NMR's ability to discriminate between (IR)- and (25)-[2-^H]-hexylfluoroacetate, 
an example of an exceptional chiral resolution, we decided to explore the limits of this 
technique when applied to fluoroalkanes. To accomplish this, it was necessary to 
synthesise racemic n-fluoro[n-^H]-alkanes, gradually increasing n, and the chain 
length, such that the fluorine atom was gradually moved towards the centre of a alkyl 
chain (table 2.2). Appropriate racemic fluorodeutero alkanes were prepared by firstly 
reducing the corresponding ketone with lithium aluminium deuteride and then 
fluorinating the resultant deuteroalcohols with DAST. All ketones, except 4-octanone 
are commercially available. 4-Octanone may, however, be prepared by the oxidation 
of4-octanol with PCC. 
Fluoroalkane Structure CH3(CH2)xCDF(CH2)yCH3 
x,y 
2-Fluoro [2-^H] -hexane 
0,3 
3-Fluoro[3-^H]-hexane 
1,2 
2-Fluoro[2-^H]-heptane 
0,4 
3-Fluoro[3-^H]-heptane 
1,3 
3-Fluoro[3-^H]-octane 
1,4 
4-Fluoro [4-^H] -octane 
2,3 
Table 2.2 Racemic fluoroalkanes 
The fluorodeutero alkanes were analysed by chiral liquid crystal ^H NMR to 
investigate whether the enantiomers could be resolved (Fig 2.9). 
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Fig 2.9a ^H NMR of 2-fluoror2-^H]-hexane in PBLG and chloroform (Bruker AC-
250 , 250.133 MHz) 
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Fig 2.9b ^H NMR of 3-fluoror3-^H]-hexane in PBLG and chloroform (Bruker AC-
250, 250.133 MHz) 
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Fig. 2.9c ^H NMR of 2-fluoro[2-^H]-heptane in PBLG and chloroform (Unity Inova 
500 MHz) 
a 7 
Fig 2.9d^H NMR of 3-fluoro[3-^H]-heptane in PBLG and chloroform (Unitv Inova 
500MHz) 
39 
Fig 2.9e ^H NMR of 3-fluoror3-^Hl-octane in PBLG and chloroform (Unitv Inova 500 
MHz) 
Fig 2.9f ^H NMR of 4-fluorof4-^Hl-octane in PBLG and chloroform Olnitv Inova 
500 MHz) 
The two enantiomers of the 2-fluoro[2-'^H]-hexane, 3-fluoro[3-'^H]-hexane, 2-
fluoro[2-^H]-heptane, 3-fluoro[3-^H]-heptane and 3-fluoro[3-^H]-octane are clearly 
resolved and the resultant spectra are shown in figures. 2.89a- 2.9e. In the NMR 
spectra of the 4-fluoro[4-^H]-octane only the deuterium-fluorine coupling is 
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Fluoroalkane AVQI - AVQ2(HZ) Machine and Field 
2-Fluoro[2-^H]-hexane 2.3 (Bruker AC-250, 
250.133 MHz) 
3 -Fluoro [3 -^H] -hexane 3.5 (Bruker AC-250, 
250.133 MHz) 
2-Fluoro[2-^H]-heptane 4.7 (Unity Inova 500 MHz) 
3-Fluoro[3-^H]-heptane 5.6 (Unity Inova 500 MHz) 
3-Fluoro[3-^H]-octane 3.7 (Unity Inova 500 MHz) 
4-Fluoro [4-^H] -octane Not Resolved (Unity Inova 500 MHz) 
Table 2.3 Resolution of racemic fluoroalkanes by ^H chiral liquid crystal NMR 
It may be concluded that ^H chiral liquid crystal NMR is a very powerfiil tool for 
examining the enantiomeric excess of fluoroalkanes. It is demonstrated that it is 
possible to resolve the enantiomers of systems chiral by virtue of deuterium 
substitution, such as of 3-fluoro[3- H]-heptane and 3-fluoro[3- H]-hexane. This, at 
present, must be viewed as the upper limit of the technique, as when the fluorine is 
moved towards the centre of a slightly longer alkyl chain (e.g. 4-fluoro[4-^H]-octane), 
the two enantiomers are no longer resolved. 
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CHAPTER 3 
Fluorine in Bioorganic Chemistry 
Introduction and Background 
3.1 A historical perspective of fluorine 
The use of the mineral fluorospar (CaF2) as a flux (an additive to aid the soldering of 
a material), was first described in 1529 by Georgius Agricola. It was due to this early 
application that A.M. Ampere suggested to Sir Humphrey Davy, in 1812, that the 
element be named le fluor (Latin fluor^ flowing). In the 17* century, scientists 
discovered the curious property that fluorospar has of emitting light when heated and, 
in 1670, H. Schwanhard found that i f a strong acid was mixed with fluorospar 
corrosive vapours were evolved which could be used to decoratively etch glass. 
However, it was not until 1771 that C. W. Scheele was able to produce a crude 
solution of hydrofluoric acid. All attempts to isolate the fi-ee element by either 
chemical reactions or electrolysis were fiiistrated due to the extremely reactive nature 
of fi-ee fluorine. Eventually, in 1886, it was H. M. Moissan who succeeded in 
electrolysing a solution of KHF2 in HF to produce a gas which caused crystalline 
silicon to burst into flames. He cautiously reported the result "One can indeed make 
various hypotheses on the nature of the liberated gas; the simplest would be that we 
are in the presence of fluorine". Moissan was rewarded for his efforts by being given 
the Nobel Prize for Chemistry in 1906. 
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3.2 The nature of the carbon fluorine bond 
It has been said that i f a man were to have the features of fluorine, he would be small, 
greedy and violent, and would therefore be either ostracised by society or governing 
it.^ Fluorine has the smallest van der Waals radius of all the halogens (135 pm) and is 
comparable in size to the smallest atom, hydrogen (120 pm). Fluorine also has the 
property of being the most electronegative of the elements. These two features 
combined lead to the C-F bond being the strongest single bond involving carbon, 10% 
stronger than the C-H bond and considerably stronger than a C-C bond, which has a 
bond dissociation energy of 243 kJmol'^ The C-F bond length lies between that of C-
H and C-OH in magnitude (Table 3.1). 
X Van der 
Waals Radius 
(pm) 
Electronegativity 
(Pauling scale) 
Bond length C-X 
(pm) 
CH3X bond dissociation 
energy 
(kJmor') 
F 135 4.0 139 460 
CI 180 3.0 178 356 
Br 195 2.8 193 297 
I 215 2.5 214 238 
H 120 2.2 109 414 
0 140 3.5 143 (in OH) 
Table 3.1 A comparison of the halogens 
3.3 Fluorine's effect upon the bioactivity of molecules 
The small size and high electronegativity of fluorine have implications for its use in 
altering the biological activity of molecules. The substitution of fluorine into a 
molecule in the place of hydrogen introduces minimal steric alterations. This is 
particularly advantageous when the conformation of a molecule is important to its 
biological role, for example, in the way in which the molecule interacts with the 
active site of an enzyme. Once introduced into a molecule, the high C-F bond energy 
renders the substituents relatively resistant to metabolic transformations. In addition 
to this, fluorine's high electronegativity can have pronounced effects upon the 
electron distribution within the molecule. Other substituents will thus be rendered 
more or less reactive. Fluorine, having a high electron density, may act as a weak 
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hydrogen bond acceptor. It is also noteworthy that the C-F bond length (139 pm) is 
very similar in magnitude to the C-OH bond length (143 pm), and thus fluorine may 
be used as a hydroxyl substitute. 
The many different outcomes of substituting fluorine into a bioactive molecule make 
it difficult to predict to what extent the molecule's activity will be enhanced. The first 
significant report of the biological activity of a molecule being successfiilly modified 
by selective fluorination was Fried's preparation of 9-a-fluoro-hydrocortisone acetate 
(3.1).' 
Fig. 3.1 9-a-Fluoro-hydrocortisone acetate (3.1) 
3.4 Fluorine's role in medicine 
The number of commercially available drugs containing fluorine is rapidly increasing. 
Many of the current blockbuster medicines such as Eli Lilly's Prozac (fluoxetine) 
(3.2), the world's most prominent antidepressant in terms of both volume and sales, 
and Ciprofloxacin (3.3), a broad spectrum antibacterial which earns almost $200 m a 
year for Bayer, contain the element. 
+ 
HoN' 
CI C O 2 H 
w / / 
Prozac (3.2) Ciprofloxacin (3.3) 
Fig. 3.2 Fluorine containing drugs 
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The modes of action of fluorine containing drugs are many and varied. One common 
use of the element is in deceptor molecules. A common theme in enzyme-catalysed 
reactions is the loss of a proton. In many medicines, for example the anticancer drug 
5-fluorouracil (3.4), the therapy takes advantage of the fact that the substitution of 
fluorine for hydrogen does not alter the size and shape of the molecule. The fluorine 
effectively acts as a deceptor. The enzyme thymidine synthase mediates the 
conversion of deoxyuridine monophosphate to thymidine monophosphate. The 
reaction proceeds with the substrate, enzyme and tetrahydrofolic acid (CH2FAH4) 
forming a ternary complex; the dissociation of this complex by the elimination of 
FAH4 to form the product requires the loss of the C-5 proton. The analogous reaction 
cannot proceed with 5-fluorouracil as this would involve the loss of a fluoro cation, an 
energetically unlikely event. Instead, the 5-fluorouracil is converted in vivo only to 5-
fluorodeoxyuridine monophosphate and DNA and RNA directed cytotoxicity result 
(Scheme 3.1).^ '^ 
Tetrahydrofo^add | c H . F A H , 
O ^ N ^ X - E 
I R 
5-fluorouracil (3.4) 
Scheme 3.1 Mode of action of 5-fluorouracil 
Another role of fluorine in medicinal chemistry is to impart increased hydrolytic 
stability to compounds. There are many bioactive molecules which contain readUy 
hydrolysed functional groups such as enol ethers, ketals and glycosidic bonds. This is 
a particular problem when orally administered medicines come into contact with the 
strongly acidic environment of the stomach. The electron withdrawing properties of 
fluorine can be exploited by introducing the element proximal to the site where 
protonation initiates hydrolysis. This has been successfully used to increase the half 
life of certain drug candidates. 
One notable case has been the increase in the hydrolytic stability of prostacyclin 
(PGI2) an inhibitor of platelet aggregation. The native molecule has a Xm = 2-3 
minutes, in contrast to 7-fluoro-PGl2 (3.5) with a ti/2= 1 month.^ 
X-Enzyme 
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.C02H 
Ha"" 
Fig 3.3 7-Fluoro-PGb (3.5) 
The exact modes of action of other drugs are less clear-cut and understood, for 
example, although it is known that the trifluoromethyl group in Prozac (3.2) increases 
the molecule's lipophilicity its function as a serotonin uptake inhibitor is not well 
documented. 
3.5 Halogenated natural products 
Until 1954 only a dozen halogenated natural products were known. In 1968, Fowden 
wrote: "present information suggests that organic compounds containing covalently 
bound halogens are found only infrequently in living organisms".^ The past half-
century has shown this to be a misconception, as today more than 3000 such 
compounds are known. This vast number may be attributed, almost equally, to 
bromine and chlorine containing compounds, though there are almost 100 known 
iodinated natural products. The majority of iodinated natural products known to date 
occur as compounds such as the thyroid hormone thyroxine (3.6). This smaller 
number may not be a true representation of the quantity of existing organoiodides, as 
the relatively unstable C-I bond may lead to difficulties in isolating such compounds. 
Over 1000 organohalogens have been isolated from marine plants. One species alone, 
the favourite edible seaweed of most native Hawaiians "limu kohu" {Asparogopsis 
taxiformis), contains almost 100 organohalogen compounds, and 80% of its weight is 
composed of bromoform (CHBrs). 
The organohalogens are structurally diverse, some of the simpler structures are those 
of the halogenated monoterpenes produced by marine algae. Compounds 3.7 and 3.8 
were first isolated from the sea hare, Aplysia californica which grazes upon algae 
containing these metabolites. The sea hare is thereby not only using the algae as a 
source of nutrition but also as a provider of chemical protection. ^ The sea hare shares 
this technique of stealing its chemical defence with the sea slug Chromodoris 
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hamiltoni. The sea slug contains four chlorinated homo-diterpenes, one of which is 
hamiltonin C (3.9), as a consequence of feeding upon sponges. Halogenated terpenes 
are also biosynthesised by terrestrial plants, for example, Asian bracken ferns contain 
various chlorinated pterosins such as pterosin F (3.10) an anti-feedant responsible for 
cattle poisoning.^ One historically noteworthy compound is the ancient Egyptian dye, 
Tyrian purple (3.11), the brominated analogue of indigo.^ 
I I. 
° > > > C O . H 
I H2N 
thyroxine (3.6) 
OH 
hamiltonin C (3.9) pterosin F (3.10) Tyrian purple (3.11), 
OH OH 
blattellastonide (3.12), 
epibatidine (3.13), 
-0 ,0 
vancomycin (3.14) 
Fig 3.4 Halogenated natural products 
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Various halogenated steroids have been isolated from an assortment of sources 
including sponges and terrestrial plants. One particularly interesting example is that of 
blattellastonide (3.12), the German cockroach pheromone.'^ 
Although there exist a huge number of known alkaloids, so far only a few halogenated 
examples have been discovered. One such compound is epibatidine (3.13), a potent 
analgesic secreted by the Equidorian frog Epipedobates tricolor}^ 
Vancomycin (3.14) is one of the rnost medicinally important of the halogenated 
natural products and also one of the most structurally complex. This huge 
glycopeptide antibiotic is the drug of choice to treat methicillin-resistant 
Staphylococcus aureus infections, particularly those occurring in hospitals.'^ The 
chlorine atoms are essential for enforcing the molecule into the required conformation 
for receptor binding. 
3.6 Mechanisms for biohalogenation 
The biohalogenation of secondary metabolites has traditionally been thought to 
proceed via a haloperoxidase type mechanism. The haloperoxidase enzyme catalyses 
the oxidation of a halide ion to the corresponding hypohalous acid. The halogen is 
thus activated as an electrophile and may halogenate the organic substrate. 
(Scheme 3.2) 
haloperoxidase 
H2O2 + X" , HOX + 140 
Scheme 3.2 The haloperoxidase reaction 
The various haloperoxidases are classified firstly with respect to their oxidising 
capabilities:-
Chloroperoxidases may oxidise CI, Br and I . 
Bromoperoxidases may oxidise Br and I 
lodoperoxidases may oxidise only iodine. 
Secondly, the enzymes are categorised with respect to the nature of their active site. 
Three different classes emerge :- haem-containing, vanadium-containing and metal-
free haloperoxidases. It has been suggested that the mode of action of the metal-free 
haloperoxidases is firstly the perhydrolysis (lysis with hydrogen peroxide) of acetic 
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acid to form peracetic acid. The peracetic acid then diffiises away from the active site 
of the enzyme and oxidises a halide. (Scheme 3.3)'^ 
^ enzyme ^ 
+ H2O2 — II + H2O 
OH ^ ^ ^ 0 - O H 
0 0 
+ X" + H"" 11 + H2O 
0—OH ^ ^0—X 
Scheme 3.3 Activation of halogens bv peracetic acid formed from acetic acid and 
hvdrogen peroxide 
There exists some dispute within the literature as to whether these enzymes are true 
haloperoxidases. The enzymatic ability to catalyse perhydrolysis is not as rare as 
initially thought, and is not limited to haloperoxidases. It has been shown, using the 
same in vitro conditions employed in the study of metal free haloperoxidases, that 
lipases are able to catalyse the perhydrolysis of the corresponding long chain 
carboxylic acids. Esterases were also shown to catalyse the perhydrolysis of acetic 
acid. In addition, it has been demonstrated that the rates of halogenation catalysed by 
the metal free haloperoxidases are significantly lower than those displayed by the 
metal-containing microbial haloperoxidase derived from Curvularia verruculosa}^ 
The literature also raises the question as to whether it is more likely that NADH 
dependant halogenases are responsible for biohalogenation than haloperoxidases. 
The analysis of the genes responsible for pyrrobitrin biosynthesis (3.19) showed no 
evidence for the presence of a haloperoxidase on the biosynthetic pathway. An 
alternative mechanism, that would lead to greater substrate specificity and 
regiospecificity, has been proposed. In this hypothesis, the enzyme would react first 
with the substrate to be halogenated, activating it as the epoxide for subsequent 
nucleophilic attack by a halide anion. (Scheme 3.4)^ ^ 
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CO2H NADH, O2. NAdt H2O 
3.15 
H CO2H 
CI NH2 H 
H2O 
H, CO2H 
H COoH 
Scheme 3.4 Pvrrolnitrin biosynthesis 
3.7 Fluorinated secondary metabolites 
Fluorine is the most abundant halogen in the earth's crust, however, paradoxically 
there exist only a few known fluorinated natural products; these include fluoroacetate 
(section 3.7.2), the co-fluorofatty acids (section 3.7.3), fluoroacetone (section 3.7.4), 
fluorocitrate (section 3.7.5) and nucleocidin (section 3.7.1). The fluorinated 
metabolites have been predominantly isolated from tropical and sub-tropical plant 
species and, to date, there are no known examples biosynthesised in the marine 
environment or by members of the animal kingdom. 
One reason for the dearth of fluorinated secondary metabolites is fluorine's poor bio-
availability. Although fluorine is the 13* most abundant element in the earth's crust, 
many of the mineral fluorides (e.g. fluorospar) are insoluble in water. This becomes 
very apparent when examining the relative concentrations of fluoride and chloride 
present in the earth's crust and in sea-water. 
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Cbncentratioii in the earth's crust (ppm) Concentration in sea water (ppm) 
F 544 1.3 
CI 126 19 000 
Table 3.2 Concentrations of fluorine and chlorine in the earths crust and in sea water 
Another reason for the low occurrence of fluorinated secondary metabolites is the 
difficulty of activating fluorine so that it may become involved in biochemical 
processes. 
The fluoride anion is a poor nucleophile, fluoride also has a high enthalpy of 
hydration and a sphere of surrounding water molecules fijrther compromise the 
anion's nucleophilicity. Activation of fluorine for electrophilic chemistry, by a 
haloperoxidase reaction, also appears unlikely as this would require overcoming an 
extremely high redox potential. 
Heat of hydration of X" (kJmor*) Standard redox potential (V) 
F 490 -3.06 
CI 351 -1.36 
Br 326 -1.07 
I 285 -0.54 
Table 3.3 Comparative heats of hvdration and redox potentials of the halogens 
3.7.1 Nucleocidin 
In 1957, a culture of the bacterium Streptomyces calvus, that had been isolated from 
an Indian soil sample, was observed to produce a novel secondary metabolite. The 
natural product displayed broad spectrum antibiotic activity, and was an especially 
effective antitrypanosomal agent. Clinical use of this antibiotic was curtailed by its 
extreme toxicity. The empirical formula of C11H16N6SO8 was initially ascribed to the 
compound. During the 1960's the formula was revised twice, and it was eventually 
realised that some of the complexity in the ^H NMR was due to protons coupling with 
fluorine rather than hindered rotation, as previously believed. Total synthesis of the 
compound, in 1976, finally confirmed it to be 4'-fluoro-5'-0-sulfamoyl-adenosine 
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1 Q 
(3.20). The presence of fluorine in the metabolite was rather a surprise as the 
medium in which the micro-organism had been grown had not been supplemented 
with fluoride. However, levels of the antibiotic produced were low, and it was 
discovered that the fluoride was present as a trace impurity in the com liquor used to 
culture the bacterium. 4'-Fluoro-5'-0-sulfamoyl-adenisine (nucleocidin) is the only 
metabolite known to display a fluoro-sugar moiety. Subsequent attempts to encourage 
the organism to produce the compound again have failed, and the compound's 
biosynthesis remains a mystery. 
OH 
Fig 3.5 Nucleocidin (3.20) 
3.7.2 Fluoroacetate 
Fluoroacetate is by far the most abundant of the fluorometabolites. To date, at least 30 
plant species, principally leguminous varieties, have been found to accumulate 
considerable quantities of the compound.'^ Fluoroacetate was first identified by 
Marais, in 1943, as the toxic component in the South African plant Dichapetalum 
cymosum?^ This plant is responsible for considerable cattle death in the Transvaal 
region. The plant is most toxic in the early spring, having the capability to accumulate 
up to 2500 ^ig g"* dry weight, in the yoimg leaves. 
O 
O 
F 
Fig 3.6 Fluoroacetate (3.21) 
To date, the highest levels of fluoroacetate accumulation have been observed in the 
Brazilian plant Palicourea margravii and the seeds of the Tanzanian plant 
Dichapetalum hraunii. The flower stalk and seeds of the former plant can accumulate 
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fluoroacetate up to 5000jLig g''dry weight,^ Vhereas the latter has the ability to 
accumulate a very high level of 8000|ig g"' dry weight.^^ 
The level of fluoroactetate has been observed to vary considerably between the 
different organs of one particular species of plant, the leaves and the seeds tending to 
accumulate the compound to a higher concentration. Fluoroacetate concentrations 
have also been shown to fluctuate through the seasons, the maximum protection being 
afforded to the young leaves, in the spring, to deter grazers. Geographical location, 
also, impacts upon the levels of fluoroacetate found within the same species. This 
may reflect the amount of fluoride present in the soil, but also suggests considerable 
genetic variability exists within the species in its ability to produce fluoroacetate. 
Many plants have the capacity to biosynthesise and bioaccumulate fluoroacetate and 
fluorocitrate, to some level, when grown in soils with a sufficient fluoride 
concentration. For example, commercial tea from the plant Thea sinensis can contain 
as much as 30 \ig g"^  dry weight of fluorocitrate, and levels of 60 |xg g'^  have been 
reported in oatmeal. (Such levels are well below toxilogical significance.^ "*) 
This finding suggests that plants, in general, have the latent ability to biosynthesise 
and store the fluorometabolite toxins to some extent. It is an evolutionary refinement 
that has amplified this ability, in some plants, for use as a defence mechanism. 
3.7.3 (o-Fluorofattv acids 
Dichapetalum toxicarium is a shrubby plant from Sierra Leone which is know to 
accumulate fluoroacetate in its leaves. It has also been shown to store various co-
fluorofatty acids in its seeds (concentrations in the region of 1800|ig g"^  dry weight). 
Up to 3 % of the lipids within the seed are fluorinated, the most abundant being co-
fluoro-oleic acid (CI8:IF).^^' Eight other oo-fluoro compounds including saturated 
and unsaturated acids have been identified:- CIO.OF, CMIOF, CI6:OF, CI6:IF, CI8:OF, CI8:2F, 
C20:0F, and C20:1F. 
The relative concentrations of these ©-fatty acids mirror those of the unfluorinated 
analogues. This suggests that the co-fluorofatty acids are processed via the enzymes 
associated with fatty acid metabolism. Fatty acid synthases (FASs) have broad 
substrate specificity and may utilise a range of different starter units. The fluorofatty 
acids identified to date all have fluorine at the co-position, implying that enzymatic 
constraints operate at subsequent stages of the biosynthetic process. It would appear 
that fluoroacetate incorporated as the starter unit iato these oo-fluorofatty acids, is not 
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biosynthesised within the seed. Results from a study of the distribution of 
fluoroacetate within the plant, point to fluoroacetate first being biosynthesised within 
the young leaves and then being transported, after fertilization of the flower, to the 
developing embryo where fluoroacetyl-CoA is then incorporated into the fatty acids. 
777reo-18-fluoro-9,10-dihydroxystearic acid (3.26) has been isolated from the 
saponified seed oil of D. toxicarium. It is envisaged that this compound is 
biosynthesised from co-fluorooleic acid (3.23) via an intermediate 9, 10-epoxide 
(3.24). The diol may be an artefact, having arisen from hydrolysis of the epoxide 
during the isolation process. 
o 
0' 
(3.21) 
0 n X malonyl-ACP 
SCoA 
(3.22) 
0 
SACP 
n=4,6,7,8 
steroyi des^tarase 
O released as fatty acids 
^SACP 
(o-fluoropleoyl-SACP (3.23) 
[0] 
SACP 
SACP 
Scheme 3.5 Biosynthesis of threo-18-fluoro-9.10-dihydroxvstearic acid (3.26) 
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3.7.4 Fluoroacetone 
In 1967, Peters and Shorthouse discovered that when they incubated various plants, 
including Acacia georginae, with a source of inorganic fluoride, the total level of 
fluorine present was diminished. The volatiles from these tissue cultures were bubbled 
through a solution of 2,4-dinitrophenylhydrazine and the 2,4-dinitrophenylhydrazone 
derivative of fluoroacetone was identified. The amount of 2,4-dinitrophenylhydrazone 
derivative collected accounted for only 13% of the total fluorine lost, the remainder, 
they postulated, was lost as other volatile organofluorine compounds that were co-
produced.^^ This study on fluoroacetone stands alone in the literature, and the 
compound's biosynthesis was never investigated. 
A hypothetical biosynthesis of fluoroacetone (3.29) has been proposed from the 
decarboxylation of 4-fluoroacetoacetate (3.28).^ ^ 
O O malonyl-ACP 
O r SCoA 
O O 
SACP 
F F F 
(3.21) (3.22) (3.27) 
O 0 0 
OH 
F F 
fluoroacetone(3.29) 4-fluoroacetoacetate(3.28) 
Scheme 3.6 Hypothetical biosynthesis of fluoroacetone 
3.7.5 (2R, 3Jg)-2-Fluorocitrate 
A common co-metabolite of fluoroacetate is fluorocitrate (3.31). Citrate synthase on 
the citric acid cycle, mediates the condensation of fluoroacetyl-CoA (3.22) with 
oxaloacetate (3.30). This reaction is highly stereospecific, and the 2-pro-S proton of 
fluoroacetyl-CoA is abstracted exclusively. This implies that the C-C bond of the 
fluoroacetyl-CoA is locked from rotation either because of constraints induced by the 
active site of the enzyme or because of stereoelectronic control imparted by the 
presence of the fluorine atom. The condensation proceeds with inversion of 
stereochemistry affording {2R, 3/?)-2-fluorocitrate as the only stereoisomer. ' ' ' 
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S/face attack 
Ho.c^ 1 ^ ' " ' " ^ N X H O ^ C ' ^ . J ^ ^ ^ C O . H 
^ ^ ^ ^ C 0 2 H > f ^ S C o A inversion at C-2 ^ ^ C , 
H / 'HS H / 
oxaloacetate(3.30) fluoroacetyl-CoA (3.22) (2R, 3R)-2-fluorocitrate (3.31) 
Scheme 3.7 Biosynthesis of fluorocitrate (3.31) 
The toxicity of fluoroacetate arises from its conversion to (2R, 3/?)-2-fluorocitrate (the 
other 3 isomers are not toxic). Fluorocitrate is an inhibitor of aconitase the ensuing 
enzyme on the citric acid cycle, which is responsible for the interconversion of citrate 
and isocitrate.^ "^ Kinetic studies on the enzymatic inhibition of aconitase by (2R, 3Ry 
2-fluorocitrate present a Ki value of 1 ^ M , a value which is inconsistent with the 
observation that fluorocitrate is toxic at the level of 10"^  ^ iM. The discrepancy can be 
explained by the fact that (2R, 37?)-2-fluorocitrate also inhibits citrate transport across 
the mitochondrial membrane. It has been demonstrated that '"^C-radiolabelled 
fluorocitrate forms a covalent bond with the citrate carrier protein. 
Accumulation of {2R, 3i?)-2-fluorocitrate ultimately arrests the citric acid cycle (the 
energy pathway of all living organisms). In mammals, this leads to convulsions and 
ultimately heart failure and death. 
3.8 Resistance to fluoroacetate poisoning 
Fluoroacetate is not especially toxic; it is the compound's conversion via fluoroacetyl-
CoA to {2R, 3i?)-2-fluorocitrate in "the lethal synthesis", which has the fatal effect. In 
vitro studies have shown that protein extracts of the plant D. cymosum are capable of 
selectively hydrolysing fluoroacetyl-CoA over acetyl-CoA thus preventing the 
formation of {2R, 37?)-2-fluorocitrate.'^^ It has also been postulated that host plants 
have evolved so that their citrate synthase enzyme will not accept fluoroacetyl-CoA."*^ 
Alternatively, some plants may have developed the ability to segregate any 
fluoroacetate produced, removing it from the mitochondria so that it cannot be 
processed to (2/?, 3i?)-2-fluorocitrate.'*^ There are very little experimental data to 
support this hypothesis. 
The ability of some micro-organisms, such as the fungus Fusarium solani and various 
Pseudomonas Spp., to grow on fluoroacetate producing plants has been known for 
many years."^ '^ The micro-organisms are capable of utilising fluoroacetate as their 
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sole carbon source. Such organisms have the unique ability to enzymatically cleave 
the exceptionally strong C-F bond. Initial reports ascribed the defluorination ability to 
the presence of a thiol group at the active site of the enzyme. However, it is noted that 
iodoacetate and iodoacetamide, classical thiol poisons, fail to inhibit the enzyme's 
defluorination activity."^ "^  
More recently, a number of dehalogenating enzymes have been studied in detail, and 
their modes of action are better understood.'*^ Fluoroacetate dehalogenase from 
Moraxella sp. B. has an amino acid sequence that is significantly similar to that of 
haloalkane dehydrogenase fromX. autotrophicus GJIO, in the regions corresponding 
to the active site. The active site of the dehalogenase and the defluorinating enzyme 
both contain histidine and aspartate side chains as catalytic residues,'* '^ in contrast to 
the thiol residue initially proposed."*^ 
It has been suggested that the catalytic mechanism proceeds with the aspartate 
carboxylate, acting as a nucleophile, displacing the fluoride ion and forming a 
covalently bound ester intermediate. The ester is subsequently hydrolysed by water 
that has been activated by the histidine residue. 
H l s - < J 
N 
o o ^ 
Asp-C^ X O" Asp-C^ ^ 
-F-
Asp-C. 
O 
Scheme 3.8 Putative mechanism for the defluorination of fluoroacetate 
This hypothesis was investigated by incubating the enzyme vsdth fluoroacetate and 
[^^O] water. The enzyme was digested and the fragments examined by mass 
spectrometry. The aspartate residue from the active site was found to have 
incorporated two *^0 atoms,"*^  consistent with the hydrolysis of the proposed aspartate 
ester intermediate. 
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3.9 Proposed mechanisms of biological fluorination 
Although more than 50 years have past since Marais discovered the first 
fluorometabolite,^^ we know little more today than then about the mechanism by 
which nature forms the C-F bond. The literature, however, contains many 
unsubstantiated proposals as to how the fluorination event may proceed. 
3.9.1 Formation of the C-F bond by addition of fluoride to a carbon-carbon 
multiple bond 
3.9.1.1 Pyridoxal phosphate catalysed incorporation of fluoride 
Mead and Segal recognised that many plants contain a wide variety of yff-substituted 
alanines. The biosynthesis of these compounds may proceed by the nucleophilic 
attack to C-3 of the pyridoxal phosphate enamine adduct (3.32), formed after the 
eUmination of the y^-substituent from either serine or cysteine."^ '^ 
H2O3PO 
CO2H 
H2O3PO 
X=OH, serine 
X=SH, cysteine 
X=OAc, 0-acetylserine 
CO2H 
H2O3PO 
CO2H 
XO2 
NHs 
B-substituted alanines Isolated from Acada spp. include:- Y=CN (3.33), Y=SH (3.34) 
H2N NH N 
HO 
(3.35) (3.36) N 
(3.37) 
Scheme 3.9 The putative biosynthesis ofy?-substituted alanines 
The fact that many different y^-substituted alanines have been identified in plants (e.g. 
3.33-3.37) implied that the enzyme regulating the nucleophilic addition to the 
enamine adduct, had low substrate specificity. Mead and Segal questioned whether 
this enzyme would accept fluoride as a nucleophile. Were this the case, attack of 
fluoride at C-3 of the pyridoxal phosphate enamine adduct would generate 
fluoropyruvate bound to pyridoxamine phosphate. Conversion to fluoroacetate could 
then proceed either by hydrolysis to fluoropyruvate (3.38) and then oxidative 
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decarboxylation to fluoroacetic acid, or by direct decarboxylation and hydrolysis to 
fluoroacetaldehyde (3.39) which could be subsequently oxidised to fluoroacetic 
acid.^ ^ There is some evidence for the former mechanism as intact cells of D. 
cymosum have been shown to mediate the oxidative decarboxylation of 
fluoropyruvate to fluoroacetate. 
F 
I 
,co; 
NH3 
+ 
B-fluoroalanine 
(3.40) 
H2O3PO 
CO2H 
H2O3PO 
hydrolysis 
fluoroacetaldehyde (3.39) 
CO2H 
fluoropyruvate(3.38) 
fluoroacetic acid (3.21) 
Scheme 3.10 A proposed mechanism by which pyridoxal phosphate catalyses the 
incorporation of fluoride 
To investigate their hypothesis. Mead and Segal examined the conversion of L-
cysterne to pyruvate, in acetone powders of A. georginae. They discovered that when 
cyanide was added the conversion was inhibited and y9-cyanoalanine (3.33) was 
produced instead. This suggested that the pyridoxal phosphate enamine adduct had 
undergone nucleophilic addition by CN", and implied a lack of substrate specificity by 
the enzyme. Unfortunately, when they repeated the experiment, using fluoride in 
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place of cyanide, no fluoride uptake was evident and no fluoropyruvate was 
observed 53 
3.9.1.2 Fluorination of ethylene 
Peters and Shorthouse observed the ability of Acacia georginae to diminish the levels 
of fluoride administered to it. They were able to trace 13% of this fluoride being 
converted to fluoroacetone but, clearly, 87% remained unaccounted for. Noting the 
plants capacity to produce the hormone ethylene (3.41), Peters questioned whether the 
plant was able to fluorinate the ethylene and loose the resultant volatile. He speculated 
that the ethylene was converted to either vinyl fluoride (3.43) or fluoroethane (3.42) 
and then these compounds were converted to fluoroacetate. No plausible mechanism 
was proposed for these reactions and the proposals remain speculative.^ "^  
Ethylene oxide (3.44) is known to be a major product of ethylene metabolism in 
plants.^ '^ Fluorination of this activated compound would provide another 
explanation as to how fluorine is incorporated into the organic system. 
H F 
> ^ C H 3 
H 
fluoroethane (3.42) 
H2C—CH2 
ethylene (3.41) 
O 
H 
CH, 
vinyl fluoride (3.43) 
OH 
H-7 
H H 
ethylene oxide (3.44) fluoro ethanol (3.45) 
O 
OH 
fluoroacetatic acid (3.21) 
Scheme 3.11 A Putative biosynthesis of fluoroacetic acid from ethylene 
However, it should be noted that Peters and Shorthouse also demonstrated that non-
fluoroacetone / fluoroacetate producing plants were also able to lose fluoride. To 
explain this, one has to argue that these plants are unable to convert the volatile 
intermediates to fluoroacetone or fluoroacetate. In addition, concentrations of vinyl 
fluoride and fluoroethane should be significant in the atmosphere. Extensive research 
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into the atmospheric composition, in relation to studies on the diminution o f the ozone 
layer, has not revealed any fluorocarbons for which an anthropogenic source has not 
been clearly identified. ' 
3.9.2 Nucleophitic substitution by fluoride 
A number o f micro-organisms have the capability o f utilising fluoroacetate as their 
sole source o f carbon. This requires a defluorination process (see section 3.8). 
Enzymes catalysing the conversion o f fluoroacetate to glycolate and fluoride, have 
been isolated fi:om several micro-organisms.'^^ 
The reactions catalysed by enzymes are, by definition, reversible; thus it is possible 
that the mechanism o f defluorination might hold the key to biological fluorination. 
The substitution o f a hydroxyl group o f a glycolate, by fluoride is not energetically 
demanding and could, in theory, occur under normal physiological conditions i f 
coupled energetically to a reaction that proceeds spontaneously. Though the hydroxyl 
moiety is not a good leaving group, it could be activated, for example, as a phosphate 
moiety, which could be more readily displaced by fluoride. 
Goldman and Milne, investigated whether the defluorination enzyme fi-om a 
Pseudomonas sp. could mediate the reverse reaction. They incubated the enzyme with 
fluoride and glycolate in the presence o f [^^O] water, and argued that even i f the 
amount o f fluoroacetate produced was chemically undetectable, the reversibility o f 
the reaction should be reflected by a level o f uptake o f ^^O into the glycolate. 
However, no significant uptake o f ^^O was detected in the glycolate, by mass 
spectrometry.^^ 
3.9.3 Nucleophilic attack by fluoride on a halonium ion 
Haloperoxidase reactions with alkenes have been shown to be dependent upon the 
relative concentrations o f the anions. I f there is a sufficiently high concentration o f the 
anion a 1,2-dihalo species may be formed. 
haloperoxidase 
K 
/ " 
Br" H2O2 
R" 
Br Br 
Scheme 3.12 Reaction o f a haloperoxidase with an alkene to form a 1.2-dihalo species 
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Neidleman and Geigert were able to exploit this idea. Using equivalent concentrations 
o f fluoride and iodide in the presence o f horseradish peroxidase and H2O2, they 
demonstrated the conversion o f allyl alcohol (3.46) to 2,3-fluoroiodopropan-l-ol 
(3.47).^^ 
horseradish peroxidase 
HO 
H2O2, i r F -
I 
ailyl alcohol (3.46) 2, 3-fluoroiodopropan-1-ol(3.47) 
Scheme 3.13 The horseradish peroxidase catalysed formation o f 2 3 -
fluoroiodopropan-l-ol from allvl alcohol 
On the basis o f this experiment, Neidleman and Geigert, proposed that fluoroacetate 
could be biosynthesised by the iodofluorination o f an ©-unsaturated fatty acid; the 
fatty acid subsequently undergoing de-iodination and P-oxidation. 
CO2H 
iodoperoxidase 
CO2H CO2H 
2e'+ H"" 
0 p-oxidation 
0- CO2H 
Scheme 3.14 Neidleman and Geigert's proposed biosynthesis o f fluoroacetate by 
iodofluorination o f an cp-unsaturated fatty acid 
This hypothesis would have contradicted the role o f fluoroacetate as a starter unit in 
co-fluorofatty acid biosynthesis, and is, therefore, weakened. In addition, the study 
provided no evidence to substantiate this theory, but suggested that the examination o f 
the iodine content o f fluoroacetate producing plants might be revealing.^^ Detailed 
GCMS studies have not revealed the presence o f any co-iodofatty acids in the extracts 
o f D. toxicarum seeds. 
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3.10 Contemporary studies into biological fluorination 
I n order to arrive at a better understanding o f the mechanism o f biological 
fluorination, fluoroacetate emerges as the most obvious system to study. Not only is it 
the most common o f the fluorinated natural products, but it is also, structurally, the 
least complex. 
Investigations into the biosynthesis o f fluoroacetate have been thwarted by many 
factors, which one by one are gradually being overcome. Initial problems with 
detection and analysis o f fluorinated compounds have, to some extent, been solved by 
the advent o f more sensitive GCMS techniques and the use o f '^F NMR. There are 
also many problems associated with working with whole plant systems. Difficulties 
arise in acquiring fresh supplies o f uniform genotype o f the plants capable o f 
biosynthesising fluoroacetate. Such species tend to be native to the less accessible 
areas o f Australia, Africa and South America. The development o f a callus tissue 
culture o f D. cymosum provided a more amenable system in which to study biological 
fluorination, however the levels o f fluoroacetate production were very low. 
I n 1985, a significant break through was achieved. Workers investigating ways in 
which to improve the production o f the p-lactam antibiotic, thienamycin (3.48), by the 
bacterium Streptomyces cattleya^ discovered that the organism had produced two new 
metabolites. The metabolites were fluoroacetate, and the previously unknown amino 
acid, 4-fluorothreonine (3.49). The workers were particularly surprised, as the growth 
media had not been supplemented with any fluoride. On analysis o f the broth 
components, the soy bean casein that had been employed was revealed to have a 
fluoride content o f 0.7%.^^ 
OH O 
"O 
NH^ 
thienamycin (3.48) 4-fluorothreonine (3.49) 
Fig 3.7 Thienamycin and 4-fluorothreonine 
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3.11 The Biosynthesis of fluoroacetate and 4-fluorothreonine 
The biosynthesis o f fluoroacetate and 4-fluorothreonine has been extensively 
investigated in resting cells o f S. cattleya. The resting cell systems are prepared from 
batch cells o f the organism that has just reached the idiophase. The organism is no 
longer involved in primary metabolism and cell growth, but in sporulation and 
secondary metabolism (see section 1.1.2). The cells are harvested and suspended in 
buffer. A system is used in which the putative intermediates administered are the only 
carbon source available to the organism. 
Initial studies by Sanada et al., demonstrated that 4-fluoroglutamate, fluoroacetate, 
and KF could all be utilised as a source o f fluorine for the biosynthesis o f 4-
fluorothreonine, whereas fluorocitrate was ineffectual. I t was noted that when 
fluoroacetate was utilised as the source o f fluoride, after 48 hours, there was a 
diminution o f 4-fluorothreonine. The workers also showed the conversion o f 
fluoroglutamate and 4-fluorothreonine to fluoroacetate, by resting cells o f S. cattleya. 
From this information, a biosynthesis was proposed in which an unknown substrate is 
fluorinated and then converted to fluoroacetate. The fluoroacetate (3.21) is 
subsequently converted to fluoroacetaldehyde (3.39), which in turn undergoes a 
condensation reaction with glycine to yield 4-fluorothreonine (3.49) (Scheme 3.15).^^ 
o o OH o 
F + unknown substrate f ^ \ I ^ 
F F F NH3^ 
fluoroacetate (3.21) fluoroacetaldehyde (3.39) 4-fluorothreonine (3.49) 
Scheme 3.15 A proposed biosynthesis o f 4-fluorothreonine from fluoroacetate 
I n 1995, Soda et al published an account o f their investigations into the biosynthesis 
o f fluoroacetate and 4-fluorothreonine in S. cattleya.Using ^^ F N M R to measure the 
relative concentrations o f the two fluorometabolites, they observed that fluoroacetate 
accumulated first, in the resting cells, and 4-fluorothreonine became visible three days 
later. From this finding, it was concluded that fluoroacetate is a precursor o f 4-
fluorothreonine. Such concentration studies are not necessarily a reliable method o f 
determining a metabolite's position on a biosynthetic pathway. I t cannot be ruled out 
that 4-fluorothreonine formed first but existed in a low steady state concentration, due 
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to its rapid conversion to fluoroacetate, and as such was not detectable by the 
relatively insensitive *^ F N M R technique employed to measure the concentrations. 
Studies by Reid et al. ^"^contradict the findings o f Soda,^^ stating that 4-
fluorothreonine was detectable in the culture medium 24 hours before fluoroacetate. 
Soda et al. sought to determine the origin o f the carbon skeleton o f fluoroacetate by 
administering various radio-labelled, putative intermediates to resting cells o f 5". 
cattleya. [U-'^^C]Glycerol, glucose, p-hydroxypyruvate and L-serine were seen to be 
incorporated at a level o f 0.2-0.4%, whereas [3-*'^C]pyuvate, [2,3-''^C]succinate and 
[U-'^^C] aspartate were only incorporated to an extent o f 0.04-0.08% implying that 
these latter metabolites are more remote from the fluorination event. 
A key experiment was performed, incubating [2-^^C]glycerol (3.50) with resting cells 
o f a mutant organism, S. cattleya NTG29 that had been generated by treating the wild 
type, S. cattleya NRRL 8057, with N-methyl-N'-nitro-N-nitrosoguanidine, a chemical 
mutagen. Analysis o f the resultant fluoroacetate by ^H, '^C and '^F N M R indicated 
that the label was incorporated exclusively into the carbonyl carbon o f the 
fluoroacetate at a level o f 40%. 
OH S. cattleya O 
HO. 
[2-''^C]glyGerol (3.50) 
Scheme 3.16 Incorporation o f glycerol into fluoroacetate 
The study was extended to incorporation experiments with [U-'^^C], [3-*'*C] and [ 1 -
'"^Cl-p-hydroxypyruvate. Incorporation o f the label from the first two compounds into 
fluoroacetate was observed, but very little isotope incorporation resulted from C-1 o f 
the hydroxypyruvate. Clearly, only the C-2 and C-3 o f P-hydroxypyruvate are 
significantly incorporated into fluoroacetate. I t was concluded that the carbon 
skeleton arises from glycerol, which is converted to p-hydroxypyruvate and is then 
processed through to fluoroacetate by fluorination and decarboxylation. 
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decarboxylation 
O 
Q_ fluorination 
OH \ . 
glycolate (3.52) O 
O 
glycerol p-hydroxy pyruvate 
(3.51) O 
fluorination p \\ q- 'clecarboxylation 
O 
(3-fluoropyruvate (3.53) 
Scheme 3.17 Possible biosynthetic routes to fluoroacetate through P-hydroxvpyruvate 
I n order to explore whether the decarboxylation or fluorination event occurred first, 
[2-*^C] and [1,2-^^C] glycolate were administered to separate cultures o f S. cattleya. 
I n the event, only low incorporation resulted, and it was concluded that glycolate is 
not significant in fluoroacetate biosynthesis. However, the workers did not observe 
any p-fluoropyruvate in the culture broth either, nor was any labelled p-
fluoropyruvate administered to the organism. The fact that no P-fluoropyruvate was 
found in the culture broth is not conclusive evidence that the compound is not the first 
fluorometaboHte on the pathway. P-Fluoropyruvate is rapidly defluorinated in vivo by 
pyruvate decarboxylase, and i f it were formed it would either undergo this fate or be 
rapidly processed towards fluoroacetate and 4-fluorothreonine. Levels o f the 
compound, observable by '^F N M R , would be unlikely to build up. 
To test the hypothesis o f Sanada et al.,^^ that fluoroacetate and glycine combine to 
form 4-fluorothreonine, Reid and co-workers incubated resting cell cultures o f S. 
cattleya with 4-fluorothreonine and also with fluoroacetate.^^ From these experiments 
the rates o f interconversion were noted to be 20 fold too low to account for the 
biosynthesis o f one metabolite from the other. Incubation o f resting cells with glycine 
had no effect on the relative concentrations o f the two metabolites, also supporting 
this finding. Finally, an experiment was performed by incubating resting cells with 
^H2-labelled fluoroacetate. Less than 5% deuterium incorporation was observed, into 
the 4 position o f the 4-fluorothreonine, as judged by ^^ F NMR. This low level o f 
interconversion between the fluoroacetate and 4-fluorothreonine, can, most 
reasonably, be explained in terms o f defluorination and then re-incorporation o f the 
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released fluoride by the de novo synthesis, similar to previous observations with D L -
fluorosuccinate, fluorofimiarate, 4-fluoroglutamate and 3-fluoroalanine. 
H 
[1-^^C]-glycine 
(3.54) 
S. cattleya 
O 
little incorporation 
H 
/ O H 
H 2 N ^ % ^ 
[2-''^C]-glycine 
S. cattleya 
u 
H identical labelling 
OH 
[1,2-^^C2]-glycine 
Scheme 3.18 Incorporation o f labelled glycine into fluoroacetate 
Further experiments, incubating individual resting cell cultures with [1-^^C], [2-^^C] 
and [l,2-'^C2]-glycine (3.54) are revealing. [1-*^C]-Glycine was incorporated to a 
level lower than 4%, where as [2-*^C] and [ 1,2-'^C2]-glycine both gave rise to 
incorporations o f 40%. A high degree o f double labelling was also observed to occur 
(Scheme 3.18). These results were interpreted in terms o f glycine generating serine. 
Glycine is cleaved with C-2 processed via N^, iV'^-methylene-tetrahydrofolate by 
serine hydroxymethyltransferase where it is condensed with another molecule o f 
glycine to generate serine. The serine could then be metabolised to pyruvate by serine 
dehydratase.^^ To fijrther investigate the relationship o f pyruvate to the biosynthesis 
o f the two fluorometaboUtes, resting cells were incubated with labelled pyruvate^^ 
Although little incorporation o f label from [1-^^C]-pyruvate was detected by GCMS, 
incubation o f individual resting cell cultures with [2- C] and [3- C]-pyruvate 
separately, resulted in a 37% incorporation o f label at C-1 o f fluoroacetate and a 2 1 % 
incorporation into the C-2 o f fluoroacetate, respectively. These results are evidence 
that the C-2 and C-3 o f pyruvate, similar to hydroxypyruvate, are incorporated as an 
intact unit into fluoroacetate, with C-3 contributing to the fluoromethyl carbon. The 
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role o f pyruvate on the biosynthetic pathway is corroborated by a similar 
incorporation o f L-[3-^^C]-alanine (a pyruvate surrogate) which is transaminated in 
vivo to release pyruvate. 
serine 
2 x 
glycine 
hydroxym ethyl 
transferase H3N 
OH 
CO: 
senne 
senne 
dehydratase 
O 
transamination O 
H 3 N " ^ C O f 
alanine 
(pyruvate 
surrogate) 
O 
pyruvate 
Scheme 3.19 A n explanation for the incorporation pattern resulting from the feeding 
o f labelled glycine 
Hamilton et al postulate that pyruvate might have one o f two fates.^^ Oxidative 
decarboxylation to fiimish acetyl-CoA would seem an unlikely step to take towards 
the fluorometabolites as it would result in a methyl group which is no longer activated 
towards nucleophilic attack. A more likely fate for pyruvate would be conversion to 
oxaloacetate, mediated by pyruvate carboxylase, followed by the decarboxylation o f 
oxaloacetate to phosphoenolpyruvate. The glycolytic pathway is now entered. There 
are a range o f glycolytic intermediates containing a phosphate group at C-3 which 
could potentially be replaced by fluoride. The study investigated the possibility o f 
oxaloacetate as a precursor to the fluorometabolites, by incubating resting cells with 
[ HaJ-aspartate and [ ILtJ-succinate (compounds readily metabolised to oxaloacetate in 
vivo). Though aspartate was only incorporated at the 6.5% level, 2% o f the 
fluorometabolites retained both deuteria. The succinate was incorporated at the much 
higher level o f 20% and, consistent with succinate being processed through the Krebs 
cycle, only one deuterium was retained. These results reinforce the intermediacy o f 
oxaloacetate upon the pathway. 
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The authors tenaciously suggest that although they have shown pyruvate to be a 
highly effective precursor o f the two fluorometabolites, it can not be postulated that 
either pyruvate or p-hydroxypyruvate is the substrate for enzymatic fluorination. They 
carefiilly stipulate that the high levels o f incorporation arising from the feeding o f 
labelled pyruvate could be as much due to the substrate being tightly channelled 
through the various enzymatic processes, as to its proximity to the fluorination 
event.^^ 
OH O 9 ^ • D I D ! 
H O ^ ^ - ^ k ^ O H ^- ^^^^^^^ D A / ^ Q - D^YY^^' 
F F ISIH3 DD 
(2R)-[1-^H2]-glycerol 
S. cattleya ^ OH OH O 
H O v ^ ^ A ^ O H ^ A ^ C O ; 
DD F F ISIHa 
(2S)-[1-2H2]-glycerol 
Scheme 3.20 Results from the incubation of (2R)-[\-^U2}- and (^251-[l-^H2]-glycerol 
with resting cell cultures o f S. cattleva 
Further insight into the problem has been provided by the feeding o f both ( 2 ^ ) - [ l -
H 2 ] - and (25) - [ l - H2]-glycerol to resting cell suspensions o f the bacteria. Deuterium 
was only incorporated into fluoroacetate from (2R)-[\- H2]-glycerol, with two 
deuteria labelling the fluoromethyl group at a level o f 28%. Therefore, the pro-S 
hydroxymethyl o f the glycerol must be cleaved during the biosynthesis. The fact that 
two deuteria are carried through to the fluorinated products places considerable 
mechanistic limitation upon the subsequent processes leading up to the fluorination 
event. I t may therefore be postulated that the glycerol is phosphorylated at its pro-R 
position to generate 5«-glycerol-3-phosphate thus activating the carbon atom which 
may subsequently be attacked by fluoride. 
I n addition to this, the incorporation o f label into the C-1 and C-2 o f fluoroacetate 
mirrors those into C-3 and C-4 o f 4-fluorothreonine in terms o f magnitude and 
regiochemistry, from the various feeding experiments. This observation leads the 
authors to propose that the two sets o f carbons share a common biosynthetic origin 
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and that there is a single fluorinating enzyme operating in S. cattleya. With the 
likelihood being that the substrate to be fluorinated lies between pyruvate and glycerol 
implicating an intermediate upon the Krebs cycle. 
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CHAPTER 4 
The Stereochemical Course of Biological Fluorination 
in Streptomyces cattleya 
4.1 Introduction 
To gain fiirther insight into the mechanism o f biological fluorination in Streptomyces 
cattleya, a study was undertaken to establish the stereochemical course (retention or 
inversion) o f the fluorination reaction during the biosynthesis o f fluoroacetate. From 
earlier studies (see section 3.11), it has been shown that the most likely substrate for 
the enzymatic fluorination is a metabolite closely related to glycerol (4.1) or pyruvate 
(4.2). Clearly, intermediates upon the glycolytic pathway emerge as candidate 
substrates for this enzyme. 
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CH,OP HOCT^, 
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OP 
1,3-bisphosphoglycerate 
Fluormation ? 
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OH 
2-phosphoglycerate 
H OP 
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H CO2H 
phosphoenol 
pyaivate 
Scheme 4.1 Glycolytic intermediates as candidate substrates for biological 
fluorination 
Previous experiments in which both (2R)-[l-^U2] and (25)-[l-^H2]-glycerol were 
administered to resting cell cultures of S. cattleya, showed that the pro-R 
hydroxymethyl is retained as the fluoromethyl group, whereas the pro-S 
hydroxymethyl group is cleaved. These experiments also demonstrated that when 
(2i?)-[l-%]-glycerol was administered, both deuteria from the pro-R hydroxymethyl 
group were retained (see section 3.11). In order to determine the stereochemical 
course of the biological fluorination, it is necessary to incubate S. cattleya with 
glycerols bearing stereoselectively deuterated pro-R hydroxymethyl groups. One 
method is to synthesise and feed {\S, 2;?)-[l-^H]- and {\R, 2i?)-[l-^H]-glycerols. A 
complementary approach is to administer [2,2,3,3- H4]-succinate. The stereochemical 
processing of succinate through the Krebs cycle and glycolysis is well established 
(section 4.2) and [2,2,3,3-^H4]-succinate can be employed to stereoselectively 
deuterate the pro-R hydroxymethyl group of glycerol and other related glycolytic 
intermediates. 
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4.2 The stereochemical processing of succinate through the Krebs cycle and 
glycolysis 
4.2.1 The conversion of succinate to fumarate 
The enzyme, succinate dehydrogenase, mediates the stereospecific removal of two 
vicinal hydrogen atoms from succinate (4.3) to generate fumarate (4.4). Accordingly, 
when [2,2,3,3-^H4]-succinate is administered to the enzyme, [2,3-^H2]-fumarate is 
generated (Scheme 4.2). 
HO2C 
COpH 
succinate 
D CO2H 
dehydrogenase { 
HO2C D 
4.4 
Scheme 4.2 The succinate dehydrogenase mediated conversion of [2,2,3,3- H4I-
succinate(4.3) to[2,3-^H?]-fumarate (4.4) 
The conversion has been shown to proceed with the a«r/-elimination of one URe and 
one Hsi atom, from succinate when held in an <2«^/-periplanar conformation.^ Tchen 
and van Milligan demonstrated the steric course of the biotransformation by 
administering threo and erythro [2,3-^H2]-succinic acids to a Keilin-Hartree 
preparation of heart sarcosome^ that contained succinate dehydrogenase. The threo 
and erythro [2,3-^H2]-succinic acids were afforded by the known syn hydrogenation 
with a platinum catalyst of fumaric (4.4) and maleic acid (4.5) respectively. When 
threo [2,3-^H2]-succinic acid was administered [2-'^H]-fumaric acid (4.4 a) resulted; 
whereas when erythro [2,3- H2]-succinic acid was administered [2,3- H2]-fiimaric 
acid (4.4 b), and unlabelled fumaric acid (4.4) resulted (scheme 4.3). This is 
consistent with the a«^/-elimination of one H/?e and one Us, atom. 
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H CO2H D2 / R 
HO2C H 
4.4 
HO2C HO2C 
D ' ^ H + H ' / ^ D sucdnate 
D ^ H 
CO2H CO2H 
erythro 4.3 
H COoH 
dehydrogenase 
HO2C D 
4.4a 
HOsC^^ CO2H D2 / R 
H H 
4.5 
HO2C 
CO2H 
threo 4.3 
succinate D CO2H H CO2H 
dehydrogenase y — ^ + 
HO2C D HO2C H 
4.4b 4.4 
Scheme 4.3 Tchen and van Milligan's demonstration of the steric course of the 
conversion of succinic acid (4.3) to fumaric acid (4.4), mediated bv the enzyme 
succinate dehydrogenase 
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4.2.2 The conversion of fumarate to malate 
The flw/'/'-addition of water across the double bond of fiimarate (4.4) to afford (S)-
malate (4.6) is mediated by the enzyme fiimarase.^ Incubation of the enzyme with 
fumarate and malate in the presence of H2O leads to the incorporation of one 
deuterium at the C-3 position of malate (scheme 4.4). Even after prolonged periods of 
incubation, no deuteria are incorporated into the ftimarate. This indicates that the 
enzyme operates with very high stereo specificity. A comparison of synthetic 
(±ythreo-[3-^ll\]mahc acid with the malic acid derived from the incubation 
experiment, by NMR, reveals that the biosynthetic material is erythro and that the 
water is added in an anti fashion."^ 
CO2H OH 
D 
H- H Si fumarase 
CO2H 
Re CO^H 
HO2C 
fumaric acid (4.4) ^2S, 3/?)-[3-2Hi]-malic acid (4.6) 
Scheme 4.4 The fumarase mediated conversion of fiimaric acid (4.41 in the presence 
of ^H.O. to (IS. 3i?Vr3-^H.1-malic acid (4.6) 
Consequently, this means that when [2,2,3,3-^H4]-succinate is administered, the 
resultant [2,3-^H2]-fumarate is processed to {2S, 35)-[2, 3-^H2]-malic acid. 
4.2.3 The Conversion of malate to phosphoenol pyruvate 
Malate dehydrogenase, in the presence of NAD^, mediates the oxidation of the 
hydroxyl group at the C-2 of malate (4.6) to an a-keto-acid affording oxaloacetate 
(4.7). This conversion involves no alteration in the stereochemistry at C-3. (35)-[3-
H2]-Oxaloacetate results from the processing of [2,2,3,3- II4]-succinate around the 
Krebs cycle (scheme 4.5). 
0 
malate 
aenydrogenase H 
CO2H 
CO2H 
malate (4.6) 
NAD"" CO2H 
oxaloacetate (4.7) 
Scheme 4.5 The malate dehydrogenase mediated conversion of malate (4.6) to 
oxaloacetate (4.7) 
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The enzyme phosphoenol pyruvate carboxylase mediates the reversible carboxylation 
of phosphoenol pyruvate (4.8) to oxaloacetate (4.7). The steric course of this 
biotransformation, as it affects C-3, has been studied by Rose and co-workers.^ 
Utilising the known anti-ehrmnaXion of water from phosphoglyceric acid (4.9) to form 
phosphoenol pyruvate (4.8)^, they administered stereospecifically tritiated 2-
phosphoglycerates (4.9), of known configuration, to obtain the E and Z-[3-^H] 
phosphoenol pyruvates (4.8). The position of tritium in the resultant oxaloacetate, 
demonstrated that CO2 is added to the Si-face of the phosphoenol pyruvate at C-3 
(scheme 4.6). 
H 
HO2C 
an?/-elimination 
of water nU2^- 'OP S/-addition CO2H 
OH 
phosphoglyceric 
acid (4.9) 
phosphoenol 
pyruvate (4.8) 
CO2H 
oxaloacetate (4.7) 
Scheme 4.6 The stereochemical course of the phosphoenol pyruvate carboxylase 
mediated conversion of phosphoenol pyruvate (4.8) to oxaloacetate (4.7) 
Analysis of the configuration of the resultant oxaloacetate was achieved by the use of 
the knovm biochemical sequence: oxaloacetate (4.7) malate (4.6) fumarate (4.4) 
(see section 4.3.2). 
4.2.4 Metabolic processing of [2,2,33-^H4l-succinate 
The processing of [2,2,3,3-^H4]-succinate through the Krebs cycle to (37?)-[3-^Hi]-2-
phosphoglycerate is illustrated in scheme 4.7. The stereochemistry is retained at C-3 
as the compound for each of the intermediates upon the glycolytic pathway. It follows 
that upon feeding [2,2,3,3-^H4]-succinate, the carbon centre to be fluorinated has the R 
stereochemistry by virtue of deuterium substitution (scheme 4.7). 
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Scheme 4.7 Metabolic processing of [2.2,33-^ 114]-succinate 
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4.2.5 r2,2,3.,3-^H4l-Succinate feeding experiments 
Sodium [2,2,3,3- H4]-succinate was administered to 8 day old resting cells of 
Streptomyces cattleya at a final concentration of 8.7 mM. The cells were incubated for 
48 hours, after which time the fluoroacetate was harvested by lyopMlization of the 
acidified, freeze-dried supernatant. The experiment was repeated with further resting 
cells until 7 mg of fluoroacetate had been collected. 
The level of labelling in the resultant fluoroacetate was between 10 and 15%. The 
[ Hi]-fluoroacetate content is chiral by virtue only of deuterium substitution. This is 
intrinsically a difficult system to resolve by methods of conventional analysis. 
However, the comparatively new technique of chiral liquid crystalline H NMR had 
been shown to be capable of resolving (2»S) and (25)-[2-"^H]-fluoroacetates as their 
hexyl ester derivatives (see section 2.5). 
The sodium fluoroacetate, derived from the feeding of sodium [2,2,3,3- H4]-succinate, 
was added to a portion of unlabelled commercial fluoroacetate, to ease handling of the 
material, and derivatised as the hexyl ester. The resulting compound was dissolved in 
poly y-benzyl L-glutamate and chloroform, and examined by ^H NMR (fig 4.1a). By 
comparing this ^H NMR spectra with the chiral liquid crystal ^H NMR spectra of the 
synthetic (25)-[2-^H|-fluoroacetate (fig 4.1b), it is apparent that the biosynthetic 
material has predominantly the i^-configuration. 
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C D C l ; (5) {R) 
^'11 1 
100 
1 — 1 — I — I — I 
-100 
configuration, after incubation of S. cattleva with [2.233- Hj|-succinate. 
C D C l 
' ' ' ' I — ^ 
100 0 
2i 
•100 
Fig 4.1b ^H NMR of synthetic hexyl [2-^H]- fluoroacetate 38 % ee in favour of (6^-
configuration 
The spectra are obtained by analysing the compounds in a liquid material composed 
of PBLG and chloroform on a Bruker AC-250, 250.133 MHz. In addition to relying 
upon the integrals of the peaks to provide information as to the relative amounts of 
each enantiomer, the peaks were cut out from the paper that they were printed on and 
weighed. The two methods of analysis provided the same answer. 
Fig 4.1 
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4.2.6 Conclusion 
The [1-^H]-fluoroacetate recovered after incubation of [2,2,3,3-^H4]-succinate with S. 
cattleya, has predominantly ^-configuration. As the C-3s of the glycolytic 
intermediates resulting from the metabolic processing of [2,2,3,3-'^ H4]-succinate are 
known, also, to be in the (i?)-configuration, it may be deduced that the fluorination 
event proceeds with retention stereochemistry. Despite a poor signal to noise ratio in 
the "^ H NMR spectrum, an enantiomeric excess of approximately 25% may be 
calculated. 
The enantiomeric excess is lower than anticipated and several possibilities exist to 
rationalise this. One reason for the low ee could be that the stereospecificity of the 
fluorinating enzyme is low. A second explanation could be that one or more of the 
steps upon the Krebs cycle and the glycolytic pathway operate with poor 
stereochemical integrity within S. cattleya. 
4.3 Experiments with a^)-fl-^H?l- and (25^-fl-^H7l-glvcerols 
The substrate to be fluorinated is known to be bio synthetically proximate to glycerol. 
In order to corroborate the information provided by the incubation [2,2,3,3- H4]-
succinate with resting cells of S. cattleya (2i?)-[l- H2]- and (2iS)-[l- HiJ-glycerols 
(4.10, 4.10a) were synthesised and administered to the organism. 
Glycerol is processed through glyceraldehyde 3-phosphate and subsequently onto 1,3-
bisphosphoglycerate, 3-phosphoglycerate, and 2-phosphoglycerate. These enzymatic 
transformations affect only the chemistry at C-2 and do not alter the stereochemistry 
at C-3, the carbon centre that undergoes fluorination. Therefore, it was anticipated 
that, as glycerol enters the glycolytic pathway by an alternative route to succinate, and 
is not necessarily processed through the Kreb's cycle, it would be possible to assess 
the stereochemical integrity of the fluorinating enzyme itself 
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4.3.1 Synthesis of chiral glycerols 
As glycerol occupies a central position in the network of primary metabolic pathways, 
isotopically labelled glycerols are frequently used in biosynthetic investigations.^' ^ 
Glycerol is achiral, however, by substituting each of the four hydroxymethylene 
protons in turn by deuterium, four stereoisomers are generated. 
Q n ij D 
HO' Y OH HO-^ Y HO^ Y ^OH HO" Y °" 
OH OH OH OH 
(1S, 2f?)-[1-2H]-Glycerol 2R)-[1-2H]-Glycerol (1S, 2S)-[1-2H]-Glycerol (1R, 2S)-[1-2H]-Glycerol 
4.10 4.10a 
Fig. 4.2 The four stereoisomers of mono-deuterated glycerol 
The literature contains various accounts of the synthesis and characterisation of each 
of the stereoisomers.^ '^ '^' However, the early reports of the synthesis of the (15, 
27?)-[l-^H]- and (IR, 2^)-[1-^H]-glycerols either lead to compounds of low 
enantiomeric excess,^  or involve an arduous eight step synthesis using D-glucose as 
the chiral starting material.'' A shorter route to the (l^*, 2R)-[l-^K\- and (IR, 2R)-[l-
^H]-glycerols was developed more recently in our lab.'"^  This three step procedure 
exploits the observation that propargylic alcohols undergo trans reduction when 
treated with lithium aluminium hydride.'^ Grant and Djerassi*^ demonstrated the trans 
reduction of a series of propargyUc alcohols solvated in THF. However, when ether 
was used as a solvent some cis reduction was also observed. This, the workers 
attributed to the lower degree of Lewis basicity of the ether. In agreement with this 
hypothesis, the use of isopropyl ether led to predominant cis reduction in a ratio of 
3:1. It had previously been noted that a propargylic hydroxyl group was necessary for 
any reaction to occur;accordingly, a mechanism was proposed in which the first 
step was the formation of a bond between the oxygen of the hydroxyl group and the 
aluminium. The fact that no increase in rate was observed when a greater than 
stoichiometric amount of lithium aluminium hydride was used, suggested an 
intramolecular transfer of hydride. Labelling studies demonstrated that hydride is 
regioselectively delivered to C-2, concomitant with the formation of a vinyl carbanion 
(scheme 4.8). It was proposed that when a Lewis basic solvent is employed the 
lithium counter cation is solvated and not available to stabilise the anionic charges in 
the transition state. This results in the conformation offering the greatest separation of 
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the charges being adopted. Hydrolysis of this transition state complex fiimishes the 
trans reduction product. In agreement with this hypothesis, it was demonstrated that 
when dicyclohexyl-18-crown-6 is used in conjunction with the weakly Lewis basic 
solvent, isopropyl ether, the level of trans reduction increases dramatically. 
It was also found that lowering the temperature increased the amount of cis reduction 
product. 
HC=C-CH2 I 
OH 
solvent with low Lewis 
basicity 
HC=C-CH2 
0 
H-AI—H 
H- L 
solvent with high Lewis 
basicity 
H2 
6- / 
H--AIH2 
Li- 5-
.C=C 0 
H--AIH2 
5-
H 
Li+ 
^ .CH2OAIH2 
c - c 
CH2OH 
H 
cis reduction product 
/CH2OAIH2 
H H 
D,0 
H H 
trans reduction product 
Scheme 4.8 The reaction of lithium aluminium hydride with propargyl alcohol in 
Lewis basic and Lewis acidic solvents 
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Nieschalk prepared both the Z- and £'-[3-^H]-allyl alcohols (4.12, 4.12a) from 
propargyl alcohol and 3-[^Hi]-propargyl alcohol(4.11, 4.11a), respectively. THF 
was used as solvent to promote the formation of the trans reduction products. 
i) LiAIH4, THF 
/ = \ Z:E=15:1 
~ ~ \ ^ i i)D20 D ^ O H 
^•'^'^ Z-[3-2H]-allyl alcohol (4.12) 
i) LiAIH4, THF D^ ^ 
^ iiA M_n " \ Eonly OH '•) H2O 
4.11a OH 
2. E-[3-^H]-allyl alcohol (4.12a) 
Scheme 4.9 The trans reduction of propargyl alcohol and 3-[^H J-propargyl 
alcohoir4.11, 4.11a) 
Nieschalk noted that in addition to the Z-[3- H]-allyl alcohol produced, following the 
D2O quench, some [2-2H]-aUyl alcohol was also formed due to hydride attack at the 
terminal carbon of the acetylene. However, labelling at C-2 was not envisaged to be a 
problem for feeding experiments, as the proton from the C-2 of glycerol is not 
incorporated into the fluoroacetate. 
The two resultant aUyl alcohols were converted to their corresponding benzoate 
derivatives which were then asymmetrically dihydroxylated using Sharpless 
methodology'^ and commercially available AD-mix-B. The reaction afibrded the 3-
hydroxypropyl benzoates with an ee of 74 %. This was raised to 95 % by 
recrystallisation of the product. The benzoate protected glycerols were hydrolysed 
with sodium hydroxide to afford both (15", 2i?)-[l-^H]- and {\R, 2i?)-[l-^H]-glycerols 
in high enantiomeric excess. 
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4.3.2 Synthesis and feeding of (15,2/?)-fl-^H1-glycerol 
(15', 2/?)-[l-^H]-Glycerol was prepared in gram quantities according to Nieschalk's 
procedure (scheme 4.10). The reduction of propargyl alcohol (4.11) with lithium 
aluminium hydride, using the Lewis basic solvent, THF, followed by a D2O quench 
predominantly yielded the trans reduction product, Z-[3-^H]-allylalcohol (4.12). The 
Z-[3-^H]-aUylalcohol was esterified to afford Z-[3-^H]-aUylbenzoate (4.13). ^H NMR 
analysis confirmed that the product consisted of 12% ^-[3-^H]-allylbenzoate (4.13a), 
78% Z-[3-^H]-allylbenzoate (4.13), and 10% of material deuterated at the 2 position 
(4.13b). The allylbenzoate was reacted with AD-mix-6 to fiimish [3(5)-^H]-2(/?), 3-
dihydroxypropyl benzoate (4.14), which initially had the appearance of a pale yellow 
oil. Purification over silica gel transformed the yeUow oil to a white crystalline solid. 
The enantiomeric excess of the compound was assessed by comparing the integrals of 
the ortho benzoate hydrogen atoms in the ' H NMR spectra using a europium chiral 
shift reagent, Eu(hfbc)3. Recrystallisation of the material increased the ee from an 
initial value of 67% to 84%. 
i) LiAIH4 / THF 
ii) D2O 
4.11 
OH 
HO 
iii) PhCOCI, 30 % NaOH. EtsBnN+CI-, , 
D ^ O H 32% D ^ Q - ^ P h 
4.12 
iv) AD-mix-p, 
t-BuOH/H201:1 
OH 
V) NaOH(1equiv.] 
H2O, acetone 
81 % 
OH 
(1S, 2/?)-[1-H]-glycerol (4.10) 
6 5 % 
O 
HO' Y ^ O ^ P h 
OH 
4.14 
Scheme 4.10 The synthesis of(\S. 2i?)-fl-^H|-glycerol 
Glycerol was afforded by hydrolysis of the ester in aqueous sodium hydroxide and 
acetone. Six glycerols are contained within the mixture, the major component being 
the (l^*, 2i?)-[l-^H]-glycerol (scheme 4.11). 
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Z-[3- H]-allylbenzoate (4.13), resulting from the trans reduction of propargyl alcohol 
with lithium aluminium hydride, is the major product (78%) of the first step of the 
synthesis. The reaction of Z-[3- H]-allylbenzoate with AD-mix-B leads, 
predominantly, to the addition of two hydroxyl moieties behind the plane of the 
double bond; following hydrolysis {\S, 27?)-[l-^H]-glycerol (4.10) is afforded. A 
small amount of addition also occurs from in front of the plane of the double bond 
leading to (1/?, 25)-[l-^H]-glycerol (4.10b). The reduction reaction also produced 
12% of the cis reduction product, £-[3-^H]-allyl benzoate (4.13a); the major and 
minor compounds formed following dihydroxylation to the back and front faces of 
the double bond of 4.13a are glycerols 4.10a and 4.10c, respectively. During the 
reduction some hydride attack occurred at the terminal C-atom of the acetylene this 
resuhed in 10% of the reduction product containing deuterium at C-2 (4.13b). Ester 
4.13b is dihydroxylated to afford [2- H]-glycerols 4.10d and 4.10e as the major and 
minor products respectively. 
It is known that deuterium from the C-2 of glycerol is not incorporated into 
fluoroacetate, thus glycerols 4.10d and 4.10e are not relevant contaminants. 
Deuterium labels the pro-S hydroxymethyl group of glycerols 4.10b and 4.10c, this is 
known to be cleaved in the biosynthesis of fluoroacetate by S. cattleya. Only two of 
the six glycerols contribute deuteria to the fluoroacetate:- (1*S, 2i?)-[l-^H]-glycerol 
(4.10) and {\R, 2i?)-[l-^H]-glycerol (4.10a). I f the ratio of dihydroxylation in front 
and behind the plane of the double bond, with Z-[3-^H]-allylbenzoate (4.13) is 
equivalent to that with £'-[3-^H]-aUylbenzoate (4.13a), the resultant (1^ , 27?)-[l-^H]-
glycerol would have an ee of 73%. 
The glycerol was analysed by chiral liquid crystal ^H NMR using poly-s-
carbobenzoxy-L-lysine (PCBL) in dimethyl formamide as the chiral solvent (Fig 4.3). 
The analysis showed 3 different components:- 75 % (15, 27?)-[1-^H]-glycerol (4.10), 
13% {\R, 2/?)-[l-^H]-glycerol (4.10a), and 10% of glycerol 4.10d. These values 
compare closely to the amounts of the various [3-^H]-aUylbenzoates ( 78% cis^ 12% 
trans and 10% deuterated at C-2). 
It may be concluded that the AD-mix-B predominantly mediates dihydroxylation from 
behind the face of the double bond of the [3-^H]-allylbenzoate. The stereochemistry of 
the resultant glycerol is therefore, largely governed by the stereochemistry of the 
lithium aluminium hydride reduction of the propargyl alcohol. From the Chiral liquid 
crystal ^H NMR it may be concluded that the synthetic (liS, 2i?)-[l-^H]-glycerol has a 
70% ee. 
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The glycerol was administered to 8 day old resting cells o f Streptomyces cattleya at a 
final concentration o f 8.7 mM. After 48 hours o f incubation, the cells were harvested. 
The resultant [2-^Hi]-fluoroacetate was extracted and analysed in the same manner as 
the [2- Hi]-fluoroacetate produced following the feeding o f [2,2,3,3- H4]-succinate to 
S. cattleya (f ig 4.5a). 
4.3.3 Synthesis oijlR, 2ig)-fl-^Hl-glycerol 
{\R, 2i?)-[l-^H]-Glycerol was synthesised following Nieschalk's procedure. The 
terminal proton o f the alkyne was exchanged with deuterium by treating the 
propargylic alcohol wi th butyl lithium and quenching the resultant anion with D 2 O . 
The lithium aluminium hydride, trans reduction o f the resulting [3-^H]-propargyl 
alcohol (4.11a) was then performed and the reaction quenched to afford E-{?>- H] allyl 
alcohol (4.12a) as the only isomer. The N M R o f the £-[3-^H]-allylbenzoate 
(4.13a) exhibited a single peak at 5.34 ppm. 
The £'-[3-^H]-allylbenzoate was dihydroxylated using AD-mix-B; purification over 
silica afforded white crystalline [3(/?)-^H]-2(i?), 3-dihydroxypropyl benzoate (4.14a). 
The enantiomeric excess was increased fi-om 72% to 95% by recrystallisation. The 
protected glycerol was hydrolysed using aqueous sodium hydroxide and acetone to 
afford ( l i? , 2i?)-[l-^H]-glycerol (4.10a) in gram quantities. 
iii) LiAIH. / THF D 
V) PhCOCI. 30 % NaOH. Et-,BN+CI-
38°/ 
iv) D2O 
4.13a 4.12a 4.11a 
vi) AD-mix-p, 
t-BuOH/HjOl:! 
64% 
vii) NaOH(1equiv.) Q ' O 
H2O, acetone ? 11 
OH OH 
2R)-[1-2H]-glycerol 
4.10a 4.14a 
Scheme 4.12 The synthesis o^(\R. 2i?Vri-^H1-glvcerol 
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The {\R, 2i?)-[l-^H]-glycerol was analysed by chiral liquid crystal N M R using 
PCBL in dimethyl formamide as the chiral solvent (Fig 4.4). The resultant spectrum 
indicated the presence only one glycerol component, the (\R, 2i?)-[ l- H]-glycerol 
(4.10a). 
4.10a 4.10a 
(Fig 4.4) N M R o f synthetic (IR, 27g)-[l-^H]-glvcerol using PCBL in dimethyl 
formamide as the chiral solvent (Bruker AC-250, 250.133 MHz) 
The (\R, 27?)-[l-^H]-glycerol was administered to 8 day old resting cells o f 
Streptomyces cattleya at a final concentration o f 8.7 m M After 48 hours o f 
incubation, the cells were harvested. The resultant [2-^Hi]-fluoroacetate was extracted 
and analysed in the same manner as the [2-^Hi]-f[uoroacetate produced following the 
feeding o f [2,2,3,3-^H4]-succinate to S. cattleya (fig 4.5b). 
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4.3.5 Results from the feeding of the chiral glycerols 
CDCI3 (5) (5) 
(R) 
1 ^ 
100 0 -100 
Fig 4.5a N M R o f r2-^H1-hexvlfluoroacetate. from 5'. cattleva fed (IS. IRUl-^lU-
glycerol 
(R) 
CDCI3 
i 
100 100 
Fig 4.5b N M R o f r2-^H1-hexvlfluoroacetate, fi-om^S. cattleva fed (\R, 2i?)-ri-^H1-
glycerol 
CDCI3 
100 0 -100 
Fig 4.5c N M R o f synthetic (25)-[2-^H]-hexylfluoroacetate 
The spectra are obtained by analysing the compounds in a liquid material composed 
o f PBLG and chloroform on a Bruker AC-250, 250.133 MHz. 
Fig 4.5 
I n addition to relying upon the integrals o f the peaks to provide information as to the 
relative amounts o f each enantiomer, the peaks were cut out fi-om the paper that they 
were printed on and weighed. The two methods o f analysis provided the same answer. 
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4.4 Conclusions 
Chiral liquid crystal N M R shows that (25)-[2-^H]-fluoroacetate is derived fi-om 
resting cell cultures o f Streptomyces cattleya that have been fed (l^*, 27?)-[l-^H]-
glycerol, whilst cultures that have been fed (IR, 2i?)-[l-^H]-glycerol produce {2R)-\2-
H]-fluoroacetate. These results complement the [2,2,3,3- H4]-succinate feeding 
experiment by indicating that the stereochemistry o f the carbon centre is retained 
during the biosynthetic fluorination by Streptomyces cattleya. 
CO2H 
C02H 
succinate 
Streptomyces cattleya 
glycolytic intermediate-
with R-configuration o-
(2R)-[2-H]-fluoroacetate 
25% ee 
0 
HO' Y OH 
OH 
(1S, 2R)-[1-2H]-glycerol 
70% ee 
o-
(2S)-[2-H]-fluoroacetate 
32% ee 
D 
H O ^ ' ' ~ ^ " Y ' ^ ° ^ 
OH 
(1R, 2RH1-2H]-glycerol 
95% ee 
0 
o-
(2R)-[2-H]-fluoroacetate 
70% ee 
Scheme 4.13 The stereochemical outcome o f administering [2.2.3,3- H4]-succinate, 
(IS, 2i?Vri-^H1-glvcerol anddR. 2;?Vri-^H1-glvcerol to Strevtomvces cattleva 
The enantiomeric excess o f the fluoroacetate resulting from the incubation o f [2,2,3,3-
^H4]-succinate with S. cattleya is low (25%). This may be attributed to a loss o f 
stereochemistry as the succinate is processed through the Krebs cycle (see section 
4.2.6). The fluoroacetate resulting from the feeding o f (IS, 2/?)-[l-'^H]-glycerol is 
slightly higher, with a value o f 32%. Due to the small amount o f [2- H]-fluoroacetate 
available for analysis, the spectra for this biosynthetic sample has a low signal to 
noise ratio. This makes it difficult to measure the ee exactly. Although the 
enantiomeric excess is low, it is significant that the glycerol fed had an ee o f 70%. I t 
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may be interpreted that fi-om a sample o f 85% (l^*, 2/?)-[1-^H]-glycerol the bacteria 
biosynthesised fluoroacetate o f which 66% was in the ^'-configuration. 
The incubation of (IR, 27?)-[1-^H]-glycerol with a 95 % ee (98 % o f the molecules 
with /^-configuration) with S. cattleya results in the production o f (7?)-[^H]-
fluoroacetate with an ee o f 70% (85 % o f the molecules with /^-configuration). 
I t is noteworthy that in each o f the feeding experiments a considerable loss o f 
enantiomeric purity is observed. The results indicate that the fluorination proceeds 
with an overall retention o f configuration, with a low level o f inversion occurring 
concurrently. 
4.5 Possible mechanisms of fluorination 
From the knowledge that the fluorination occurs with overall retention o f 
configuration, one explanation would be that fluorination occurs via two 
stereochemical inversions. A n amino acid residue, such as cysteine, positioned at the 
active site o f the fluorinating enzyme may be envisaged to act as a nucleophile 
attacking the substrate to be fluorinated. This covalent modification could be followed 
by nucleophilic attack by a source o f fluoride. As fluoride attacks the activated 
complex the amino acid residue is released (scheme 4.14). 
OH 
HO 
o 
o-p^-o 
o 
D H 
0 
Enzyme 
Inversion 
0 
Enzyme 
Inversion 
ONa 
RETENTION 
Scheme 4.14 Possible mechanism o f fluorination involving two inversion processes 
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CHAPTER 5 
The Biosynthesis of Longianone 
Introduction and Background 
5.1 Introduction 
Longianone (5.1) is a secondary metabolite o f the fimgus Xylaria longiana. 
Longianone was first isolated and purified along with the two known fiingal 
metabolites (R)-(-)-mellein (5.2) and 4-hydroxymellein (5.3) in 1998 by Edwards.' The 
compound was given the trivial name "eggtimerone" due to its structural resemblance 
to an eggtimer. Although longiana is an uncommon member o f the fiingal genus 
Xylaria, it is widely distributed, occurring in both tropical and temperate climates. 
Xylaria longiana is a slow growing fimgus which lives on dead and decaying wood 
and has been reported on a number o f hosts fi-om Fagus silvaticus (beech tree) in 
Switzerland to the leaves o f Nicotiana (tobacco plant)in Georgia, USA. 
longianone (5.1) 
OH O OH O 
(R)-(-)-mellein (5.2) 4-hydroxymellein (5.3) 
(stereochemistry o f hydroxyl 
group not specified) 
Fig. 5.1 Metabolites o f X. lonsiana 
Longianone, formally l,7-dioxaspiro[4,4]non-2-ene-4,8-dione, has an intriguing 
bicyclic structure consisting o f a 2H-fiirane-3-one nucleus "fiised" by a spiro centre to 
a lactone ring.Edwards confirmed the structure o f longianone by a crystal X-ray 
determination; however, this did not reveal the absolute configuration at the spiro 
centre C-5, the designation o f which remains unassigned. 
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Longianone is optically active with a strong negative rotation: [0]^^ = -85 (c = 1.0, 
EtOH) indicating a high enantiomeric excess. 
5.2 Naturally occurring analogues of longianone 
The 2H-fiirane-3-one moiety is a common structural feature in a number o f natural 
products. I n compounds isolated to date, however, it is only in chilenone A(5.4) and 
B(5.5) from the red marine alga Laurencia chilensis that the 4, 5 positions occur 
unsubstituted.^' ^In all other cases, at least one o f these sites carries a fimctional group. 
O 
H3C 
chilenone A (5.4) chilenone B (5.5) 
Fig. 5.2 Chilenones 
Few naturally occurring spirocylics containing the fiirane-3-one have been isolated to 
date. Pseurotin A (5.6) and its analogues B, C, D and E from cultures o f 
Pseudeurotium ovalis'^'^'^'^ contain the fiirane-3-one system but they also possess 
substituents at both positions 4 and 5, and the ring is fijsed to an elaborate lactam 
rather than a lactone. Hyperlactone (5.7) and its analogues from the stem and leaves o f 
Hypericum chinensis^ are, at first glance, structurally very similar to longianone; 
however the lactone ring is fiised at a different position to a substituted fijran-3-one 
and the side chains are indicative o f a terpenoid type biosynthesis. 
H3C 
pseurotin A (5.6) hyperolactone (5.7) 
Fig. 5.3 Natural products containing fiirane-3-one 
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o. 
H * 3 
secosyrin R= C2H11 (5.8) syringolide n=2 (5.10) 
R=C7H,5 (5.9) «=4(5 .11) 
Fig. 5.4 Secosyrins and svringolides 
The secosyrins (5.8, 5.9) and the syringolides (5.10, 5.11) (Fig 5.4), metabolites o f the 
bacterium Pseudomonas syringia pv. Tomato^'^^ have a much greater resemblance to 
longianone. The only significant structural difference in the former is that the carbon 
carbon double bond is hydrated and one ketone unit is replaced by an ester moiety. A 
hypothetical biosynthesis for the secosyrins proposes the combination o f a polyketide 
chain with a pentose sugar. Some support for this hypothesis has been provided in a 
biomimetic synthesis o f the secosyrins, in which l-(3'-oxodecanoyl)-D-xylulose (5.12) 
was demonstrated to aiford the syringolide (5.10) (scheme 5.1).'' I t is not 
inconceivable that longianone would share a similar biosynthesis to these metabolites 
and be o f polyketide origin. 
i) 
Oc 
HO'"-
HO 
l-(3'-oxodecanoyl)-D-xylulose (5.12) 
i )THF, AI2O3 
Scheme 5.1 Biomimetic study o f the formation o f syringolide (5.10) 
HO 
syringolide (5.10) 
5.3 Fatty acids and polyketides 
Fatty acids and polyketides share a very similar biosynthesis. Both classes o f 
metabolite are assembled by the head to tail condensation o f acetate units. Fatty acids 
are characterised by a long hydrophobic hydrocarbon chain linked to a polar 
hydrophilic carboxylic acid head. Their resultant amphiphilic quality causes the fatty 
acids to aggregate together and has been exploited by nature to form micelles and 
membrane bilayers in almost all living organisms. Fatty acids are also utilised in nature. 
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in the form o f tri-fatty acid esters o f glycerol, for long term energy storage. The tr i -
fatty acid esters may be oxidised to release energy, ultimately available in the form of 
ATP. Nature's use o f fatty acids does not stop with mechanical and energy storage 
fimctions. I n mammals, prostaglandins, elaborate C20 unsaturated fatty acids containing 
a cyclopentane ring system, are used as hormones; such molecules show marked 
similarity to the biologically active polyketides. 
The polyketides are a large family o f secondary metabolites. They range from small 
structurally non-complex molecules such as 6-methylsalicylic acid to large and 
incredibly intricate structures such as maitotoxin (5.13) (fig. 5.5)."* Many polyketides 
have important pharmaceutical properties. 
Fig. 5.5 Maitotoxin (5.13) 
The term polyketide was coined, almost 100 years ago, by John Norman Collie and 
today refers to natural products containing multiple carbonyl and/or hydroxy groups 
each separated by a methylene carbon ^. Polyketides are typically synthesised by the 
organism at the onset o f its stationary growth phase. 
5.4 Fatty acid biosynthesis 
As fatty acids are built up by the head-to-tail condensation o f acetate units, most 
naturally occurring examples are straight chains consisting o f an even number o f 
carbon atoms (5.14, 5.15). Some fatty acids with odd numbered chain lengths and 
branching exist, this structural feature is due to the incorporation o f non-acetate starter 
units (5.16, 5.17). 
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caprylic acid(5.14) capric acid (5.15) 
(5.16) (5.17) 
Fig 5.6 Fatty acids 
Fatty acid biosynthesis involves two steps. The initial process is the activation o f 
acetyl-CoA (5.18), the thioester o f co-enzyme A with acetic acid, to generate malonyl-
CoA (5.19), a process mediated by the enzyme acetyl-CoA carboxylase. This enzyme 
requires biotin as a co-factor (scheme 5.2) '^. The second step is the conversion o f 
acetyl-CoA and malonyl-CoA into the fatty acid, a process mediated by the fatty acid 
synthase enzyme (FAS) in the presence o f the co-factor NADPH. 
0 
- ^ S C o A 
acetyl CoA 
(5.18) 
acetyl-CoA 
carboxylase 
biotin 
HO 
0 O 
SCoA 
ACP CoASH 
HO 
0 0 
SACP 
malonyl-CoA 
(5.19) 
Scheme 5.2 Activation o f acetyl-CoA to malonyl-ACP 
(5.20) 
A n acyl carrier protein (ACP), onto which the malonate moiety is transesterified, acts 
as a chaperone taking the intermediate acyl thioesters around the catalytic sites o f the 
FAS. The malonyl-SACP (5.20) is first led to a site in the synthase, here it undergoes a 
decarboxylative condensation with a molecule o f acetyl-CoA which has entered the 
active site o f the FAS (Scheme 5.3). 
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II II 9 9 HO o 
""^Jy^SACP P^etoacyl-ACP synthase A ^ s A C P ^-^'JH:^^^'^ A ^ S A C P 
5.20 ^^ 5.21 f \ ^-22 
CO2 NADPH NADP+ 
-^SCoA 
^•''^ p-hydroxyacyl-ACP 
dehydratase 
further malonate condensations O enoyl-ACP reductase O 
Target fatty acid / '"^-^^SACP SACP 
5.24 I ^ 5.23 
NADPH NADP+ 
Scheme 5.3 Fatty acid biosynthesis 
The resultant p-ketobutyryl-ACP (5.21) is then passed from the active site o f one 
enzyme to another undergoing a sequence o f enzymatic operations; first by a p-keto-
ACP reductase, then by a p-hydroxy-ACP dehydratase and finally by a ^fl«^-enoyl-
ACP reductase. Finally, the acyl moiety o f the resulting butyryl-ACP (5.24) is 
transesterified to a free thiol residue at the active site o f the condensing enzyme. I t may 
now re-enter the cycle to condense with another molecule o f malonyl-ACP and extend 
the chain fiirther. 
FASs are amongst the most highly sophisticated enzyme complexes identified to date 
and a wide range o f structural diversity exists between the FASs o f different 
organisms. The most primitive examples may be found in bacteria and plants (Type 11 
FAS) where the synthase exists as a collection o f dissociated enzymes. A more highly 
developed family o f synthases exist in mammals, which possess almost all o f the 
necessary individual enzymatic activities on two multiftinctional proteins (Type I FAS). 
Typically, in all systems, the fatty acid is synthesised in its entirety without the release 
o f any intermediates. I t would appear that in fatty acid assembly there is a high level o f 
commitment for the first few condensation reactions, as chain lengths below C H are 
rare. 
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5.5 Polyketide biosynthesis 
Polyketides are constructed in a very similar way to fatty acids. The enzymes 
mediating the synthesis are not the same but ahnost certainly evolved by mutation o f 
the genes responsible for the FAS. The main difference between the biosynthesis o f 
polyketides and that o f fatty acids is that polyketide chains are "progressively 
assembled": that is, the fimctionality residual in the polyketide chains is introduced as 
the chain is assembled. For example a carbonyl group is introduced by not performing 
any o f the reductive steps at all, an alcohol by reducing once only, and an alkene 
generated by missing out the final reduction step (scheme 5.3). A large family o f 
complex polyketides exist whose structural variations depend upon differences in chain 
length and levels o f reduction, mediated entirely by the PKS ^ 
0 
SCoA 
5.18 
Acetyl CoA 
Carboxylase Biotin 
O O 
HG^^^'^^^SCoA 
5.19 
ACP 
KR = p-Keto-ACP reductase 
DM = p-hydroxy ACP-dehydratase 
ER = frans-enoyl-ACP reductase 
First 
Condensation 
O 
J O 
5.lK 
CoASH ACP 
Subsequent 
Condensations 
0 O 
S-
HS-
KR 
OH O 
DH 
ER 
s-l 
Scheme 5.4 Polyketide biosynthesis 
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5.6 Patulin and its biosynthesis 
I t is noteworthy that fiingal metabolites o f the formula C7H6O4 are restricted to 
aromatic compounds like gentisic acid, gramicin, and quinones such as terreic acid, in 
addition to the two lactones patulin and isopatulin. Patulin, a hemi-acetal lactone, is 
produced by Penicillium and Aspergillus fimgi. When first isolated in 1938, from 
Penicillium expansum, the molecule attracted much interest due to its potent antibiotic 
and antibacterial properties. There are reports o f the use o f patulin in the treatment o f 
the common cold.'^ Enthusiasm for the use o f patulin as a medicine soon dwindled 
when it was subsequently found to be toxic to mammals. The compound has most 
recently risen to notoriety as a contaminant in food arising from the fiuit used being 
infected by fimgi. Strict quality control procedures are used to screen for trace levels 
o f patulin in products such as apple juice.'' ' 
As a consequence o f the high levels o f interest shown towards patulin, its biosynthesis 
has been extensively studied. Initial biosynthetic investigations were conducted by 
Tanenbaum and Bassett who demonstrated its acetogenic origin. They also 
determined, by the feeding o f labelled biosynthetic 6-methylsalicylic acid (6-MSA), 
that 6-MSA is converted to patulin.'^ Studies by Scott showed the incorporation o f 
deuterated m-cresol.'^ This corroborated the idea that patulin is derived from 6-MSA 
which is decarboxylated to m-cresol and then oxidatively cleaved. 
o 0 0 0 0 
SCoA H O ^ ^ - ^ S C o A . . ^ ACP—S--^^-^ \ 
acetyl-CoA malonyl-CoA / 
6.18 5.20 5.25 
-H2O 
p oxidative cleavage Q H O H O O H O OH 
and rearrangennent ' ' 
— r ^ ^ ^ — HO' Y 1 ' - \ A c p - s 
O H 
Patulin 
7— X j ~ 
-CO2 H2O 
6-methylsaii(^ic acid 
5-28 5.27 5.26 
Scheme 5.5 The biosynthesis o f patulin 
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Through experiments using cell free preparations o f P. patulum, the conversion o f m-
cresol (5.28) to /w-hydroxybenzyl alcohol (5.29) was shown. This biotransformation 
required both N A D P H and molecular oxygen. The hydroxylase, mediating this 
transformation, was shown to be inhibited by carbon monoxide, an effect which could 
be reversed by light at 450 nm. This evidence implicated a mixed fimction oxidase 
involving an N A D P H dependent reductase and a pigment such as cytochrome P-450.'^ 
I n turn, the conversion o f w-hydroxybenzyl alcohol (5.29) to gentisyl alcohol (5.31) 
was demonstrated in a crude enzyme extract o f the fiingus. This biotransformation also 
reHed upon the presence o f molecular oxygen and NADPH. The enzyme was shovm to 
be very substrate specific, and would not ring hydroxylate m-hydroxybenzaldehyde 
(5.32) (Scheme 5.6).'' 
OH H H 
Crude extract of 
P. patulum 
HOH2C HOHoC 
OHC 
5.32 
Scheme 5.6 Ring hvdroxylation in the biosynthesis o f patulin 
Another intermediate, phyllostine (5.34), was isolated from P. patulum culture 
medium. Experiments showed that [2-''*C] acetate and tritiated gentisaldehyde is 
readily incorporated kito phyllostine and that ['''C] phyllostine is incorporated into 
patulin.'^ This finding provided some clues as to the nature o f the aromatic oxidation 
and ring cleavage during patulin biosynthesis (Scheme 5.7). 
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O OH 
Scheme 5.7 Processing of the aromatic ring in the biosynthesis of patulin 
Further investigations were performed to determine how the aromatic ring system is 
oxidised and then rearranged. Two mechanisms for ring cleavage were postulated: 
Scott suggested a dioxygenase process^ ^ whilst Gaucher favoured a monooxygenase 
route. Sankawa explored this issue by using an '^02 atmosphere during feeding 
experiments with [l-'^C]-acetate and [2-*^C]-acetate. By examining the '^ C NMR of 
18 
the resultant patulin, the incorporation of O was detected, at specific sites, by the 
13 18 
upfield isotope shift of C directly bonded to O. Sankawa compared these results to 
13 18 21 
those obtained when [1- C, O2]-acetate was fed as the only source of label. 
Were the biosynthesis to proceed via the dioxygenase mechanism, growing the fungus 
under an '^62 enriched atmosphere would lead to incorporation of label at each of the 
four oxygen sites in the resultant patulin. I f the mechanism were to proceed via the 
monooxygenase route, there would be '^O incorporation into all of the oxygen sites 
except the 0-11. (Scheme 5.8). 
I l l 
v . 
O OH 
Na 
O2 
5.35 
HO 
5.27 
6-methylsalicylic add 
O H C 
5.33 
gentisaldehyde 
O from [1-''^C, ''^021-acetate 
Ofrom ^®02 atmosphere 
0 OH 
CHO 
O H C T ^ 
HO 
A 
^ NADPH 
H2O + NADP 
O2+ NaDPH 
HOH2C 
O H C 
COOH 
0/0 10 
H O ^ ^ O H O ^ ^ X ^ O 
o 
phyllostine 
H O i ^ H2O 
COOH 
HOH2C 
Dioxygenase Monooxygenase 
Scheme 5.8 '^ O? Labelling experiments 
In the event, the resultant patulin gave rise to '^0 incorporations at 0-6, 0-9 and O-
10: no '^O was observed at O - l l . The cultures that had been fed [l- '^C, '*02]-acetate 
produced patulin with '*0 incorporated at the 0-11 position alone. These results were 
consistent with a monooxygenase mechanism. 
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5.7 Initial investigations into the biosynthesis of longianone in X. lonsiana 
No previous biosynthetic work has been performed on longianone, however 
longianone is an isomer of patulin and the two molecules share some common 
structural features. The well known biosynthetic pathway to patulin, through 6-MSA 
may therefore hold some clues to the biosynthesis of longianone. 
An initial investigation into the biosynthesis of longianone was conducted by feeding 
[l,2-^^C2]-acetate at a final concentration of 7 mM to a four week old culture o f X . 
longiana. The culture was grown in a medium of 3 % malt extract (Oxoid) and 6 % 
glucose and maintained at 28 °C. The cultures were maintained under constant 
illumination fi-om a low wattage lamp. After a further 4 weeks growth the culture was 
harvested and the longianone extracted into ethyl acetate and purified by column 
chromatography. 
Analysis of the resulting longianone by '^ C NMR, confirmed an incorporation of [1,2-
'^C2]-acetate of 0.035 % (Fig. 5.7). The low incorporation is most probably a result of 
the high levels of glucose required by the fungal culture to insure production of the 
longianone.' The glucose is processed by glycolysis to acetate and thus the [1,2-'^C2]-
acetate administered to the fungus, is much diluted by the endogenous acetate pool. 
113 
Fig. 5.7 '^C NMR of ri.2-'"C9l-acetate fed longianone 13. 
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Carbon Coupling constant /Hz 
2 
3 55 
4 56 
5 35 
6 34 
8 
Table 5.1 Incorporation of [1,2-'^Cj-acetate into longianone 
Intact incorporation of [l,2-'^C2]-acetate was observed at the C3/C4 and C5/C6 
positions, due to the reciprocal couplings between the '^ C nuclei. 
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This result indicates longianone to be acetogenic in its origin. Incorporations into CI , 
2, 8 and 9 could not be detected, presumably, as these carbons had become divorced 
from their original *^ C partners in the acetate, no coupling is apparent The level of 
incorporation is too low to detect the presence of a single '^ C on top of the natural 
abundance peak (1.11%). The labelling pattern is consistent with a biosynthesis similar 
to that of patulin derived from 6-MSA (Scheme 5.9). 
o 
^ S C o A 
acetyl-CoA 
5.18 
P K S 
O OH 
6-methylsalicylic acid 
5.27 
OH 
C02 
5.28 
H 2 0 ^ Q 
o 
5.35 
[O] 
OH O 
5.34 
P. patulum 
redraw 
OH OH O 
5.36 
X. longiana 
enohse and 
rearaw 
isopatulin 
5.38 
longianone 
5.1 
OH 
HOH2C 
5.29 
[O] 
HOH2C 
Scheme 5.9 A hypothetical biosynthesis of longianone which accounts for the observed 
labelling pattern following the feeding of [1,2-^^Cj-acetate 
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To further investigate the biosynthesis of longianone and its relationship to patulin, a 
series of known intermediates on the patulin pathway were synthesised carrying an 
isotopic label. Deuterium was selected as the isotope of choice as it can be readily 
exchanged into aromatic ring systems and is relatively inexpensive. Deuterium also has 
the advantage of a lower natural abundance (1.5 x 10" % ) , than C (1.11 %) and 
therefore low levels of incorporation may be more easily observed by using H NMR 
analysis. The isotopically labelled intermediates synthesised were [3,5-^H2]- 6-
methylsalicylic acid, [2,4,6-^H3]m-cresol, [7,7-^H2]w-hydroxybenzylalcohol and 
[2,4,6,7,7-^H5] w-hydroxybenzylalcohol. 
5.8 Synthesis of f3,5-^H2]- 6-methylsalicvIic acid 
Ethyl 2-hydroxy-6-methylbenzoate (5.44) was synthesised via a route previously 
described by Hauser et al}^ The sodium salt of ethyl acetoacetate (5.40) was 
generated after treatment with sodium ethoxide, and was used as a nucleophile for a 
Michael type addition with crotonaldehyde (5.41) This generated the keto-aldehyde 
intermediate (5.42). Without isolation of the product, dry HCl gas was bubbled 
through the mixture to promote an aldol condensation to form ethyl 5-methyl-3-
oxocyclohexene-4-carboxylate (5.43). The progress of the cyclisation was monitored 
by the diminution of the large singlet corresponding to the acetyl group in the ' H NMR 
spectrum. On occasion that the reaction had not proceeded to completion, fiirther HCl 
was introduced. 
fl 
O 5.41 
COsEt 
5.27a 
Q 
O 
5.42 
COsEt 
O 
CO2H 
5.43 
iii) 
COzEt CO2B. 
OH 
5.44 
i) EtOH, Na, ii) HCl, iii) Br2, AcOH, iv) DCl, D2O, MeOD, v)KOH MeOH. 
Scheme 5.10 The synthesis of [3,5-^H7]- 6-methvlsalicvlic acid 
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Following distillation, the resultant ethyl 5-methyl-3-oxocyclohexene-4-carboxylate 
(5.43) was treated with a mixture of bromine and acetic acid, a method first described 
by Lacey.^ ^ The resultant ethyl 2-hydroxy-6-methylbenzoate (5.44) was purified by 
steam distillation. 
Various methods of preparing [3,5-^H2]- 6-methylsalicylic acid (5.27a) from the white 
crystalline ester were investigated. It was anticipated that ring deuteration and ester 
hydrolysis of the ethyl 2-hydroxy-6-methylbenzoate (5.44) could be achieved in one 
step by refluxing the ester in DCI/D2O. Unfortunately, following the experiment, the 
NMR indicated that although deuterium had been exchanged into the aromatic ring, 
there was no evidence that any hydrolysis of the ester had occurred. The ester is fairly 
sterically hindered, positioned on the aromatic ring between a methyl and a hydroxyl 
moiety, and it is possible that steric constraints that disfavour acid hydrolysis. In an 
alternative experiment the material was refluxed in a solution of NaOD and D2O. 
Abstrusely, under these conditions, there was no exchange of deuterium into the ring 
but the ester was readily hydrolysed. This offered a way forward. 
6-Methylsalicylic acid, acquired by the hydrolysis of ethyl 2-hydroxy-6-methylbenzoate 
under alkaline conditions, was refluxed in D2O and DCl. In this case, although 
deuterium was exchanged into the ring, the material readily decarboxylated, under the 
acidic conditions generating /w-cresol. Finally, it proved that deuterating the ester in 
acidic media followed by hydrolysis in a basic solution was the most effective method 
of preparing [3,5- H2]-6-methylsalicylic acid. The resultant 6 MSA was found to be 
45 % monodeuterated, 21 % dideuterated and 5 % trideuterated, by mass spectral 
analysis. Proton NMR showed the material to be aknost completely deuterated at 
positions 3 and 5, and only slightly deuterated at position 4. 
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5.9 Synthesis of [2,4,6-^H3]m-cresol 
5.28 5.28a 
i) D2O, PBrs 
Scheme 5.11 Synthesis of [2,4,6- Hjw-cresol 
[2,4,6-'H3]/w-Cresol (5.39) was prepared following the method of Ojanpera et al. 
The synthesis involved the addition of phosphorous tribromide to deuterium oxide to 
generate DBr in situ. m-Cresol (5.28) was added and the mixture refluxed. ^H NMR 
and mass spectrometry confirmed the product to be almost entirely deuterated at 
positions 2,4 and 6. 
5.10 Synthesis of [7J-^H2lm-hydroxybenzyl alcohol 
MeO. 
O 
5.46 5.29a 
i)LiAlD4 
Scheme 5.12 Synthesis of [7,7-^H9]m- hvdroxybenzvl alcohol 
[7,7-^H]/w-Hydroxybenzyl alcohol (5.29a) was prepared by the lithium aluminium 
deuteride reduction of methyl /w-hydroxybenzoate (5.46). ^H NMR and mass 
spectrometry confirmed that the methylene group was almost entirely dideuterated. 
5.11 Feeding experiments with [3,5-^H2l- 6-methylsalicylic acid, [2,4,6-^H3lm-
cresol and f7,7-^H2]m-hydroxybenzyl alcohol 
In separate experiments, four week old cultures of X. longiana were supplemented 
with [3,5-'H2]- 6-methylsaUcyUc acid (5.27a), [2,4,6-^H3]w-cresol (5.28a) and [7,7-
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^H2]/w-hydroxybenzyl alcohol (5.29a) each to a final concentration of 7 mM over a 
period of 3 days. The longianone produced from each experiment was purified over 
silica with and the resultant material was subjected to NMR analysis. In each case 
deuterium incorporation into the longianone could be observed indicating that the 
three compounds are all true intermediates on the biosynthetic pathway to longianone. 
Fig 5.8 NMR Results from the feeding of the labelled aromatics 
C O 2 H 
8 7 6 5 
3 2 
ppm 
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Additionally, the labelling patterns in the resultant longianone, fi-om the three 
intermediates, is consistent with a close biosynthetic relationship to patulin. 
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Scheme 5.13 Biosvnthetic pathway to longianone accounting for the observed 
labelling patterns 
In the experiments with [7,7-^H2]w-hydroxybenzylalcohol it proved impossible to 
determine i f both deuteria had become incorporated, as the C-6 diastereotopic deuteria 
are not resolved by ^H-NMR. It was not possible to solve this problem by mass 
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i ) 
spectral analysis as a consistent fragmentation pattern for unlabelled longianone miM 
not be obtained by either electronic or chemical metlKMls of ionisation. It was therefore 
necessary to find an alternative method to determine whether one or both of ttwe 
deuteria were incorporated. The solution to this problem was to feed w-hydroxybenzyl 
alcohol that was dideuterated at the methylene position and also in the rii^. Hie 
deuterons in the resultant longianone arising from positions in the aromatic ring could 
thus be used as an internal calibration and their signals in the N M R spectrum 
integrated against those arising from the methylene group. 
5.12 Synthesis of f2,4,6,7,7-^Hf;1/yi-hvdroxybenzyl alcohol 
OH OH 
OH D 
5.29a 5.29b 
i) D2SO4, D 2 O carius tube 120 ° C, 150 atmos, for 3 tours 
Scheme 5.14 Synthesis of [2A6,7,7-^Hs1/»-hvdroxvbenzyl alcohol 
Attempts to synthesise [2,4,6,7,7-^H5]/w-hydroxybenzyl alcohol (5.29b) by first 
exchanging deuterium into the aromatic ring of methyl m-hydroxyben^ate (5.46) aixi 
then reducing the ester with lithium alimainium deuteride Med. Although h^drofysis to 
the acid occurred, no exchange of deuterium into the electron deficient ring of the 
aromatic ester could be observed by ' H N M R after the material had b m i reflujced 
under either acidic or basic conditions. 
Deuterium exchange into the ring of w-hydroxybenzyl akohol was w i t n i ^ ^ in the *H 
N M R . This exchange could be optimised by increasing the pressure at which the 
reaction was performed. 
Accordingly [2,4,6,7,7-^H5]/w-hydroxybenzyl alcohol (5.29b) was afforded hy heatii^  
[7,7-^H]/w-hydroxybenzyl alcohol (5.29a)in a weak solution of D2SO4 with I^O, in a 
Carius tube, to 120 ° C with a theoretical maximum pressure of 150 atmos. The 
resultant material was shown to be 75 % deuterated at positioiK 2,4 and 6 of the rii^. 
This proved acceptable for the required feeding experiment. 
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5.13 Feeding experiment with f2,4,6,7,7-^Hj;]m-hydroxybenzyl alcohol 
A four week old culture of X, longiana was supplemented with [2,4,6,7,7-^H5]/w-
hydroxybenzyl alcohol (5.29b) to a final concentration of 7 mM, over a period of 3 
days. The longianone isolated fi'om this experiment was purified and then analysed by 
^HNMR. 
The resultant ^H NMR showed three clear enrichments at C-2, C-6 and C-9 with 
similar intensities. As the intensities are similar it is clear that only one deuterium atom 
fi'om the hydroxymethyl group had become incorporated into the C-6 methylene group 
of longianone. 
8 7 6 5 ppm 
Fig 5.9 ^H NMR After feeding f2,4,6.7.7-^H1m-hvdroxvbenzyl alcohol 
Clearly, i f both deuterons had become incorporated into the methylene group, the 
signal at 4.4 ppm would have had twice the intensity. It follows that the hydroxymethyl 
group must be oxidised to an aldehyde at some stage during the biosynthesis. 
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5.14 Levels of incorporation of the deuterated intermediates 
Specific incorporation = no. moles of deuterated metabolite produced 
no. moles of deuterated precursor fed 
Eqn. 5.1 
Deuterated Precursor Specific Incorporation (%) 
[l,2-''C]-acetate 0.34 
[3,5-^H]- 6-methylsalicylic acid 0.08 
[2,4,6-^H]-w-cresol 0.45 
[7,7-^H]-w- hydroxybenzyl alcohol 5.62 
Table 5.2 Incorporation levels of the deuterated intermediates 
5.15 Discussion 
Through the feeding of appropriate isotopically labelled compounds it has been shown 
that the biosynthesis of longianone is acetogenic and proceeds through the 
intermediates 6-MSA, m-cresol and m-hydroxybenzyl alcohol. These compounds are 
known intermediates on the biosynthetic pathway to patulin (5.30), an isomer of 
longianone (5.1). It is apparent that the two compounds share a very similar 
biosynthesis which diverges at a late stage. In the case of both patulin and longianone 
the biosynthesis starts with the polyketide assembly of 6-MSA which then undergoes 
considerable oxidation and eventual cleavage to afford intermediate 5.36. The manner 
in which intermediate 5.36 cyclises determines whether patulin or longianone is formed 
as the final product. 
In biological screening longianone has shown only moderate cytotoxic activity in 
contrast to patulin. It is possible that longianone is the result of an evolutionary 
"mistake" by a related organism which may once have synthesised the fiingal toxin. 
The extremely high levels of production of the metabolite (100 mg in 100 ml of culture 
medium) lead one to feel that the fimgus must benefit in some way fi'om the production 
of this highly fiinctionalised, intriguing molecule. 
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CHAPTER 6 
Experimental 
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CHAPTER 6 
Experimental 
6.1 Chemical Synthesis 
6.1.1 General 
NMR spectra were recorded on Varian Mercury 200 MHz (^H at 199.992 MHz, '^ C at 
50.30 MHz), Varian Unity 300 MHz (^H at 299.908 MHz, '^ C at 75.450 MHz) or Unity 
Inova 500 MHz (*H at 499.779 MHz, '^ C at 125.669 MHz) machines. Samples were run 
in deuterochloroform, unless stated otherwise, with chemical shifts reported in parts per 
million quoted relative to CDCI3 at 6H = 7.27, 6c = 77.0. The deuterated solvent was used 
as a lock. Coupling constants are reported in hertz. 
Melting points were measured on a Gallenkamp variable heater and are uncorrected. 
Infra red spectra were recorded with absorption values in cm"^  using a Perkin Elmer fitted 
with a golden gate attachment. 
Mass spectral analysis was performed using electron ionisation on a Micromass 
Autospec, Electrospray Fisons Platform mass spectrometer equipped with a H.P.I 
capillary column (25 m long, 0.22 mm i.d., 0.2 \im film thickness) connected to a H.P. 
5890 series I I oven, unless stated otherwise. 
Reaction glassware was dried in an oven at 120 °C and cooled in a dry atmosphere of 
nitrogen. The solvents used in reactions were dried and distilled prior to use: 
tetrahydrofiiran (THE) and diethyl ether (sodium, benzophenone, under nitrogen), ethyl 
acetate (calcium chloride, under nitrogen), dichloromethane and diisopropylamine 
(calcium hydride). Petroleum ether refers to the 40-60°C boiling fraction. Non-aqueous 
reactions were carried out under an atmosphere of dry nitrogen unless otherwise stated. 
Thin layer chromatography was carried out on Merck, Kieselgel 60, F254 glass backed 
plates. Flash chromatography was carried out using Fluka silica gel-60 (35-70 mm). 
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6.1.2 Preparation of (S'i-hexvl-r^HI-fluoroacetate (2.17a) 
[7,7-^H2]-Benzyl alcohol (2.19) 
2.19 
To a stirred solution of lithium aluminium deuteride (1.41 g, 33.67 mmol) in THF (80 
ml), cooled to 0 °C, was added ethyl benzoate (6.92 g, 46.16 mmol) dissolved in THF 
(25 ml). The mixture was heated under reflux for 2 h then cooled once more to 0 °C 
before quenching the reaction using Micovic and Mihailovic's basic work up procedure.' 
The mixture was filtered and the insoluble material washed with diethyl ether (60 ml). 
The solvent was evaporated under reduced pressure to yield [7,T-^ Hz]-benzyl alcohol 
(4.90 g, 97 %) as a clear, colourless oil. v max (neat): 3307, 3027, 2975, 1495; m/z 
(EI+) 110 (]Vf, 100 %), 109 (56 %); 6H (CDCI3): 7.4 (6H, m, Ar-H). 5c (CDCI3): 64.2 
(pentet, J 23, CD2OH), 127, 128, 129 (C-Ar). 
[7-^H]-Beiizaldehyde (2.20) 
O 
D 
2.20 
[7,7-'H2]-Benzyl alcohol (4.75 g, 43.19 mmol) was added to a vigorously stirred mixture 
of pyridinium chlorochromate (PCC) (16.01 g, 74.27 mmol) and 3 A ground molecular 
sieves (75 g) in dichloromethane (DCM) (100 ml). The progress of the reaction was 
followed by thin layer chromatography (TLC) (DCM, silica plates). After 4 h, the 
mixture was filtered through a plug of silica and the residue washed with DCM (100 ml). 
The DCM was evaporated and the remaining material distilled (atmospheric pressure, 
178 °C) to yield [7-'H]-benzaldehyde (3.67 g, 77 %) as a clear colourless, almond 
scented Hquid. v max (neat): 3061, 2108, 1679, 1596, 1583; m/z (EI+) 108 (M'+l, 5 %), 
128 
107 (62 %); 6H (CDCI3): 7.6 (6H, m, Ph-H). 6c (CDCI3): 129.1, 129.8, 134.6 (C-Ph), 
192.1 (t,J27, CDO). 
(R)-17-^H]-Benxy\ alcohol (Z2l/ 
OH 
[• 
H 
2.21 
(l«S)-(-)-a-Pinene (3.7 ml, 23.5 mmol) was added to a solution of 9-borabicyclo[3.3.1] 
nonane (9-BBN) in THE (0.5 M, 43.8 ml, 21.9 mmol), stirred. The mixture was gently 
heated under reflux for 2 h then cooled to room temperature before the addition of [7-
^H]-benzaldehyde (1.81 g, 17.57 mmol). The mixture was, once again, heated under 
reflux for 2 h, cooled to room temperature, quenched with acetaldehyde (2 ml, 36 mmol) 
and stirred for 10 minutes. The THE was removed under reduced pressure and the 
residual material heated to 65 °C under a vacuum of 0.01 mbar for 3 h to remove the a-
pinene. Diethyl ether (20 ml) was added to the resultant viscous oil and the mixture 
stirred until the oil dissolved. 8-Hydroxyquinoline (3.20 g, 22.05 mmol) in diethyl ether 
(30 ml) was added to the mixture producing a vibrant yellow/green precipitate, the 
precipitate was filtered and washed with diethyl ether, the diethyl ether removed under 
reduced pressure and the resultant material distilled using a Kugelrohr apparatus. The 
crude material obtained from this distillation was fiirther purified by distillation using a 
vigreux column to yield (7?)-[7-^ H]-benzyl alcohol (1.33 g, 69 %) as a clear colourless 
oil. B.p. 205 °C, Vmax (neat): 3316, 3019, 2960, 1495; m/z (EI+) 110 (M'+l, 5 %), 
109 (49 %), 108 (99 %), 80 (84 %), 79 (60 %), 78 (55 %), 77 (81 %), 51 (100 %). 6H 
(CDCI3): 4.6 (IH, s, CDHOH), 7.3 (6H, m, Ph-H). 6c (CDCI3): 64.8 (t, JCD 22, 
CDHOH), 127.1, 127.7, 128.6 (C-Ph). 
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(5>[7-^H]-Benzyl fluoride (2.22/ 
2.22 
(i?)-[7-^H]-Benzyl alcohol (0.49 g, 4.5 mmol) was added to a stirred solution of 
diethylaminosulphur trifluoride (DAST) (0.7 ml, 5.8 mmol) in DCM (40 ml) cooled to 
-78 °C. The reaction was stirred at room temperature for 10 h then heated under reflux 
for 30 minutes to ensure completion of the reaction. Water (50 ml) was added to quench 
the reaction and the organic phase washed with water (3 x 30 ml). The organic phase 
was dried over magnesium sulphate, filtered and most of the DCM removed under 
reduced pressure, with caution taken not to allow the temperature to exceed 20 °C so as 
to minimise evaporation of the benzyl fluoride. The benzyl fluoride was not fiirther 
purified. 6F (CDCI3): -207.2 (IF, d.t, JHF 48, JDF 7, CDHF) 6H (CDCI3): 5.4 (IH, d, JHF 
48, CDHF) 7.4 (6H, s, Ph-H). 6c (CDCI3): 8.4 (dt, JFC 165, JDC 23 CDF), 127.8, 128.9, 
129.0 (C-Ph) 
(^>pH]-Fluoroacetate (2.17a) 
NaO 
2.17 
(S)-[7-^H\-BQnzy\ fluoride (398 mg, 2.22 mmol), prepared above, was added to a stirred 
solution of potassium permanganate (105 mg, 0.67 mmol) and potassium periodate (39.2 
g, 170.3 mmol) in water (200ml). The mixture was stirred at room temperature for 48 h 
and then, most of the water removed under reduced pressure. The remaining solution 
was acidified v^th sulphuric acid (2 M), and the material lyophilised. The lyophilised 
solution was neutralised using sodium hydroxide (0.1 M) and the water removed by 
fi-eeze drying to furnish (5^-[^H]-fluoroacetate as a white solid. 5F (CDCI3): -217.4 (IF, 
d.t, JHF 48, JDF 7, CDHF). 
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(5>Hexyl-[^H]-fluoroacetate (2.26) 
2.26 
Thionyl chloride (0.5ml, 5 mmol) was added to a mixture of (5;)-[^H]-fluoroacetate (10 
mg, 0.01 mmol) and commercial sodium fluoroacetate (400 mg, 4 mmol) cooled to 0 °C. 
The mixture was gently heated under reflux for 2 h, then cooled to 0 °C, once more, 
before the remaining excess thionyl chloride was quenched by the addition of a fijrther 
portion of commercial sodium fluoroacetate (200 mg, 2 mmol). Hexanol (2 ml, 16.0 
mmol) was added to quench the fluoroacetyl chloride that had been generated, and the 
mixture stirred for a fiorther 30 minutes. The material was purified by columning over 
silica using DCM as the eluant to give hexyl fluoroacetate (98 %) and (5^-hexyl-[^H]-
fluoroacetate as a colourless oil (405 mg, 50%). 6F (CDCI3): -230.4 (IF, d.t, JHF 47, JDF 
7, CDHE, 1%), -229.9 (IE, t, J 48, CH2F, 99 %), 6H(CDC13): 0.8 (3H, t, J 6, CH3), 1.2 
(6H, m), 1.6 (2H, m), 4.1 (2H, t, J 7, CH2O), 4.7 (2H, d, J 47, CH2F). 6c (CDCI3): 13.8, 
22.4, 25.3, 28.4, 31.3, 65.3, 77.4 (d, J 182, CH2E) 168 (C=0). 
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6.1.3 Preparation of various fluoro-deutero-alkanes 
6.1.3.1 Preparation of 2-fluorof2-^Hl-hexane (2.28) 
[2-^H]-Hexan-2-ol (2.27) 
2.27 
Hexan-2-one (3.99 g, 39.8 mmol) was added to a suspension of lithium aluminium 
deuteride (0.93 g, 22.1 mmol) in THF (40 ml) cooled to 0 °C, and stirred. The mixture 
was left to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C, quenching was performed using Micovic and 
Mihailovic's basic workup procedure.' The mixture was filtered and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [2-^H]-hexan-2-ol as a clear colourless oil (3.10 g, 97 %). v max (neat): 3343, 
2959, 2928, 2859, 2364. m/z (CI+, NH3) 104 (M+1, 0.13 % ) 6H(CDC13): 0.9 (3H, m), 
1.2 (3H, m), 1.3 (6H, m), 1.8 (IH, OH) . 6c (CDCI3): 13.9, 22.6, 23.1, 27.8, 38.8, 67.4 
(t, J 22, C D O H ) 
2-Fluoro[2-^H]-hexane (2.28)' 
2.28 
[2-"H]-Hexan-2-ol (0.90 g, 8.74 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (1.2 ml, 9.08 mmol) in DCM (20 ml) cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by vacuum line distillation to yield 2-fluoro[2-
'H]-hexane (0.56 g, 61 %) as a colourless Hquid. 6F (CDCI3): -189.9 (m) 6H (CDCI3): 0.9 
-1.0 (6H, m), 1.4-1.7 (6H, m), 6c (CDCI3): 9.3 (d, J 6), 14.0, 18.3 (d, J 5), 27.9 (d, J 
21), 36.7 (d, J 21), 95.0 (dt, JFC 166 JDC 23, CDF). 
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6.1.3.2 Preparation of 3-fluoro[3-^Hl-hexane (2,30) 
[3-^H]-Hexan-3-ol (2.29) 
2.29 
Hexan-3-one (4.34 g, 43.4 mmol) was added to a suspension of lithium aluminium 
deuteride (0.97 g, 23.1 mmol) in THE (40 ml), cooled to 0 °C, and stirred. The mixture 
was lefl: to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C quenching was performed using Micovic and 
Mihailovic's basic workup procedure.' The mixture was filtered, and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [3-^H]-hexan-3-ol as a clear colourless oil (4.06 g, 91 %). v max (neat): 3326, 
2958, 2927, 2873, 1462. m/z (CI+, NH3) 135 (M+1, 14 %) 6H(CDC13): 0.9 (6H, m), 1.4 
(6H, m), 1.8 (IH, OH) 6c (CDCI3): 9.7, 14.0, 18.7, 29.9, 38.9, 72.3 (t, J 22, CDOH). 
3-Fluoro[3-^H]-hexane (2.30)^ 
2.30 
[3-'H]-Hexan-3-ol (0.93 g, 8.98 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (1.2 ml, 9.08 mmol) in D C M (20 ml), cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by vacuum line distillation to yield 3-fluoro[3-
^H]-hexane (0.55 g, 58 %) as a colourless hquid. 6F(CDC13): -189.9 (m) 6H(CDC13): 0.9-
1.0 (6H, m), 1.4-1.7 (6H, m), 6c(CDCl3): 9.3 (d, J 6), 14.0, 18.3 (d, J 5), 28.0 (d, J 21), 
36.7 (d 20.5), 95.0 (dt, JFC 166, JDC 22, CDF). 
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6.1.3.3 Preparation of 2-fluoror2-^Hl-heptane (2.32) 
[2-^H]-Heptan-2-ol (2.31) 
2.31 
Heptan-2-one (3.39 g, 29.8 mmol) was added to a suspension of lithium aluminium 
deuteride (0.66 g, 15.8 mmol) in THF (40 ml), cooled to 0 °C and stirred. The mixture 
was left to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C quenching was performed using Micovic and 
Mihailovic's basic workup procedure.' The mixture was filtered, and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [2-^H]-heptan-2-ol as a clear colourless oil (3.23 g, 93 %). v max (neat): 3350, 
2955, 2929, 2859, 1459. m/z (CH-, NH3) 136 (M+NHf^+l, 5 %), 135 (M+NH,^ 66 %), 
118 (M+1, 1 %), 117 (M, 6 %). 6H(CDC13): 0.8-0.9 (3H, m), 1.1 (3H, m), 1.2-1.4 (6H, 
m), 1.8-1.9 (2H, m) 2.4 (IH, O H ) 6c (CDCI3): 13.9, 22.5, 23.1, 25.3, 31.7, 39.0, 67.3 (t, 
J 37, CDOH) . 
2-Fluoro[2-^H]-heptane (2.32)^ 
2.32 
[2-'H]-Heptan-2-ol (1.10 g, 9.40 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (1.2 ml, 9.08 mmol) in D C M (20 ml) cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by vacuum line distillation to yield 2-fluoro[2-
'H]-heptane (0.58 g, 52 %) as a colourless hquid. 6F(CDC13): -180.5 (m) 6H(CDC13): 0.9 
(3H, t, J 6), 1.3 (3H, s), 1.3-1.4 (8H, m), 6c(CDCl3): 13.7, 20.6 (d, J 23), 22.4, 25.1, 
31.6, 36.7 (d, J 21), 90.4 (dt, JFC 163, JDC 23, CDF). 
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6.1.3.4 Preparation of 3-fluoro[3-^Hl-heptane (2.34) 
[3-^H]-Heptan-3-ol (2.33) 
2.33 
Heptan-3-one (3.23 g, 28.4 mmol) was added to a suspension of lithium aluminium 
deuteride (0.66 g, 15.8 mmol) in THE (40 ml), cooled to 0 °C, and stirred. The mixture 
was left to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C, quenching was performed using Micovic and 
Mihailovic's basic workup procedure.' The mixture was filtered, and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [3-^H]-heptan-3-ol as a clear colourless oil (2.20 g, 66 %). v max (neat): 3322, 
2957, 2925, 2858, 1458. m/z (CI+, NH3) 133 (M+NHi^+l, 8 %), 132 (M+NH4^ 100 
%), 115 (M+1, 10 %), 114 (M, 10 %). 6H (CDCI3): 0.8-0.9 (6H, m), L2-1.5 (8H, m), 2.5 
(CDOH), 6c (CDCI3): 9.7, 13.9, 22.6, 27.7, 29.7, 36.3, 72.7 (t, J 21) 
3-Fluoro[3-^H]-heptane (2.34)^ 
2.34 
[3-'H]-Heptan-3-ol (0.93 g, 8.98 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (1.2 ml, 9.08 mmol) in DCM (20 ml), cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by vacuum line distillation to yield 3-fluoro[3-
^H]-heptane (0.55 g, 58 %) as a colourless Uquid. 6F (CDCI3): -182.4 (m) 6H (CDCI3): 
0.9-1.0 (6H, m), 1.3-1.7 (8H, m), 6c(CDCl3): 9.3 (d, J 6), 13.9 (d, J 10), 22.6, 27.2 (d, J 
5), 27.9 (d, J 21), 34.3 (d 24), 95.3 (dt, JFC 166, JDC 23, CDF). 
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6.1.3.5 Preparation of 3-fluoror3-^H1-octane (2.36) 
[3-^H]-Octan-3-ol (2.35) 
2.35 
Octan-3-one (6.79 g, 53.1 mmol) was added to a suspension of lithium aluminium 
deuteride (1.40 g, 33.4 mmol) in THF (40 ml), cooled to 0 °C, and stirred. The mixture 
was left to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C quenching was performed using Micovic and 
Mihailovic's basic workup procedure.' The mixtxire was filtered, and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [3-^H]-octan-3-ol as a clear colourless oil (4.68 g, 67 %). v max (neat): 3322, 
2957, 2925, 2858, 1458. m/z (CI+, NH3) 150 (M+NH4^+1, 3 %), 149 (M+NHj^ 23 %), 
131 (M, 3 %). 6H (CDCI3): 0.9-1.0 (6H, m), 1.2-1.5 (10 H, m), 1.9 (IH, OH) 6c 
(CDCI3): 9.9, 14.1, 22.7, 25.4, 30.1, 32.0, 36.9, 72.8 (t, J21, CDOH). 
3-Fluoro[3-^H]-octane (2.36)^ 
2.36 
[3-'H]-Octane-3-ol (2 .17 g, 16.53 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (2.4 ml, 18.16 mmol) in DCM (20 ml) cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by Kugelrohr distillation to yield 3-fluoro[3-
'H]-octane (0.55 g, 58 %) as a pale yellow Uquid. 6F (CDCI3): -182.5 (m) 6H (CDCI3): 
0.9-1.0 (6H, m), 1.3-1.7 ( 1 0 H , m), 6c(CDCl3): 9.5 (d, J 6), 14.1, 22.8, 25.0 (d, J 5), 
28.1 (d, J22) , 31.9, 34.7 (d 20.9), 95.3 (dt, JFC 166, JDC 23, CDF). 
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6.1.3.6 Preparation of 4-fluoro[4-^H1-octane (2.39) 
4-Octanone (2.37) 
2.37 
4-Octanol (4.94 g, 37.98 mmol) was added to a vigorously stirred mixture of PCC (12.4 
g, 57.6 mmol) and 3 A ground molecular sieves (40 g) in DCM (200ml). The progress of 
the reaction was followed by TLC (DCM, silica plates). After 5 h, the mixture was 
filtered through a plug of silica and the residue washed with DCM (100 ml). The DCM 
was evaporated under reduced pressure to yield 4-octanone (3.72 g, 77 %) as a clear, 
colourless Uquid. v max (neat): 2874, 1709, 1461. m/z (CI+, NH3) 147 (M+NHj^+l, 7 
%), 146 (M+NH4^ 100 %), 129 (M+1, 15 %), 128 (M, 7 %). 6H (CDCI3): 0.7-0.8 (6H, 
m), 1.0-1.2 (2H, m), 1.2-1.5 (4H, m), 2.1-2.3 (4H, m). 6c (CDCI3): 13.3, 13.4, 16.9, 
22.0, 25.6, 42.1,44.2,210.6. 
[4-^H]-Octan-4-ol (2.38) 
2.38 
Octan-4-one (3.57 g, 27.9 mmol) was added to a suspension of lithium aluminium 
deuteride (0.65 g, 15.5 mmol) in THE (40 ml), cooled to 0 °C and stirred. The mixture 
was left to warm to room temperature then heated under reflux for 3 h. After cooling the 
reaction mixture, once again, to 0 °C, quenching was performed using Micovic and 
Mihailovic's basic workup procedure.^  The mixture was filtered, and the insoluble 
material washed with diethyl ether. The solvent was evaporated under reduced pressure 
to yield [4-^H]-octan-4-ol as a clear colourless oil (2.38 g, 65 %). v max (neat): 3314, 
2956, 2928, 2872, 1456. m/z (CI+, NH3) 150 (M+NHi^+l, 3 %), 149 (M+NH4^ 40 %), 
131 (M+1, 2 %), 130 (M, 3 %). 6H(CDC13):0.8-0.9 (6H, m), 1.2-1.3 (lOH, m), 2.6 (IH, 
broad, OH) . 6c (CDCI3): 13.8, 13.9, 18.6, 22.6, 27.6, 36.8, 39.3, 70.7 (t, J 22, CDOH). 
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4-Fluoro[4-^H]-octane (2.39/ 
2.39 
[4-'H]-Octane-4-ol (0.89 g, 6.81 mmol) was added to a solution of diethylaminosulphur 
trifluoride (DAST) (1 ml, 7.56 mmol) in DCM (20 ml) cooled to -78°C. The reaction 
mixture was heated under reflux for 3 h with stirring. The mixture was cooled to 0 °C 
and quenched by the addition of water. The organic phase was washed with water (3 x 
20 ml) and dried over magnesium sulphate. The solvent was cautiously removed under 
reduced pressure and the product purified by Kugelrohr distillation to yield 4-fluoro[4-
^H]-octane (0.42 g, 46 %) as a pale yellow liquid. 6F (CDCI3): -181.7 (m) 6H (CDCI3): 
0.9-1.3 (6H,m), 1.3-1.6 ( 1 0 H , m), 6c(CDCl3): 13.8 (d,J3), 18.4 (d,J5), 22.6, 27.3(d, 
J 5), 34.8 (d, J 21), 37.1, 37.3, 93.6 (dt, he 166, JDC 20, CDF). 
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6.1.4 Preparation of (15,2i?)-ri-^H1-glvcerol (4.10) and ilR. 2i?)-fl-^Hl-
glvcerol (4.10a)'^ 
Z-[3-^H]-(2-Propenyl) benzoate (4.13)^ 
O 
4.13 
Propargyl alcohol (5.01 g, 91.0 mmol) was added dropwise to a suspension of lithium 
aluminium hydride (4.25 g, 132 mmol) in THE (110 ml) cooled to 0 °C and stirred. The 
mixture was left to warm to room temperature and stirred for 3 h. The reaction was 
quenched by slowly adding a ndxture of THE (10 ml) and deuterium oxide (5 ml) until 
hydrogen gas ceased to be evolved. The mixture was filtered, the insoluble material 
washed with dichloromethane (200 ml) and the filtrate added to an aqueous sodium 
hydroxide solution (30 %, 50 ml), which contained benzyl triethyl ammonium chloride 
(2.03 g, 9 mmol), with vigorous stirring. A solution of benzoyl chloride (16.90 g,) in 
dichloromethane (40 ml) was added to this mixture, and gradually a dense white 
precipitate formed. After 2 h, water was added to dissolve the precipitated material. The 
organic phase was separated, and the aqueous extracted with dichloromethane. Washing 
of the combined organic phase with water until neutral and drying over magnesium 
sulphate, afforded the crude product after solvent removal. 
Purification over silica (ethyl acetate/ petroleum ether 1:8) gave Z-[3-^H]-(2-Propenyl) 
benzoate (4.78 g, 32 %) as a colourless oil. v max (neat): 3063, 2943, 1716, 1601, 1451. 
m/z (EI+) 163 (M^, 22 %), 162 (4 %), 85 %D. 6H (CDCI3): 4.9 (2H, d, J 6 Hz, CH2), 5.3 
(IH, d, J 10 Hz, 3'-H tram\ 6.0-6.2 (IH, m, 2'-H), 7.4-7.5 (2H, m, 3-H, 5-H), 7.5-7.6 
(IH, m, 4-H), 8.0-8.1 (2H, m, 2-H, 6-H). 6D (CHCl3):5.3 (ID, s, 3'-D trans, 12 %), 5.5 
(ID, s, 3'-D cis, 78 %), 6.1 (ID, s, 2'-D, 10 %) 6c (CDCI3): 65.3 (C-1'), 117.7 (t, J 24 
Hz, C-3'), 128.2 (C-3, C-5), 129.5 (C-2, C-6), 130.1 (C-1), 132.1 (C-2'), 132.8 (C-4), 
166.0 (C02Ph). 
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^-[3-^H]-(2-Propenyl) benzoate (4.13a)^ 
Ph 
4.13a 
A solution of propargyl alcohol (6.50 g, 116 mmol) in dry THF (150 ml) was treated 
with «-butyl lithium (125 ml, 1.6M in hexane, 200 mmol) at -78 °C, and left to warm to 
room temperature. Deuterium oxide (8.0 ml, 400 mmol) was added, the mixture filtered, 
to remove precipitate, dried over magnesium sulphate, filtered once more and 
concentrated by distilling off the solvents through a vigreux column at atmospheric 
pressure. The remaining solution was slowly added to a solution of lithium aluminium 
hydride (6.89 g, 181 mmol) in dry THF (105 ml) at 0 °C and stirred at this temperature 
for 3 h. A 2:1 water THF mixture was added carefiilly until fizzing ceased and the crude 
^-[3-"H]-aUyl alcohol was benzoylated and purified as described above to give £-[3- H]-
(2-propenyl) benzoate (7.21 g, 38 %) as a colourless oil. 
V max (neat): 2942, 2360, 2345, 1718 (C=0), 1602 (C=C), 1451. m/z (EI+) 163 (M^, 
4.84 %), 162 (3.58 %), 57 %D. 6H (CDCI3): 4.8 (2H, d, J 6 Hz, CH2), 5.4 (IH, d, J 17 
Hz, 3'-H CIS), 6.0-6.2 (IH, m, 2'-H), 7.4-7.5 (2H, m, 3-H, 5-H), 7.5-7.6 (IH, m, 4-H), 
8.1 (2H, m, 2-H, 6-H). 6D (CHCl3):5.3 (ID, s) 6c (CDCI3): 65.5 (C-1'), 118.0 (t, J 24 
Hz, C-3'), 128.3 (C-3, C-5), 129.6 (C-2, C-6), 129.7 (C-1), 132.1 (C-2'), 132.9 (C-4), 
166.2 (COsPh). 
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[3(5)-^H]-2(i?), 3-Dihydroxypropyl benzoate (4.14/ 
D O 
HO" ^ ^O' Ph 
OH 
4.14 
AD-mix-p (43.01 g) was added to a mixture of water (144 ml) and tert-butyl alcohol 
(144 ml). The mixture was stirred for 30 minutes until all of the AD-mix-P was in 
solution, the solution was then cooled to 0 °C and stirred for a fiirther 30 minutes. Z-[3-
^H]-(2-Propenyl) benzoate (5.24 g, 32.1 mmol) was added and the mixture stirred for 
4 h. Sodium disulphite (50.1 g, 262 mmol) was added and the mixture allowed to warm 
to room temperature and stirred for a ftirther hour. The aqueous phase was extracted 
into ethyl acetate (4 x 100 ml) and the combined organics dried over magnesium 
sulphate. Evaporation of the solvent under reduced pressure gave the crude product, 
which was purified by column chromatography (ethyl acetate/petroleum ether 2:1). The 
resultant material was recrystallised fi-om diethyl ether and petroleum ether to yield 
[3(5)-^H]-2(7?), 3-dihydroxypropyl benzoate (4.13 g, 65 %) as a fine white powder.mp. 
55-56 °C (ht 61 °C)', [a]D=+28.8,(c 2.5, EtOH) v max (neat): 3362 (OH), 2882 (CH), 
1698 (C=0), 1268 (C-0). m/z ( C I ^ 3 ) 198 (M'+l, 46 %), 180 (100 %). 6H (CDCI3): 
2.2 (IH, br, OH), 2.6 (IH, br, OH), 3.8 (IH, br, 3'-H), 4.1 (IH, br, 2'-H), 4.4 (2H, m, 
I'-H), 7.4-7.5 (2H, m, 3-H, 5-H), 7.5-7.6 (IH, m, 4-H), 8.0-8.1 (2H, m, 2-H, 6-H). 6D 
(CHCl3):3.7 (ID, s) 6c (CDCI3): 63.1 (t, J 20 C-3'), 65.6 (C-2'), 70.1 (C-1'), 128.3 (C-
3, C-5), 129.5 (C-1, C-2, C-6), 133.1 (C-4), 132.9 (C-4), 166.8 (COjPh). 
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[3(i?)-^H]-2(i?), 3-Dihydroxypropyl benzoate (4.14af 
[3(^-^H]-2(i?), 3-Dihydroxypropyl benzoate (4.33 g, 67 %) was obtained fi-om £-[3-
^H]-(2-propenyl) benzoate (5.35 g, 32.81 mmol) as described above for 4.14. 
Recrystalisation afforded a fine white powder of m.p. 56-57 T (lit 63 °C)'*. [a]D=+5.3, {c 
2.5, EtOH) V max (neat): 3499 (OH), 3459 (OH) 2928 (CH), 1697 (C=0), 1271 (C-0). 
m/z (Cf+NH3) 198 (M'+l , 100 %), 180 (72 %). 6H(CDC13): 2.3 (IH, br, OH), 2.8 (IH, 
br, OH), 3.7 (IH, br, 3'-H), 4.1 (IH, br, 2'-H), 4.4 (2H, m, I'-H), 7.4-7.5 (2H, m, 3-H, 
5-H), 7.5-7.6 (IH, m, 4-H), 8.0-8.1 (2H, m, 2-H, 6-H). 6D (CHCI3): 3.80 (ID, s) 6c 
(CDCI3): 63.2 (t, J 19, C-3'), 65.9 (C-2'), 70.5 (C-1'), 128.6 (C-3, C-5), 129.7 (C-1, C-
2, C-6), 133.5 (C-4), 132.9 (C-4), 167.1 (COjPh). 
{IS, 2J?)-[l-^H]-Glycerol (4.10)^ 
D 
HO" ^ ^OH 
OH 
4.10 
[3(5)-^H]-2(/?), 3-Dihydroxypropyl benzoate (4.13 g, 20.1 mmol) was dissolved in 
acetone (151 ml) and an aqueous sodium hydroxide solution (0.5 M, 42 ml, 21 mmol). 
The mixture was heated to 65 °C with stirring for 1 h. The solvents were evaporated to 
dryness, under reduced pressure, and the resultant solid ground up, washed with dry 
analar acetone and the filtrate combined and concentrated. The crude material was 
purified over silica (water/acetone 5:95) to afford glycerol (2.55 g, 81 %) as a viscous 
oil. V max (neat): 3250 (OH), 2932, 2885 (CH), 1646, 1408. m/z (ES+) 94 (M'+l, 5 %). 
6H(D20): 3.3-3.4 (IH, m, 3-Ha), 3.4 (2H, m, 1-Hb, 3-Hb), 3.6 (IH, m, 2-H). 6D(H20): 
3.4 (ID, S) and 3.6 fi-om 15 % [2-'H,]-glycerol. 6c (D2O): 66.6 (t, J 22 C-1), 66.9 (C-3) 
76.4 (C-2). 
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(IR, 2i?)-[l-^H]-GIycerol (4.10a/ 
OH 
OH 
4.10a 
(IR, 27?)-[l-'H]-Glycerol (1.93 g, 75 %) was obtained from [3(Ry^H\-2{R), 3-
dihydroxypropyl benzoate (5.43 g, 27.6 mmol) as described above for 4.10. 
V max (neat): 3260 (OH), 2884 (CH), 1684, 1404. m/z (ES+) 94 (IVT+l, 2 % ) . 6H(D20): 
3.4 (2H, dd, J 6, J 11, 1-Ha, 3-Ha), 3.5 ( IH , dd, J 4, J 11, 3-Hb), 3.6 ( IH, m, 2-H). 6D 
(H2O): 3.5 ( ID, s). 6c (D2O): 62.3 (t, J 22 C-1), 62.6 (C-3), 72.1(C-2). 
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6.1.5 Preparation of deuterated compounds with which to investigate 
the biosynthesis of longianone 
6.1.5.1 Preparation of [S.S-^H?]- 6-niethvlsalicvlic acid (5,27a? 
Ethyl 5-niethyl-3-oxocyclohexene-4-carboxyIate (5A3f 
Ethyl acetoacetate (35 ml, 280 mmol) was added to a stirred solution of sodium (204 
mg, 9.87 mmol) dissolved in ethanol (50 ml). The mixture was cooled to 0 °C and 
crotonaldehyde (23 ml, 280 mmol) was added, over the course of 1 h, with stirring. The 
reaction was left to stir at room temperature for 16 h. The resultant yellow, turbid 
solution was cooled to 0 °C, saturated with dry hydrogen chloride gas then stirred at 
room temperature for a further 24 h. It was seen, by *H NMR, that the reaction had not 
gone to completion. The reaction was saturated with dry hydrogen chloride gas, once 
more, and stirred for a fiirther 24 h. The solvent and some biproduct were removed on 
the water aspirator at 50 °C, and the mixture was purified by distillation (90 °C, 27 kgm' 
s^"^  ) to yield ethyl 5-methyl-3-oxocyclohexane-4-carboxylate (32 g, 68 %) as a pale 
yeUow oil. b.p. 90 °C, 27 Pa, v max: 2963, 1734, 1673. m/z (EI+) 183 (Nf+1, 18 % ) , 
131 (100 % ) , 123 (36 % ) , 85 (29 % ) . 6H(CDC13): 1.1 (3H, d, J6, C5-CH3), 1.3 (3H, t, 
J 7, CO2CH2CH3), 2.1 ( IH , m, C5H), 2.5 (2H, m, C6H2) 3.1 ( IH , d, J 12, C4H), 4.1 
(2H, q, J 7, CO2CH2CH3), 6.1 ( IH , dom, J 9, C2H). 6c (CDCI3): 14.4 (CO2CH2CH3), 
20.0 (C5CH3), 33.1 (C6), 33.6 (C5), 61.3 (C4), 61.9 (CO2CH2CH3), 129.0 (C2), 149.9 
(CI), 170.1 (COjEt), 194.7 (C3). 
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Ethyl 2-hydroxy-6-methylbeiizoate (5,44)' 
5.44 
Bromine (4.3 ml, 850 mmol) in acetic acid (10 ml) was added slowly to a stirred solution 
of ethyl 5-methyl-3-oxocyclohexane-4-carboxylate (14.30 g, 846 mmol) in chloroform 
(100 ml) at 0 °C. The mixture was allowed to warm to room temperature, stirred for 1 h, 
and was then heated to reflux for 16 h. The dark orange/brown reaction mixture was 
cooled to room temperature, dichloromethane added (75 ml) and the organics washed 
with water (3 x 100 ml) and saturated sodium hydrogen carbonate solution (1 x 50 ml). 
The solvent was removed, under reduced pressure, and the resulting brown tar purified 
by steam distillation. Ethyl 2-hydroxy-6-methylbenzoate (9.86 g, 69 %) was recovered as 
a white solid with needle like crystals having a strong phenolic smell. m.p. 38-40 °C (lit. 
42 °C)', V max 2978.5, 1738.7, 1642.0, 1600, 1459. m/z (EI+) 181 (IVT+l, 7 % ) , 180 
(54 % ) , 135 (37 % ) , 134 (100 % ) , 106 (18 % ) , 77 (27 % ) , 51 (24 % ) . 6H(CDC13): 1.5 ( 
3H, t, J 7, CO2CH2CH3), 2.6 ( 3H, s, CHs-Ph), 4.5 (2H, q, J 7, CO2CH2CH3), 6.8 ( IH, 
d, J 7, C3H), 6.9 ( I H , d, J 8, C5H), 7.3 ( IH , d.d, J 8, C4H), 11.4 (lH,s, OH, disappears 
on shaking with 'H2O). 6c (CDCl 3): 14.4 (CO2CH2CH3), 24.2 (CH3-Ph), 61.7 
(CO2CH2CH3), 112.5 (CI), 115.7 (C3), 123.0 (C5), 134.2 (C4), 141.5 (C6), 163.0 (C2), 
171.9 (C02Et). 
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Ethyl [3,5-^H2]-2-hydroxy-6-niethylbenzoate (5,45) 
5.45 
Deuterium chloride ( 2 ml) and deuterium oxide (2 ml) were added to ethyl 2-hydroxy-6-
methylbenzoate (1 .00 g, 5 mmol), which had been previously treated by stirring with 
deuterium oxide. The mixture was heated under reflux for 1 6 h, cooled and the product 
removed by filtration through a sinter. NMR indicated that only a third of the protons 
had been exchanged by deuterons. The material was heated under reflux for a fiirther 1 6 
h with deuterium chloride (2 ml) and deuterium oxide (2 ml). The resulting product was 
collected by filtration, through a sinter fiinnel, and dried under reduced pressure to yield 
2-hydroxy-6-methylbenzoate (0 .81 g, 81 %) that was 2 7 % mono, 55 % di and 7% 
trideuterated. m.p. 38-40 ° C (lit. 4 2 ° C ) ^ v max: 2980, 1739, 1643, 1598, 1460. m/z 
(EI+) 183 ( ]Vf+l , 4 % ) , 182 (31 % ) , 181 ( 1 2 % ) , 180 (4 % ) , 137 (22 % ) , 136 (100 % ) 
135 ( 3 7 % ) , 134 ( 1 2 % ) . 6H(CDC13): 1.5 ( 3 H , t, J 7, CO2CH2CH3), 2.6 ( 3 H , s, CH3-
Ph), 4.5 ( 2 H , q, J 7, CO2CH2CH3), 6.7 ( 0 . 1 2 H , d, J 4 , Ph), 6.9 ( 0 . 1 2 H , d, J 6, Ph), 
11.4 ( I H , s, O H , disappears on shaking with ^H20). 6c (CDCI3): 14.4 (CO2CH2CH3), 
24.2 (CH3-Ph), 61.7 (CO2CH2CH3), 112.5 ( C I ) , 115.7 (t, J 2 7 , C3) , 123.0 (t, J 3 1 , C5) , 
134.0 (t, J 1 1 , C 4 ) , 141.2 ( C 6 ) , 162.9 (C2) , 171.9 (C02Et). 
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6-Methylsalicylic acid (5.27) ^ 
5.27 
A solution of ethyl 2-hydroxy-6-methylbenzoate (1.01 g, 6 mmol) in aqueous sodium 
hydroxide (5 ml, 1 M) was heated under reflux for 8 h. After cooling, the reaction 
mixture was acidified with aqueous hydrogen chloride (1 M) and extracted into ethyl 
acetate (3 x 20 ml). The combined ethyl acetate was dried over magnesium sulphate and 
removed by rotary evaporation to yield 6-methylsalicyIic acid (0.82 g, 90 % ) . Mp 169-
170 °C (Ht. 170-171 °C)', V max: 3422, 3050, 2977, 2848, 2595, 1646, 1599. m/z (EI+) 
152 (16 % ) , 151 (88 % ) , 150 (100 %) 149 (34 % ) . 6H (CDCI3/CD3OD): 2.6 (3H, s, CH3-
Ph), 6.7 ( I H , d, J 7, C3H), 6.8 ( I H , d, J 8.4, C5H), 7.4 ( IH , d.d, J 8, C4H). 6c 
(CDCI3/CD3OD): 23.6 (CH3-Ph), 112.3 (CI), 115.0 (C3), 122.7 (C5), 133.7 (C4), 142.0 
(C6), 162.7 (C2), 174.1 (CO2H). 
[3,5-^H2]- 6-Methylsalicylic acid (5.27a) 
COoH 
5.27a 
Using the procedure detailed above, ethyl [3,5-^H]-2-hydroxy-6-methylbenzoate (1.02 g, 
6 mmol) was converted to [3,5-^H2]- 6-methylsalicylic acid (0.84 g, 91 % ) . m.p. 167-
169°C (Ut. 170-171 °C, undeuterated)^ v max: 3420.9, 3048.9, 2974.7, 2847.0, 
2593.66, 1645.25, 1598.84. m/z (EI+) 154 (7 % ) , 153 (29 % ) , 152 (62 %) 151 (40 % ) , 
150 (24 % ) , 149 (17 % ) , 148 (4 % ) . 6H (CDCI3/CD3OD): 2.6 (3H, s, CH3-Ph), 6.7 
(O.IH, d, J 8, C3H), 6.8 (O.IH, d, J 8, C5H), 7.4 (0.9H, d.d, J 8, C4H). 6c 
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(CDCI3/CD3OD): 23.6 (CH3-Ph), 112.0 (CI), 115.0 (t, J 19, C3), 122.7 (t, C5), 133.7 
(C4), 142.0 (C6), 162.7 (C2), 174.1 ( CO2H). 
6.1.5.2 Preparation of r2.4.6-^H.1/ii-cresoi (5.28af 
5.28a 
A suspension of phosphorus tribromide (1.2 ml) in deuterium oxide (10 ml) was stirred 
at 0 °C. After 30 minutes, w-cresol (1.10 g, 10.3 mmol) was added. The mixture was 
stirred for a fiirther 30 minutes, at 0 °C, then heated under reflux overnight. After 
cooling, the mixture was extracted into diethyl ether (3 x 50 ml) the organic extracts 
were combined and then dried over magnesium sulphate. The solvent was removed 
under reduced pressure to yield [2,4,6-^H3]/w-cresol (1.11 g, 98 % ) . v max: 3316.0, 
2357.4, 1587.9, 1489.8. m/z (EI+) 112 (IVT+l, 15 % ) , 111 (100 % ) , 110 (99 % ) , 109 
(52 % ) . 6H (CDCI3): 2.3 (3H, s, CH3-Ph), 7.1 ( IH , s, C5H). 6c (CDCI3): 21.3 (CH3-Ph), 
112.1 (t, J21), 115.8 (t, J 22), 121.5 (t, J 22), 129.3 (C5), 139.8 (C3), 155.1 (CI). 
6.1.5.2 Preparation of [T^T-^Hil/yi-hydroxybenzyl alcohol (5,29a) 
OH 
5.29a 
To a stirred solution of lithium aluminium deuteride (0.82 g, 19.61 mmol) in THF (50 
ml) cooled to 0 °C, was added m-hydroxy methyl benzoate (4.00 g, 26.32 mmol) 
dissolved in THF (10 ml). The mixture was allowed to warm gradually to room 
temperature and then heated under reflux for 48 h. The reaction was quenched using 
Micovic and Mihailovic's basic workup procedure.' The mixture was filtered, and the 
insoluble material washed with ethyl acetate. The solvent was evaporated under reduced 
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pressure to yield [7,7-^H2]w-hydroxybenzyl alcohol (2.32 g, 70 % ) . m.p. 69-70 °C (lit. 
non. deuterated 67-68 °C)\ v max: 3357, 3053, 2947, 1587, 1496. m/z (EI+) 127 
(]yr+l , 9 % ) , 126 (100 % ) , 125 (19 % ) , 124 (8 % ) . 6H(D20): 6.6-6.7 (3H, m, 2-H, 4-H, 
6-H), 7.0-7.2 ( I H , m, H-5). 6c (D2O): 63.2 (p, J 44, CD2OH,), 115 (C4), 116 (C6), 119 
(C2), 130 (C5), 142 (C3), 158 (CI). 
6.1.5.4 Preparation of [2,4,6 J J-^Hgl/w- hvdroxvbenzvl alcohol 5^.29^ ) 
OH D 
5.29b 
[7,7- H2]w-Hydroxybenzyl alcohol (0.61 g, 4.87 mmol), deuterium oxide (5 ml) and 
cone, deuterosulphuric acid (1 drop) were placed in a carius tube which was heated to 
120 ° C, 1.52 X 1 0 ' Pa, for 3 h. The material was filtered and neutralised with aqueous 
sodium hydroxide (0.01 M), and the water removed on a freeze drier. Purification over 
silica (ethyl acetate / dichloromethane 9 : 1 ) gave [2,4,6,7,7-^H5]w- hydroxybenzyl 
alcohol as a white solid, (0.51 g, 83 %) m.p. 69-70 °C (lit. non. deuterated 67-68 °C)8, v 
max: 3358, 3053, 2946, 1587, 1497, 1390, 1283, 1244, 1084, 1077, 779. m/z (EH) 130 
(IVf+l , 94 % ) , 129 (30 % ) , 128 (48 % ) , 127 (36 % ) , 126 (17 % ) , 125 (5 % ) . 6H(D20): 
6.6-6.7 (3H, m, 2-H, 4-H, 6-H, 20 % of signal remains), 7.0-7.2 ( IH , m, H-5, 100 % of 
signal remains). 6D (H2O): 4.4 (2D, CD2OH), 6.7 (2.4 D, 2-D, 4-D, 6-D, 81% 
deuterated) 6c (D2O): 63.2 (p, J 44, CD2OH,), 114.7 (t, J 23, C4), 115.2 (t, J 24, C6), 
119.5 (t, J25, C2), 130.5 (C5), 142.6 (C3), 156.2 (CI). 
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6.2 Biological 
6.2.1 General details 
The manipulation of both micro-organisms, Streptomyces cattleya and Xylaria 
longiana, was carried out in a Galenkemp flow hood. Surfaces were washed with 70 
% ethanol, 30 % water (v/v), and all flask rims flame sterilised. Glassware, media and 
consumables were sterilised in a portable gas heated autoclave at 121°C and 1.46 xlO^ 
Pa for 20 minutes. Liquid volumes greater than 100 ml were sterilised for 50 minutes. 
Supplementation of extraneous materials to culture broths was performed through 
sterilised 0.2 ^m filters. 
6.2.2 Strevtomvces cattleva 
An authentic culture of Streptomyces cattleya NRRL 8057 was obtained from Professor 
D. Harper, The Queen's University of Belfast, microbial Biochemistry Section, Food 
Science Department, Belfast (originally from United States Department of Agriculture, 
Agricultural Research Service, Midwest Area Northern Regional Research Laboratories, 
Peoria, Illinois, USA). 
6.2.2.1 Agar 
Cultures were maintained on agar slants containing soybean flour (2% w/v), mannitol 
(2% w/v), agar (1.5% w/v) and deionised water. The slants were grown for 14 days at 
28 °C before the static cultures were sealed and stored at 4 °C. 
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6.2.2.2 Starter and batch cultures 
Starter and batch cultures of S. cattleya were grown on chemically defined media, which 
was prepared by combining previously mixed and sterilised stock solutions. 
Ion solution, sterilised by autoclaving 
NH4CI (6.75 g), NaCl (2.25 g), MgS04.7H20 (2.25 g), CaCOs (1.13 g), FeS04.7H20 
(0.11 g) C0CI2.6H2O (45 mg), ZnS04.7H20 (45 mg) and distiUed water (900 ml) 
Carbon source solution, sterilised by filtration (Nalgene filter sterilisation units) in 75 
ml portions into presterilised Schott bottles. 
Glycerol (45 g), monosodium glutamate (22.5 g), wyo-inositol (1.8 g), para-
aminobenzoic acid (450 p,l of freshly prepared 1 mg / 1 ml solution) and distilled water 
(450 ml). 
Phosphate buffer solution, sterilise by autoclaving. 
KH2PO4 (20 g /1), pH adjusted to 7.00 (± 0.02) with KOH (2 M) 
Fluoride solution, sterilised by autoclaving. 
NaT (0.5 M) 
The prepared and sterilised solutions (ion solution (150 ml), carbon source solution (75 
ml), phosphate buffer solution (75 ml), fluoride solution (3 ml)) were mixed with distilled 
water (450 ml) that had been sterilised in a 1 1 Erlenmeyer flask. An aliquot of the 
resultant solution (90 ml) was decanted into a 500 ml Erlenmeyer flask and subsequently 
inoculated with a loop of vegetative mycelium from an agar slant. The remainder of the 
medium was stored at 4 °C until required. The starter culture was incubated at 28 °C for 
four days, on an orbital shaker at 175 rpm. Portions of the remaining defined medium (90 
ml) were decanted into sterile 500 ml Erlenmeyer flasks and warmed to 28 °C. The flasks 
were inoculated from the starter culture (0.3 ml) and then incubated for 8 days at 28 ° C 
on an orbital shaker at 175 rpm. 
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6.2.2.3 Resting cell experiments with S, cattleva 
Resting cell experiments were performed under aseptic conditions. All the equipment and 
solutions were sterilised prior to use. All manipulations were carried out in a laminar 
flow hood. Cells were harvested by centrifiigation (25 minutes, 14,000 rpm, 25 °C) and 
the pellet washed three times by resuspension in 100 ml of 50 mM MES 
(morpholineethanesulphonic acid monohydrate) buffer at pH 6.50 (± 0.02) followed by 
centrifiigation and fiirther resuspension. Once fiilly washed, the bacterial pellet was 
resuspended in 50 mM MES buffer at a concentration of 0.18 g/ ml (wet weight). 45 ml 
of the resultant cell suspension was pipetted into a 500 ml Erlenmeyer flask. Sodium 
fluoride solution (3 ml, 40 mM) and fiirther MES buffer (48 ml) were added to the flask. 
The deuterated precursor (3 ml, 200 mM), sterilised by membrane filtration, was then 
added to the cell suspension and the cells then incubated at 28 '^ C for 48 h on an orbital 
shaker at 175 rpm. 
[2,2,3,3-^H4]-Succinate 
A solution of [2,2,3,3-^H4]-succinate (200 mM in sterile 50 mM MES buffer and 
adjusted to pH 6.50 ± 0.02 with 2M KOH) was filter sterilised and administered to 
resting cells of S. cattleya at a final concentration of 8.7mM. 
(15, 2J?)-[l-^H]-Glycerol 
A solution of (IS, 2/?)-[1-^H]-glycerol (200 mM in sterile 50 mM MES buffer) was filter 
sterilised and administered to resting cells of S. cattleya at a final concentration of 
8.7mM. 
(IR, 2i?)-[l-^H]-Glycerol 
A solution of (17?, 27?)-[1-^H]-glycerol (200 mM in sterUe 50 mM MES buffer) was filter 
sterilised and administered to resting cells of S. cattleya at a final concentration of 
8.7mM. 
6.2.2.4 Harvesting fluoroacetate 
After 48 h of incubation with the deuterated precursors, the fluoroacetate produced by 
the cells was harvested by centrifiiging the cells at 14,000 rpm at 25 °C for 25 minutes, 
decanting off the supernatant and freeze drying it. The pH or the freeze dried supernatant 
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was first adjusted to pH 3.00 ± 0.02 with 2 M H2SO4, and the material lyophilised to 
remove most of the sodium fluoride (pKa = 3.45). The residual material was then fiirther 
acidified to pH 2.5 and lyophilised once more to extract the fluoroacetate (pKa 2.59), the 
fraction containing the fluoroacetic acid was adjusted to pH 6.00 ± 0.02 using 0.02 M 
NaOH and the resultant solution freeze died once more. 
6.2.3 Xvlaria lonsiana 
An authentic cuhure of X. longiana was obtained from Raymond L. Edwards 
(University of Bradford) and initiated onto agar slants. Aqueous cultures were 
maintained in 200 ml of medium, prepared (as indicated below) from commercially 
available materials, in 400 ml Thompson bottles, stoppered with tightly wound cotton 
wool. Cultures were kept in a constantly illuminated incubator at 28°C, and harvested 
after 4 weeks growth. Inoculation was achieved by adding aqueous solution 
containing fimgal mycelia (1 ml) to the culture medium, under sterile conditions. 
6.2.3.1 Agar 
Warm distilled water (250 ml) was added to malt extract (7.5 g, Oxoid) and agar 
powder (3.75 g). The powder was fiilly dissolved, stirring and heating the mixture as 
required. The pH of the medium was not adjusted. The sterilised agar gel was allowed 
to cool to w 60°C before pouring into sample bottles and allowing it to set at an angle. 
Xylaria longiana was inoculated onto the cooled slant by first scraping the agar, to 
produce a rough surface, and then by adding 0.2 ml of starter culture medium from an 
existing culture of 8 weeks of age, or more. The Xylaria longiana was stored on the 
agar slants at 28°C until required to inoculate a starter culture. 
6.2.3.2 Culture medium 
Distilled water (200ml) was added to malt extract (6 g, Oxoid) and glucose (12 g) 
The pH of the medium was not adjusted. The medium was placed into a Thompson 
bottle and sterilised. Cultures were inoculated from an existing starter culture, that 
was at least 8 weeks old, by the addition of 1 ml of the culture medium. The cultures 
were incubated at a temperature between 23 and 28°C. 
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6.2.3.3 Feeding of labelled precursors to X, lonsiana 
[1,2-^^C2]-Acetate 
A 23 day old culture o f X . longiana was pulse fed [ 1,2-^ ^C2]-acetate, on 3 consecutive 
days, to a final concentration of 7 mM. The culture was incubated for a fiirther 27 days 
before harvesting. 
[2,4,6-^H3]/ii-Cresol (5.28 a) 
A culture of X. longiana was pulse fed [2,4,6-^H3]w-cresol at an age of 23 days and at 
29 days to a final concentration of 7 mM. The fiingus looked very unhealthy for a 
considerable period of time following the feeding of the m-cresol, and was thus 
incubated for a fiirther 88 days before work up. 
[3,5-^H2]- 6-Methylsalicylic acid (5.27 a) 
A culture of X. longiana (in 200 ml of culture medium) was pulse fed [3,5-'H2]- 6-
methylsalicylic acid dissolved in methanol (0.5 ml) at an age of 23 days and at 29 days to 
a final concentration of 7 mM. Again the fimgus appeared unhealthy and stopped 
growing for a considerable period of time, and was thus incubated for a fiirther 60 days 
before harvesting. 
[7,7-^H2]m-Hydroxybenzylalcohol (5.29 a) 
A 23 day old culture oiX. longiana was pulse fed [7,7-^H2]w-hydroxybenzylalcohol, on 
3 consecutive days, to a final concentration of 7 mM. The culture was incubated for a 
fiirther 27 days before harvesting. 
[2,4,6,7,7-^H5]w- Hydroxybenzylalcohol (5.29 b) 
A 23 day old culture of X. longiana was pulse fed [2,4,6,7,7-'H5]W-
hydroxybenzylalcohol, on 3 consecutive days, to a final concentration of 7 mM. The 
culture was incubated for a fiirther 27 days before harvesting. 
6.2.3.4 Extraction of longianone from X. lonsiana 
The fimgal mycelia were removed from the culture broth by reduced pressure 
filtration, and washed with ethyl acetate (2 x 25 ml). The filtrate was extracted into 
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ethyl acetate (3 x 300 ml), the ethyl acetate portions were combined, dried over 
magnesium sulphate and the solvent removed under reduced pressure, taking care that 
the temperature of the extract should never exceed 35°C. The sticky brown 
components from the fimgal broth, which coated the crude crystals of longianone, 
were removed by dissolving the entire extract into DCM (20 ml) loading the solution 
onto a dry column of silica gel and eluting with DCM (20 ml), and then with ethyl 
acetate (20 ml). The second fraction containing longianone (on average, 150 mg). The 
solvent was removed under reduced pressure and the longianone left to crystallise at 
room temperature. 
V max (KBr): 1790, 1709. m/z 6H(CDC13): 2.71 ( IH , d, J 18.3), 3.04 ( IH , d, J 18.3), 
4.40 (2H, s), 5.83 ( I H , d, J 2.6), 8.32 ( IH , d, J 2.6). 6c (CDCI3): 37.7, 74.0, 89.5, 
106.9, 172.4, 177.7, 199.2. 
6.3 The preparation of samples for analysis by chiral liquid crystal 
^H-NMR 
PBLG (120 mg, DP~800, MW 150,000-350,000) was weighed into an NMR tube 
(5mm in diameter). The deuterated sample was weighed into the NMR tube (for hexyl 
fluoroacetate 3 mg was used, for the fluoroalkanes 30 mg was used). Chloroform 
(803 mg, dried over molecular sieves) was finally added to the NMR tube. The tube 
was left for 2 h to allow the PBLG to dissolve. The contents of the tube were mixed 
thoroughly by drawing the material from one end of the NMR tube to the other, 40 
times, by application of a centrifugal force. Following centrifiigation the NMR tubes 
were weighed and sealed. The ^H-NMR of the samples were run immediately after 
mixing, before homogeneity could be lost. Experiments were performed at the Institut 
de Chimie Moleculaire d'Orsay, Universite de Paris Sud, France on a Bruker AC-250, 
and some repeated at the University of Durham on a Unity Inova 500 MHz. Gradient 
shimming was employed to increase the resolution of the spectra. 
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O 
Longianone, a metabolite of Xylaria longiana, is an isomer of 
the well known fungal toxin, patulin; it is demonstrated that 
longianone is biosynthesised from 6-methylsalicylic acid in a 
pathway closely related to that found in patulin bio-
synthesis. 
The isolation and structure of the metaboUte longianone 1 was 
recently reported from Xylaria longiana.^ Longianone 1 
posesses an intriguing spiro-bicyclic ring structure (1,7-dioxa-
0 
HO 
2 R = C5H„ 
3 R = C7Hi5 
4 n = 2 
5 n=4 
spiro[4,4]non-2-ene-4,8-dione). It is optically active, however 
the absolute configuration of the natural product is unknown at 
present. Structurally, longianone 1 represents a rare parent ring 
system. The only related bicyclic ring systems are the 
secosyrins 2 and 3 and their more elaborated co-metabolites, the 
syringolides 4 and 5, metabolites of the bacterium Pseudomo-
nas syringia pv. tomato?^ A biosynthesis has been proposed^ 
for the secoserins 4 and 5 which involves the combination of a 
polyketide chain with a pentose sugar moiety, however this is 
not based on experimental evidence. Another related ring 
system is found in the hyperlactones A-C 6 isolated from 
Hypericum chinensis.'^ However, in that case the ester function-
aUty occupies a different site in the ring system and the 
hyperlactones are clearly terpenoid in origin and have no 
biosynthetic relationship to longianone 1 or the secosyrins. It is 
noteworthy that longianone 1 has a structural formula (C7H6O4) 
which is isomeric with the fungal mycotoxin, patulin 7. Patulin 
7 has an intriguing biosynthetic origin derived from oxidative 
ring opening of the aromatic polyketide metaboUte, 6-methylsa-
UcyUc acid (6-MSA) S -^* and the pathway to patulin bio-
synthesis is illustrated in Scheme 1. The interesting structure of 
longianone 1 and its constitutional relationship to patulin 7 
stimulated us to initiate a biosynthetic investigation of 1 from X. 
longiana. 
An initial experiment involved feeding [l,2-'3C2]acetate to 
static cultures ofX. longiana.^ This resulted in a low (0.4%) but 
detectable incorporation of isotope into the resultant longianone 
1. ' 3 C NMR analysis revealed reciprocal couplings between C-
3/C-4 (/13C-13C = 55 Hz) and C-5/C-6 ( / i 3 c - i 3 c = 34 Hz) of 1, 
indicating the incorporation of two intact acetate units. This was 
the first indication of a polyketide origin, and the labelling 
pattern was consistent with the intermediacy of 6-MSA 8 and a 
similarity to patulin biosynthesis, as illustrated in Scheme 1. In 
order to reinforce this hypothesis an experiment witfi [S^S-^I^-
6-MSA 8a was conducted. A sample of ediyl 2-hydroxy-
6-methylbenzoate was synthesised following an estid>lished 
route,9 then deuterium was exchanged into the aromatic nucleus 
by lefluxing with DQ, D2O and MeOD for 24 h and the ester 
was hydrolysed to [3,5-2H2]-6-MSA 8a by refluxing with 
NaOH. The subsequoit feeding expoiment resulted in a saiiq>le 
of longianme which was enriched with deuterium (^H NMR 
analysis) at C-2 [Fig. \{b)]. There was a minor enrichment at C-
3 arising from some exchange into the aromatic precursor 8a at 
C-4 during isotope exchange [Fig. l(ft)]. m-Gresol 9 and m-
hydroxybenzyl alcohol 10 are establi^ied intmnediates in 
patulin biosynthesis'^  and in order to assess i f tficy have a role in 
longianone biosynthesis diey were each prepared enriched with 
deuterium, and fed in separate expoimoits Vo X. longiana 
cultures. An experiment with [2,4,6-2H3]-m-cresol 9a, prepared 
acetyl-CoA 
+ — 
3 X malonyl-CoA 
OH O 
OH OH , 
OH OH 
OH 10 OH 11 
OH OH 
Scheme 1 
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Fig. 1 (a) ' H NMR ( C D C I 3 ) spectrum and assignment of longianone 1; (b) 
m NMR ( C H C I 3 ) spectrum of 1 after feeding 8a; (c) 2H NMR (CHCI3) 
spectrum of 1 after feeding 9a; (d) NMR (CHCI3) spectrum of 1 after 
feeding 10a; (e) m NMR ( C H C I 3 ) spectrum of 1 after feeding 10b. 
by reaction with PBrs and D20,^^ resulted in deuterium 
incorporation into 1 at C-2 and C-9 as determined by NMR 
[Fig. 1(c)]. The methylene hydrogens at C-9 are diastereotopic 
and well resolved by NMR, and the resulting NMR spectrum 
after feeding 9a indicated a stereospecific enrichment into C-9, 
however upon storage (3 months) a slow racemisation was 
witnessed. Incorporation of 3-hydroxy[a,a-2H2]benzyl alcohol 
10a, prepared by reducing methyl 3-hydroxybenzoate with 
L i A l D 4 , resulted in labelling at C-6 in 1 [Fig. 1(d)]. It was not 
clear from this latter experiment whether both deuterium atoms 
were processed through to the C-6 methylene group of 
longianone 1 as these deuterium atoms, which are formally 
diastereotopic, have nonetheless similar chemical shifts in the 
resultant and NMR spectra. In order to gain information 
on this issue a second experiment was carried out using 10b, 
which was prepared with deuterium atoms located both at the 
hydroxymethyl group and at C-2, C-4 and C-6 of the aromatic 
ring. The resultant NMR spectrum [Fig. 1(e)] of longianone 
1 showed three clear enrichments at C-2, C-6 and C-9, with 
similar intensities. We have drawn the conclusion therefore that 
only one deuterium atom from the methylene group of 
3-hydroxybenzyl alcohol 10b became incorporated into the C-6 
methylene group of longianone and therefore the hydrox-
ymethyl group is oxidised up to the aldehyde level during the 
biosynthesis. 
The isotopic labelling experiments reveal a common bio-
synthetic pathway to both longianone 1 and patulin 2 which 
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diverges at a late stage. Both metabolites are derived from 
6-MSA 8 and have 9 and 10 as common biosynthetic 
intermediates. Also oxidation of the hydroxymethyl group to 
the aldehyde level is revealed as common to both cases and the 
aromatic ring is cleaved across the same bond. The conversion 
of gentisaldehyde 12 to phyllostine 13 is a biochemically 
characterised stepi^ in patulin biosynthesis and the inter-
mediacy of neopatulin (also termed isopatulin) has been 
established from mutant studies,^  so reasonably the pathway 
progresses through I412 with hydrolysis to 15. Different E/Z 
isomers of 15 emerge as the likely branchpoint of the two 
pathways, with straightforward ester and intramolecular 
Michael-type cyclisations to generate both rings of longianone. 
An alternative cyclisation of 15 (ester and hemiacetal forma-
tions) generates neopatulin 16 which is a precursor to patulin 7 
requiring an oxidation and a reduction. Perhaps longianone 1 is 
a shunt metabolite of an organism which has lost the capacity to 
complete patulin 7 biosynthesis. 
In view of the above experimental evidence an alternative 
hypothesis to that recently proposed .^s emerges for the 
biosynthesis of the secosyrins 2 and 3 and the syringolides 4 and 
5. This would involve an origin from a longianone skeleton 
derived from 6-MSA, followed by acylation a to the lactone to 
generate intermediate 17, as illustrated in Scheme 2. Elabora-
tions such as reduction and hydration would generate 4 and 5 
and a retro-aldol reaction would generate 2 and 3. It remains to 
be determined whether this or the previous proposaP is the more 
valid for the biosynthesis of those metabolites. 
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